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SYNOPSIS 
Protein plays a crucial role in nearly all life processes-in catalysis, transport, 
coordinated motion, and the control of growth and differentiation. These remarkable 
ranges of functions arise from the folding of protein into many unique three-dimensional 
structures. A specific amino acid sequence determines folding, functions and degradation. 
Correspondingly evolution has to compromise between rigidity (stability) and flexibility 
(function). An important challenge arises here; how it is possible for the one dimensional 
sequence to code not only the final native structure but, in addition, for a set of three 
dimentional non-native intermediate conformation and their connection into a temporal 
folding sequence? This protein-folding problem challenged the imagination of 
generations of biologists as well as scientists for the related areas. 
The mechanism by which protein fold from a structure less denatured state to 
their unique biologically active state is an intricate process. However, recent advances in 
biophysical techniques both thermodynamic and kinetic have showed the presence of 
stable intermediate conformational states in a number of proteins, which helped in the 
understanding of protein folding phenomenon. The folding process is even more complex 
in multidomain and multimeric proteins where each domain/ subunit may be capable to 
refold independently and interdomain interactions may affect the overall folding process. 
Hence, there has been a growing recognition of the importance of residual structural 
preferences in protein folding reactions, as the factors involved in their stability would 
provide important insight into the interactions responsible for their formation as well as 
their role in protein folding. 
3'^ '' chapter 
Stem bromelain [EC. 3.4.22.32] fi:om Ananas cosmosus belongs to the a+P class of 
cystein proteinases. It is a monomeric protein of 23 kDa, which shows strong sequence 
similarity to other cystein proteinases of papain family. Our laboratory uses stem 
bromelain as a model protein to understand the unfolding/refolding processes of cystein 
proteinases, which contains a a-helical domain and a p-sheet domain. 
Initially, in order to avoid complication due to autocatalysis, our laboratory studied 
unfolding/refolding studies on catalytically inactive enzyme. The inactive enzyme was 
made by blocking active site cystein (Cys-26) by carboxymethylation. During acid 
induced unfolding of modified stem bromelain, a partially folded intermediate state was 
detected at pH 2.0 which was found to transform into molten globule state either on 
lowering the pH below to 0.8 or addition of salts or alcohols. Since inactive enzyme 
cannot be native even if observed physical parameters are very similar to the active 
enzyme. Therefore, in this study, the conformation of native SB was examined over the 
pH 0.8-3.0 regions by circular dichroism, tryptophanyl fluorescence, l-anilino-8-
naphthalenesulfonate (ANS) binding, and tryptophanyl fluorescence quenching study. 
The pH 0.8-3.0 regions were selected to study the acid induced unfolding of SB because 
no autolysis of the enzyme was observed in these pH regions. The results show that SB at 
pH 2.0 is maximally unfolded and characterizes by significant loss of secondary structure 
(-80%) and almost complete loss of tertiary contacts. However, on further decreasing the 
pH to 0.8 a MG state was observed, with secondary structure content similar to that of 
native protein but no tertiary structure. We also made a comparative study of these acid 
induced states of SB with acid induced states of modified stem bromelain (mSB), 
reported by our laboratory earlier. We have shown that modification of SB for 
inactivation significantly affects the N-UA transition but neither affects the UA-MG 
transition nor the stability of the MG state. 
The effect of increasing concentration of low, medium and high molecular weight 
poly(ethylene glycol)s (e.g. PEG-400, 6,000 and 20,000) on the structure of acid 
unfolded state of unmodified stem bromelain obtained at pH 2.0 has also been studied. 
Addition of PEG-400 to UA led to an increase in the mean residue ellipticity (MRE) value 
at 222nm indicating formation of alpha helical structure. On the other hand, PEG-6,000 
and 20,000 led to a decrease in the MRE value at 222nm indicating unfolding of residual 
helical structure of acid unfolded (UA) state of stem bromelain. Interestingly, at 70 % 
(w/v) PEG-400 and 40 % (w/v) PEG-20,000 MRE values at 222mn almost approach the 
native state (pH 7.0) and unfolded state (6 M GnHCl) of stem bromelain respectively. 
PEG-6,000 was found to stabilize/induce mainly P sheet structure from the UA state. The 
probes for tertiary structure (near-UV CD, and tryptophanyl fluorescence) showed 
formation of non native tertiary contacts in the presence of 70 % (w/v) PEG-400 while 40 
% (w/v) PEG-6,000 and 20,000 were found to stabilize unfolded state of SB. An increase 
II 
in binding of hydrophobic dye, l-aniHno-8-naphthlene sulfonic acid (ANS) and decrease 
in fractional accessibility of tryptophan residues (fa) to acrylamide quenching compared 
to UA in the presence of 70 % PEG 400 were noted. These results are indicating that 
PEG-400 induced state has significant amount of exposed hydrophobic patches and is 
more compact than UA. The results imply that PEG-400 induced state has characteristics 
of molten globule (MG) and higher molecular weight PEGs led to the unfolding of acid 
unfolded state. 
4"" Chapter 
The urea induced unfolding of 'N' isomer (occurring at pH 7.0) and 'B' isomer 
(occurring at pH 9.0) of human serum albumin was studied by fluorescence and circular 
dichroism spectroscopic measurements. Urea induced destabilization in different domains 
of both the isomers was monitored by using domain specific ligands, hemin (domain-I), 
chloroform, (domain-II) bilirubin (at domain I /domain II interface) and diazepam 
(domain-Ill). Urea induced denaturation of N and B isomers of HSA showed a two-step, 
three-state transition with accumulation of intermediates around 4.8-5.2 M and 3.0-3.4 
M urea concentrations respectively. During first transition (0-4.8 M urea for N isomer 
and 0-3.0 M urea for B isomer) a continuous decrease in diazepam binding suggested 
major conformational changes in domain-Ill prior to intermediate formation. On the other 
hand, binding of hemin, a ligand for domain-IB and chloroform, whose binding site is 
located in domain IIA remains unchanged up to 5.0 M urea for N isomer and 3.0 M urea 
for B isomer. Similarly fluorescence intensity of Trp-214 that resides in domain-IIA 
remained unchanged upto the above-said urea concentrations and decreased thereafter. 
Absence of any decrease in hemin binding, chloroform binding and Trp-214 fluorescence 
suggested the noninvolvement of domain-IB and domain-IIA in intermediates formation. 
A significant increase in bilirubin binding prior to intermediate formation showed 
favorable conformational rearrangement in bilirubin binding cavity formed by loop 4 of 
domain-IB and loop 3 of domain-IIA. Further, a nearly complete abolishment of bilirubin 
binding to both isomers around 7.0 M and 6.0 M urea concentrations respectively 
indicated complete separation of domain I and II from each other. From these 
observations it can be concluded that N to B transition of human serum albumin shifted 
the intermediate formation towards lower urea concentration (3.0-3.4 M urea for B 
III 
isomer as against 4,8-5.2 M urea for N isomer). Further both the intermediates were 
found to possess similar a helical (-39%) content and ligand binding properties. 
The human serum albumin is known to undergo N D F (neutral to fast moving) 
isomerization between pH 7 to 3.5. The NDF isomerization involves unfolding and 
separation of domain III from rest of the molecule. Urea induced unfolding transition of F 
isomer of HSA does not show the intermediate state observed during unfolding of N 
isomer. Therefore, it provides direct evidence that the formation of intermediate in the 
unfolding transition of HSA involves unfolding of domain III. Although urea induced 
unfolding of F isomer of HSA appears to be an one step process, but no coincidence 
between the equilibrium transitions monitored by tryptophanyl fluorescence, tyrosyl 
fluorescence, far-UV CD and near-UV CD spectroscopic techniques provides decisive 
evidence that unfolding of F isomer of HSA is not a two state process. An intermediate 
state that retained significant amount of secondary structure but no tertiary structure has 
been identified (around 4.4 M urea) in the unfolding pathway of F isomer. The emission 
of Trp-214 (located in domain II) and its mode of quenching by acrylamide and binding 
of chloroform indicate that unfolding of F isomer start from domain II (from 0.4 M urea). 
But at higher urea concentration (above 1.6 M) both the domain unfold simultaneously 
and the protein acquire a random coil structure around 8.0 M urea. Further much higher 
Ksv of NATA (17.2) than completely denatured F isomer (5.45) of HSA (8.0M urea) 
suggests the existence of residual tertiary contacts within local regions in random coil 
conformation (probably around lone Trp-214). 
The effect of guanidine hydrochloride (GnHCl) on the global stability of human 
serum albumin (HSA) has been studied by fluorescence and circular dichroism 
spectroscopic measurements. The differential stability of native conformation of three 
HSA domains was explored by using domain specific ligands, hemin (domain I), 
chloroform (domain II), bilirubin (at domain I /domain II interface) and diazepam 
(domain III). GnHCl induced unfolding transition curves as monitored by probes for 
secondary and tertiary structures were cooperative but noncoincidental. A strong ANS 
binding to the protein was observed around 1.8 M GnHCl, suggesting existence of 
intermediate states in the unfolding pathway of HSA. A gradual decrease (in the GnHCl 
IV 
concentration range 0.0-1.8M) in the binding of diazepam indicates that domain III is the 
most labile to GnHCl denaturation. A significant increase in the binding of bilirubin upto 
1.4M GnHCl and decreased thereafter leading to complete abolishment of bilirubin 
binding at around 2.0 M GnHCl suggest favorable rearrangement and separation of 
domain I and II at 1.4 and 2.0 M GnHCl concentration respectively. Above 1.6 M 
GnHCl, decrease of the binding of hemin, a ligand for domain I, chloroform, which binds 
in domain II and lone tryptophanyl fluorescence (Trp-214 located in domain II) indicate 
that at higher concentration of GnHCl domain I and II start unfolding simultaneously but 
the stability of domain I (7.4 Kcal/mol) is much more than domain II (4.3Kcal/mol). A 
pictorial model for the unfolding of HSA domains, consistent with all these results, has 
been formulated, suggesting that domain III is the most labile followed by domain II 
while domain I is the most stable. A molten globule like state of domain III around 1.8 M 
GnHCl has also been identified and characterized. 
5*" Chapter 
The enzyme glucose oxidase (EC 1.1.3.4) from Aspergillus niger exists in acid unfolded 
and molten globule states at pH 2.6 and 1.4 respectively. We studied the effect of 
triflurooethanol (TFE) on the native (pH 7.0), acid unfolded (pH 2.6) and molten globule 
(pH 1.4) states of glucose oxidase (Gox) by far-UV circular dichroism, near-UV CD, 
tryptophanyl fluorescence, FAD fluorescence, and l-anilino-8-naphthlene sulfonic acid 
(ANS) binding. On addition of trifluoroethanol, Gox at pH 7 and 2.6 exhibited a 
transition from native coiled-coil state and acid unfolded state to non-associating a-
helical state at 50 % TFE (v/v). ANS binding and tertiary structure probes suggested that 
50% TFE induced state of native Gox has significantamount of exposed hydrophobic 
surfaces and possesses -80 % native tertiary contacts. While acid unfolded state lost its 
exposed surfaces and tertiary contacts. Interestingly, at pH 1.4, TFE induced the 
formation of (3-structured intermediate and loss of ANS binding site and almost all 
tertiary contacts at 15% TFE (v/v). |3-structured intermediate was found to convert in to 
open helical conformation on further addition of TFE. Our study indicates that TFE 
induced conformational transition of Gox is pH and conformation dependent. 
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PREFACE 
Understanding how linear chain of amino acid navigates its way to a unique, 
biologically active conformation has intrigued scientist from decades. A solution to the 
protein-folding problem will provide missing link between a gene sequence to 3-
dimentional structure of a protein. It is expected to have its major impact on our 
understanding of the molecular basis of several genetic diseases and new medicines. It 
will also provide opportunities for the design of proteins of desired ftmction. 
The unfolding of proteins by chemical denaturants, extremes of pH and alcohols 
(trifluoroethanol) under in vitro conditions has received greater attention as various 
partially folded intermediates have been found to accumulate during equilibrium 
unfolding of a number of proteins. There has been a considerable interest in 
characterizing these partially folded states for gaining an insight into the possible 
determinants of the protein folds and the mechanism of protein folding, because these 
intermediate states of molten globule type are generally believed to be meaningful 
counterparts of early folding intermediates. Characterization of partially folded 
intermediates is relatively complex in multidomain proteins where each domain is 
capable to unfold / refold independently and the association of different domains in the 
whole protein through various short range and long range interactions may affect the 
overall folding topology of the protein. 
We have carried out experiments to study the structural properties of multidomain 
and multimeric proteins under acidic pH condition and in the presence of pH, urea, 
guanidine hydrochloride and trifluoroethanol and identified and characterized unfolding / 
refolding intermediate states. 
The work has been compiled into five chapters. The first chapter deals with the basic 
concept, history and applications of protein folding. Experimental procedures and 
materials used in the study have been described in the second chapter. Third chapter 
contains the effect of acidic pH and poly (ethylene glycol) s induced unfolding/refolding 
of stem bromelain. Fourth chapter contains studies on urea and guanidine hydrochloride 
induced unfolding of human serum albumin domain by using domain specific ligand and 
HSA isomers. In the fifth chapter, the effect of trifluoroethanol on the conformation of 
native, acid unfolded and molten globule states of glucose oxidase has been presented. 
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ABSTRACT 
Protein plays a crucial role in nearly all life processes-in catalysis, transport, 
coordinated motion, and the control of growth and differentiation. These remarkable 
ranges of fimctions arise from the folding of protein into many unique three-dimensional 
structures, A specific amino acid sequence determines folding, functions and degradation. 
Correspondingly evolution has to compromise between rigidity (stability) and flexibility 
(function). An important challenge arises here; how it is possible for the one dimensional 
sequence to code not only the final native structure but, in addition, for a set of three 
dimentional non-native intermediate conformation and their connection into a temporal 
folding sequence? This protein-folding problem challenged the imagination of 
generations of biologists as well as scientists for the related areas. 
The mechanism by which protein fold from a structure less denatured state to 
their unique biologically active state is an intricate process. However, recent advances in 
biophysical techniques both thermodynamic and kinetic have showed the presence of 
stable intermediate conformational states in a number of proteins, which helped in the 
understanding of protein folding phenomenon. The folding process is even more complex 
in multidomain and multimeric proteins where each domain/ subunit may be capable to 
refold independently and interdomain interactions may affect the overall folding process. 
Hence, there has been a growing recognition of the importance of residual structural 
preferences in protein folding reactions, as the factors involved in their stability would 
provide important insight into the interactions responsible for their formation as well as 
their role in protein folding. 
S"^** chapter 
Stem bromelain [EC. 3.4.22.32] from Ananas cosmosus belongs to the a+P class of 
cystein proteinases. It is a monomeric protein of 23 kDa, which shows strong sequence 
similarity to other cystein proteinases of papain family. Our laboratory uses stem 
bromelain as a model protein to understand the unfolding/refolding processes of cystein 
proteinases, which contains a a-helical domain and a P-sheet domain. 
Initially, in order to avoid complication due to autocatalysis, our laboratory studied 
unfolding/refolding studies on catalytically inactive enzyme. The inactive enzyme was 
made by blocking active site cystein (Cys-26) by carboxymethylation. During acid 
induced unfolding of modified stem bromelain, a partially folded intermediate state was 
detected at pH 2.0 which was found to transform into molten globule state either on 
lowering the pH below to 0.8 or addition of salts or alcohols. Since inactive enzyme 
cannot be native even if observed physical parameters are very similar to the active 
enzyme. Therefore, in this study, the conformation of native SB was examined over the 
pH 0.8-3.0 regions by circular dichroism, tryptophanyl fluorescence, l-anilino-8-
naphthalenesulfonate (ANS) binding, and tryptophanyl fluorescence quenching study. 
The pH 0.8-3.0 regions were selected to study the acid induced unfolding of SB because 
no autolysis of the enzyme was observed in these pH regions. The results show that SB at 
pH 2.0 is maximally unfolded and characterizes by significant loss of secondary structure 
(-80%) and almost complete loss of tertiary contacts. However, on further decreasing the 
pH to 0.8 a MG state was observed, with secondary structure content similar to that of 
native protein but no tertiary structure. We also made a comparative study of these acid 
induced states of SB with acid induced states of modified stem bromelain (mSB), 
reported by our laboratory earlier. We have shown that modification of SB for 
inactivation significantly affects the N-UA transition but neither affects the UA-MG 
transition nor the stability of the MG state. 
The effect of increasing concentration of low, medium and high molecular weight 
poly(ethylene glycol)s (e.g. PEG-400, 6,000 and 20,000) on the structure of acid 
unfolded state of unmodified stem bromelain obtained at pH 2.0 has also been studied. 
Addition of PEG-400 to UA led to an increase in the mean residue ellipticity (MRE) value 
at 222nm indicating formation of alpha helical structure. On the other hand, PEG-6,000 
and 20,000 led to a decrease in the MRE value at 222nm indicating unfolding of residual 
helical structure of acid unfolded (UA) state of stem bromelain. Interestingly, at 70 % 
(w/v) PEG-400 and 40 % (w/v) PEG-20,000 MRE values at 222nm almost approach the 
native state (pH 7.0) and unfolded state (6 M GnHCI) of stem bromelain respectively. 
PEG-6,000 was found to stabilize/induce mainly p sheet structure from the UA state. The 
probes for tertiary structure (near-UV CD, and tryptophanyl fluorescence) showed 
formation of non native tertiary contacts in the presence of 70 % (w/v) PEG-400 while 40 
% (w/v) PEG-6,000 and 20,000 were found to stabilize unfolded state of SB. An increase 
il 
in binding of hydrophobic dye, l-anilino-8-n^hthlene sulfonic acid (ANS) and decrease 
in fractional accessibility of tryptophan residues (fa) to actyiamide quenching compared 
to UA in the presence of 70 % PEG 400 were noted. These results are indicating that 
PEG-400 induced state has significant amount of exposed hydrophobic patches and is 
more compact than UA. The results imply that PEG-400 induced state has characteristics 
of molten globule (MG) and higher molecular weight PEGs led to the unfolding of acid 
unfolded state. 
4*'' Chapter 
The urea induced unfolding of 'N' isomer (occurring at pH 7.0) and 'B' isomer 
(occurring at pH 9.0) of human serum albumin was studied by fluorescence and circular 
dichroism spectroscopic measurements. Urea induced destabilization in different domains 
of both the isomers was monitored by using domain specific ligands, hemin (domain-I), 
chloroform, (domain-II) bilirubin (at domain I /domain II interface) and diazepam 
(domain-Ill). Urea induced denaturation of N and B isomers of HSA showed a two-step, 
three-state transition with accumulation of intermediates around 4.8-5.2 M and 3.0-3.4 
M urea concentrations respectively. During first transition (0-4.8 M urea for N isomer 
and 0-3.0 M urea for B isomer) a continuous decrease in diazepam binding suggested 
major conformational changes in domain-Ill prior to intermediate formation. On the other 
hand, binding of hemin, a ligand for domain-IB and chloroform, whose binding site is 
located in domain IIA remains unchanged up to 5.0 M urea for N isomer and 3.0 M urea 
for B isomer. Similarly fluorescence intensity of Trp-214 that resides in domain-IIA 
remained unchanged upto the above-said urea concentrations and decreased thereafter. 
Absence of any decrease in hemin binding, chloroform binding and Trp-214 fluorescence 
suggested the noninvolvement of domain-IB and domain-IIA in intermediates formation. 
A significant increase in bilirubin binding prior to intermediate formation showed 
favorable conformational rearrangement in bilirubin binding cavity formed by loop 4 of 
domain-IB and loop 3 of domain-IIA. Further, a nearly complete abolishment of bilirubin 
binding to both isomers around 7.0 M and 6.0 M urea concentrations respectively 
indicated complete separation of domain I and II from each other. From these 
observations it can be concluded that N to B transition of human serum albumin shifted 
the intermediate formation towards lower urea concentration (3.0-3.4 M urea for B 
III 
isomer as against 4.8-5.2 M urea for N isomer). Further both the intermediates were 
found to possess similar a helical (-39%) content and ligand binding properties. 
The human serum albumin is known to undergo N ^ F (neutral to fast moving) 
isomerization between pH 7 to 3.5. The N—F isomerization involves unfolding and 
separation of domain III from rest of the molecule. Urea induced unfolding transition of F 
isomer of HSA does not show the intermediate state observed during unfolding of N 
isomer. Therefore, it provides direct evidence that the formation of intermediate in the 
unfolding transition of HSA involves unfolding of domain 111. Although urea induced 
unfolding of F isomer of HSA appears to be an one step process, but no coincidence 
between the equilibrium transitions monitored by tryptophanyl fluorescence, tyrosyl 
fluorescence, far-UV CD and near-UV CD spectroscopic techniques provides decisive 
evidence that unfolding of F isomer of HSA is not a two state process. An intermediate 
state that retained significant amount of secondary structure but no tertiary structure has 
been identified (around 4.4 M urea) in the unfolding pathway of F isomer. The emission 
of Trp-214 (located in domain II) and its mode of quenching by acrylamide and binding 
of chloroform indicate that unfolding of F isomer start from domain II (from 0.4 M urea). 
But at higher urea concentration (above 1.6 M) both the domain unfold simultaneously 
and the protein acquire a random coil structure around 8.0 M urea. Further much higher 
Ksv of NATA (17.2) than completely denatured F isomer (5.45) of HSA (8.0M urea) 
suggests the existence of residual tertiary contacts within local regions in random coil 
conformation (probably around lone Trp-214). 
The effect of guanidine hydrochloride (GnHCl) on the global stability of human 
serum albumin (HSA) has been studied by fluorescence and circular dichroism 
spectroscopic measurements. The differential stability of native conformation of three 
HSA domains was explored by using domain specific ligands, hemin (domain I), 
chloroform (domain II), bilirubin (at domain I /domain II interface) and diazepam 
(domain III). GnHCl induced unfolding transition curves as monitored by probes for 
secondary and tertiary structures were cooperative but noncoincidental. A strong ANS 
binding to the protein was observed around 1.8 M GnHCl, suggesting existence of 
IV 
intermediate states in the unfolding pathway of HSA. A gradual decrease (in the GnHCl 
concentration range 0.0-1.8M) in the binding of diazepam indicates that domain III is the 
most labile to GnHCl denaturation. A significant increase in the binding of bilirubin upto 
1.4M GnHCl and decreased thereafter leading to complete abolishment of bilirubin 
binding at around 2.0 M GnHCl suggest favorable rearrangement and separation of 
domain I and II at 1.4 and 2.0 M GnHCl concentration respectively. Above 1.6 M 
GnHCl, decrease of the binding of hemin, a ligand for domain I, chloroform, which binds 
in domain II and lone tryptophanyl fluorescence (Trp-214 located in domain II) indicate 
that at higher concentration of GnHCl domain I and II start unfolding simultaneously but 
the stability of domain I (7.4 Kcal/mol) is much more than domain II (4.3Kcal/mol). A 
pictorial model for the unfolding of HSA domains, consistent with all these results, has 
been formulated, suggesting that domain III is the most labile followed by domain 11 
while domain I is the most stable. A molten globule like state of domain III around 1.8 M 
GnHCl has also been identified and characterized. 
5'" Chapter 
The enzyme glucose oxidase (EC 1.1.3.4) firom Aspergillus niger exists in acid unfolded 
and molten globule states at pH 2.6 and 1.4 respectively. We studied the effect of 
triflurooethanol (TFE) on the native (pH 7.0), acid unfolded (pH 2.6) and molten globule 
(pH 1.4) states of glucose oxidase (Gox) by far-UV circular dichroism, near-UV CD, 
tryptophanyl fluorescence, FAD fluorescence, and l-anilino-8-naphthlene sulfonic acid 
(ANS) binding. On addition of trifluoroethanol, Gox at pH 7 and 2.6 exhibited a 
transition fi-om native coiled-coil state and acid unfolded state to non-associating a-
helical state at 50 % TFE (v/v). ANS binding and tertiary structure probes suggested that 
50% TFE induced state of native Gox has significantamount of exposed hydrophobic 
surfaces and possesses ~80 % native tertiary contacts. While acid unfolded state lost its 
exposed surfaces and tertiary contacts. Interestingly, at pH 1.4, TFE induced the 
formation of P-structured intermediate and loss of ANS binding site and almost all 
tertiary contacts at 15% TFE (v/v). p-structured intermediate was found to convert in to 
open helical conformation on fiirther addition of TFE. Our study indicates that TFE 
induced conformational transition of Gox is pH and conformation dependent 
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INTRODUCTION AND REVIEW OF LITERATURE 
T 
1.1. Introduction 
The name protein is derived from the Greei< Proteios, which means first. The name is 
well chosen. We all learned that proteins are vital components of all structures, processes and 
reactions, which describe life. Muscle fibers that make our own body, major part of the plants 
and animals we eat, the enzymes that catalyze various biochemical reactions, the hemoglobin 
that carries oxygen to our tissues, the insulin that signals our bodies to store excess sugar, the 
antibodies that fight infection, the actin and myosin that allow our muscles to contract, and 
the collagen that makes up our tendons and ligaments-all are proteins. In fact, proteins are 
necessary to regulate the functions of DNA that is thought to contain all the informations of 
life. Chemically, Proteins are heteropolymers built out of 20 different amino acid monomers. 
To make proteins, 'machines' known as ribosomes string together amino acids in order by 
which they are guided by genetic information, into long, linear chains. For the proteins to 
perform their assigned job properiy, they must adopt a unique three-dimensional 
conformation from their unfolded sequence of amino acids. The process by which a protein 
assembles itself into its correct native structure by arranging its chains of amino acids into 
structural motifs and orientating them relative to one another is referred to as protein folding. 
Thus the central dogma of the molecular biology (Figure I.I) is all about prx)tein biogenesis. 
How this occurs has come to be known as the 'protein-folding problem'. The problem 
involves following related questions. How does the amino acid code for the fold, given that 
the backbone of all proteins has the same composition, in other words, how do the side 
chains dictate the overall fold? How does a given sequence find its specific native structure 
in a finite time among the astronomical number of possible conformations that a polypeptide 
could adopt? How is the folding process initiated and what is (are) the pathway (s) of 
folding? What is the physical basis of the stability of native conformations? Are the main 
rules of protein folding deduced fi-om in vitro studies valid for folding in vivo'? 
The protein folding is a topic of tremendous intellectual interest because, it complete the 
genetic information transfer from DNA (RNA in some viruses) to 3D native protein. Thus it 
represents the last part of genetic message transfer. Furthermore, understanding of folding is 
important for the analysis of many events involved in cellular regulation, the design of 
protein with novel fimction, the utilization of sequence information fix)m various genome 
projects, and the development of novel therapeutic strategies for treating or preventing 
diseases that are associated with the failure of proteins to fold correctly [1]. 
Gene to protein 
DNA 
iiiRNA 
Protein 
sequence 
3D Native 
Proteui 
Gene 
i How? 
Figure 1.1, Flow of genetic information from gene to biologically active protein. 
1.2. Historical Perspective 
1.2.1. Anfinsen's original work 
The work began with classic experiment of Anfmsen in 1961. The classic 
experiments of Anfinsen showed that ribonuclease A fold spontaneously and reversibly into 
their native conformation by forming correct disulfide bonds. In addition, he found that some 
incorrect disulfide bonds are formed initially but are reduced and rearranged in the presence 
of suitable reducing agent. Moreover, he found that an enzyme protein disulfide isomerase 
(PDI) achieve this rearrangement in vivo [2]. These works of Anfinsen illuminated the point 
that process of RNA translation produces an unfolded polypeptide chain and chain must fold 
before it becomes a biologically active protein. In this way, science of molecular biology and 
the field of protein chemistry were connected and draw the attention of scientists in both the 
fields on solving the mechanism of protein folding. 
1.2.2. Levinthal's Paradox: Search for folding pathway 
A protein sequence must satisfy two requirements to fold into native state within a time 
frame: one thermodynamic and other kinetic. The thermodynamic requirement is that 
molecules acquire a unique folded structure with biological activity, which is stable under 
physiological conditions. The kinetic requirement is that unfolded polypeptide chain can fold 
into native conformation within a reasonable time. A polypeptide chain can adopt so many 
conformations that there must be a way to reach the native state in a time many orders of 
magnitude shorter than that required for a random search. In 1968, Levinthal formulated a 
simple argument that points out the non-random characteristic of protein folding kinetics [3]. 
His formulation can be understood as follows. If a protein is made up of a polypeptide chain 
of 100 amino acids residues and we assume there are only two possible configurations for 
each residue, there are of about 100 °^ possible conformations. If only 10'" s is required to 
convert one configuration into another, a random search of all conformations would require 
lO" years. Most of the proteins fold in the time scale of millisecond to second. Thus, there is 
a specific pathway due to which proteins avoid most conformations en route to their native 
state. It became a crucial aim to understand how a protein finds the right pathway and avoids 
the others. In addition, it was suggested that partially folded state of proteins accumulates in 
the folding pathway. If they could be detected and studied, these states might provide 
important clues in understanding the mechanism of protein folding. 
1.3. Protein Folding Pathway 
1.3.1. Folding models 
The emergence of specific folding pathway concept and the appreciations of the existence 
of metastable partially folded states of proteins led to the origin of many protein-folding 
models (table 1.1). These mechanisms simplified the search for folded state by uncoupling 
the formation of secondary structure from tertiary structure, thus removing the stringent 
requirement of simultaneous formation of secondary and tertiary structure. 
Table 1.1. Protein Folding Models 
Protein folding models 
Framework model 
Diffusion collision model 
Nucleation model 
Hydrophobic-col lapse model 
Jigsaw-puzzle model 
Postulates of the model 
Local secondary structure elements form independent of tertiary 
structure 
These secondary structures diffuse, collided, adhered and 
coalesced to give tertiary structure. 
Neighboring residues of sequence form native secondary 
structure that act as a nucleus from which native structure form 
step wise 
Protein collapses rapidly around hydrophobic side chains then 
rearranges from restricted conformational space occupied by 
intermediate state 
Each molecule of the protein folds by a different path 
The first model proposed to explain the cooperativity of protein folding transitions was 
helix-coil theory [4]. This represented cooperativity between neighbors in a polypeptide 
chain and stated that a residue has a higher propensity to be in a helical conformation if its 
neighbors in the sequence is also in a helical conformation. Thus, a helix can propagate 
quickly and co-operatively once a few adjacent amino acids adopt a helical conformation in a 
chance nucleation event. Although obviously limited, this theory provides a basis for much 
work into models for die entire protein folding process. Subsequently, many models have 
been proposed to explain the protein-folding problem (table 1.1). The framework model 
proposed that local secondary structure elements could form independently of tertiary 
structure [5-8]. These elements would diffuse until they collided, successfully adhered, and 
coalesced to give the tertiary structure (diffusion-collision niodel)[9]. The nucleation model 
postulated that some neighboring residues of sequence would form native secondary 
structure that would act as a nucleus from which the native structure would propagate, in a 
stepwise manner [10]. The hydrophobic-collapse model hypothesized that a protein would 
collapse rapidly around its hydrophobic side chains and then rearrange from the restricted 
conformational space occupied by the intermediate state [11, 12]. The jigsaw-puzzle model, 
on the contrary believed that each molecule of the protein fold by a different path [12]. The 
hydrophobic collapse mechanism and the framework model imply the existence of protein 
folding intermediates, whereas nucleation model does not. Because of the subsequent finding 
of so many apparent folding intermediates, it was assumed that the presence of intermediates 
on pathways is an essential requirement for folding, and so nucleation mechanism dropped 
out of favor. Modifications of the nucleation model whereby a difiiise folding nucleus is 
formed and consolidated through the transition state, concomitant with tertiary structure 
formation leads to the "nucleation-condensation model" proposed by Fersht [13-15]. The 
nucleation-condensation model has been supported by experimental evidence from several 
small proteins including chymotrypsin inhibitor-II [16] and lysozyme [17]. 
Folding Funnel theory 
A more general description of protein folding pathway has emerged more recently termed 
"folding funnel" theory. The folding funnel (figure 1.2 A and B) is a conceptual mechanism 
for understanding the self-organization of a protein and how it avoids the Levinthal paradox 
[18]. The Levinthal paradox is that there is no driving force to push the protein in the 
direction of folding. In the funnel the downhill bias of energy drives the protein to the proper 
folded state. 
At the top of the fijnnel, there is a fight between maximization of entropy to keep the 
protein in random state and minimization of enthalpy trying to drag down the protein. 
Progress down the funnel is measured by a parameter Q and it is a measure of native state 
contacts formed. The depth of the funnel represents energy and Q while the width represents 
entropy. The unfolded protein occupies brim of the funnel where both energy and entropy are 
maximum. The native state with minimum energy and entropy occupies the apex of funnel. 
Native 
Structure 
Discrete Folding 
Intermediates 
Figure 1.2. A schematic representation of the energy landscape for a minimally frustrated 
heteropolymer as required in folding (A). The energy surface of a folding funnel from 
experimental data for the folding of lysozyme. The axes are defined as follows: E 
represents the energy of the system, Q is defined as the proportion of native contacts 
formed, and P is a measure of the available conformational space. Three pathways are 
shown corresponding to (yellow) fast folding, (green) slow folding pathway that crosses the 
high energy barrier, and (red) slow folding pathway which returns to a less folded state 
before following the pathway for fast folding (B) (Dobson et aL, 1998). 
while intermediate state lies intervening between the two states [19]. The Q value has used to 
determine the state of protein. The MG state is formed with a Q around 0.27 and transition 
state occurs around 0.6[20]. The most important breakthrough in our understanding of 
folding today is that there is not a single specific folding pathway as was suggested in some 
early models. A predefined pathway with compulsory intermediates simply does not exist 
[21]. The downhill bias of the energy landscape is sufficient to drive random folding in a 
reasonable time period. Folding proceeds one amino acid at a time in no particular order 
through an unlimited continuum of undefined intermediates and paths [22]. Different routs 
might be populated and/ or different intermediates and transition states observed as a 
consequence of relatively small alterations of a common free energy. 
1.3.2. Protein folding intermediates 
Because of the vast number of possible conformations for a polypeptide chain, LevinthaJ 
[3] postulated the presence of a specific folding pathway, in which a protein has to go 
through a sequence of intermediate to acquire 3D native structure. Occurrences of 
equilibrium unfolding intermediates have been reported in many globular proteins since mid 
1970s [23, 24]. The unfolding intermediates identified in 1970s did not receive much 
attention because the relationship between equilibrium intermediates and specific folding 
intermediates was not very clear at that time. Latter it was observed that intermediates 
characterized in different proteins shared common structural features such as native like 
secondary structure and compactness and no or fluctuating tertiary structure. Ohgushi and 
Wada [25] and Dolgikh et at [26] termed such a species as molten globules (MG). Kuwajima 
et al [27] and Ikeguchi et al [28] observed the molten globule sate of a-lactalbumin was 
identical to its transient folding intermediate in kinetic refolding fh)m guanidine 
hydrochloride induced unfolded state. Latter it has been proposed that MG state is a general 
intermediate of protein folding [29^0]. Thus identification and characterization of MG state 
in globular proteins has become major subject of experimental studies of protein folding. 
Collating characteristic of MG state fi-om a number of different protein systems may provide 
certain common trend that will lead to a unified mechanism of protein folding. 
13.2.1. Structure of molten globule state 
The common structural features of MG state are as following (1) Secondary structure: 
far UV CD and IR spectra suggest that molten globule contains high contents of secondary 
structure [31, 32]. (2) Compactness: data on the intrinsic viscosity [31 ] and radius of gyration 
[33] of many proteins show that molten globule has intermediate compactness between 
native and unfolded state. Although, data on compactness of most of the proteins are not 
available (3) Internal water: approximately 50% increase in partial specific volume and 
large heat capacity suggest that MG state is not empty (it contains internal water). (4) Core: 
there is clear evidence that the non-polar group in the protein core remain in contact in MG 
state, although this packing is not as tight as in the native protein [32]. (5) Fluctuating 
environment of side chain: ' H - N M R spectra of the acid molten globule state of many proteins 
show that rigid mutual arrangement of aromatic and aliphatic side chains in the protein core 
is largely destroyed and are much more similar to those of the unfolded protein [34]. In a 
similar way, the near UV CD spectra of many proteins are practically absent or greatly 
reduced in the molten globule state, suggesting that local environment of the aromatic side 
chains is much more flexible [35-37]. (6) Cooperativity and stability of molten globule state: 
Originally, it was thought that the molten globule state was formed in a non-cooperative 
manner. The a-LA molten globule, a paradigm of the classic molten globule state, shows no 
observable heat absorption peak in thermal unfolding, apparently suggesting non-cooperative 
unfolding transition [30, 38]. However, many thermodynamic studies have provided many 
example of the cooperative unfolding transition of molten globule state in other proteins such 
as equine and canine milk lysozyme, cytochrome c, staphylococcal nuclease and others [31, 
39]. The degree of cooperativity of the molten globule unfolding transition remarkably 
depends on protein species. It is almost non-cooperative in a-lactalbumin, apoMb, tryptophan 
synthase a-subunit and dihydrofolate reductase, while highly cooperative in certain other 
proteins [31]. The variations in cooperativity are not only observed among different proteins 
but also within the same protein by changing the experimental conditions or by introducing 
amino acid replacements [40]. (7) Native like structural organization: recent advances in 
experimental technique, including hydrogen exchange NMR, solution X-ray scattering, and 
protein engineering, have provided detailed picture of the molten globules of many proteins 
[41-44]. These studies have shown that MG state has heterogeneous structures in which one 
portion of molecule is more organized and native like with other portions being less 
organized. How much native like structure is present depends on protein species and solution 
conditions, and there is remaricable diversity of molten globule structure among different 
proteins. Thus, it will be useful tc describe the MG structure of each of the typical globular 
proteins so that we can see the features in common as well as differences among the different 
proteins. 
13.22. Occurrence of molten globule state 
After the molten globule state was first described for bovine and human a-LA, a number 
of other proteins have been reported to have similar properties. Bychkova and Ptitsyn have 
studied more than 20 proteins and found that nearly all adopted a molten globule state under 
mild denaturing conditions [45]. In our lab. Khan R.H. and coworkers have identified and 
characterized molten globule state of more than 10 proteins under various solvent conditions 
[35-37, 46-52]. Thus the presence of the molten globule state is almost general in globular 
proteins, although certain very small proteins often do not show the stable molten globules 
[16] 
The MG state in general observed under mildly denaturing conditions. Certain protein 
such as a-LA and carbonic anhydrase are transformed directly into the molten globule state 
by acidification. On the other hand, certain proteins such as apoMb and cyt c are unfolded at 
acidic pH, but the addition of stabilizing anion fix>m acid or salt refolds the protein into 
intermediate conformations that resemble the MG state [53, 54]. The molten globule state is 
also observed at moderate concentrations of chemical denaturants (urea and GnHCl) [55-57], 
Low concentration of alcohol or fiuoroalcohol promotes formation of the MG state, although 
the addition of a large amount of alcohol usually leads to another conformation, an extended 
form with high helicity [58-63]. In certain proteins, thermally unfolded protein itself can be 
molten globule [64]. The denaturation by hydrostatic pressure also brings about partially 
folded states similar to the molten globule state in several globular proteins [65]. Removal of 
a ligand in ligand binding proteins or dissociation into a monomer in oligomeric proteins 
often results in the molten globule state [66, 67]. Site directed mutations and chemical 
modifications of proteins also lead to molten globule like states [68,69]. 
13.23. Role of molten globule state in protein folding 
As mentioned above, the molten globule state is an equilibrium intermediate state 
observed in many globular proteins. Whether it is an intermediate of protein folding or not, 
was a matter of debate until the early 1980s [70]. At present, however, it is firmly established 
that the MG state is an equilibrium counterpart of the kinetic folding intermediate that 
accumulate transiently during the refolding from the fully unfolded state. These have been 
become possible due to resent advances in kinetic refolding experiments, using stopped flow 
CD, pulsed hydrogen exchange, real time NMR, continuous flow mixing, and stopped flow 
X-ray scattering. The latest experimental techniques, which are used to measure folding, 
have been described in table 1.2. 
From a stopped flow-CD study of refolding of GnHCI induced unfolded a-LA, Arai and 
Kuwajima [71] observed an intermediate state within the dead time of measurements and was 
called burst phase intermediate (BPl). The CD spectrum and the stability of the BPI were 
identical with the equilibrium MG state. Furthermore, Engelhard and Evans [72] by using 
stopped flow fluorescence technique showed that this species has maximum affinity for ANS 
Table 1.2. Experimental Techniques Used to Monitor Protein Folding 
Techniques 
Protein Engineering 
Informatioii about folding process 
Role of individual amino acid in stability 
Laser scattering and gel filtration chromatography Radius of gyration 
DSC 
Fluorescence 
a. Intrinsic 
b. Polarization and Anisotropy 
cFRET 
d. Quenching 
e.REES 
f. Stopped flow 
Thermodynamics of folding process 
Environment and orientation of Trp 
Dynamic of fluorophore 
Distance between two point in a protein 
Accessibility and environment of fluorophore 
Difference between environment of fluorophore 
Time scale of fluorescence changes 
g. Ligand binding (Substrate and Inhibitor) Formation of native structure at active site 
Circuhir DIchroism (CD) 
a. Far-UV 
b.Near-UV 
c. Stopped Flow 
Hydrogen Exchange 
a. Native state exchange 
b.NMR 
Real time NMR 
Dynamic NMR 
Laser temperature Jump 
Mass spectrometry 
Secondary structure 
Tertiary structure 
Time for secondary and tertiary structure formation 
Detection of metastable state 
Rate of formation of backbone hydrogen bonds and protection 
from exchange of amino acid side chain 
Environment of protein side chain 
Detect equilibrium species 
Trigger folding / unfolding at nano seconds 
conformational properties of protein ensembles 
binding, a hydrophobic probe widely used for detecting the MG state. Eliezer et al [73], Arai 
et al [74] and Chen et al [75] have studied kinetic refolding of protein by stopped flow X-ray 
scattering and showed that early refolding intermediate have MG like compactness. These 
results strongly suggest the identity between MG state and the refolding BPI. The BPI has 
also been identified and characterized in many other proteins. Observation of MG like BPI in 
these proteins indicates that it is a general folding intermediate in many proteins. 
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Kinetic refolding of a-LA from GnHCI induced unfolded state was also monitored with 
real time NMR by Balbach et al [76]. They found that 1D NMR spectrum at the beginning of 
refolding was very similar to the spectrum of MG state. The refolding kinetic monitored by 
side chain proton signals in the ID NMR spectra and by main chain signals in the 2D 
experiments are both coincident with the kinetics measured by CD and fluorescence. These 
results demonstrate that a-LA refolds through MG state. Pulsed-hydrogen exchange 
combined with multidimensional NMR or mass spectrometry is undoubtedly the most 
powerful technique for analyzing the conformational properties of protein ensembles [77, 
78]. The transient folding intermediate and the equilibrium folding intermediate were both 
characterized by hydrogen exchange techniques in many proteins and had been shown to be 
identical with each other by comparison of the hydrogen exchange profiles. These studies 
thus provide firm evidence that the MG state is the specific folding intermediate formed at 
early state of folding. 
Molten globule state is also found to play kinetic role in the protein folding. It has been 
shown that MG state is the specific folding intermediate in which the specific native like 
structure is already organized in a portion of the protein molecule [31]. This is apparently in 
contrast with the theoretical prediction that nonspecifically collapsed globules accumulate at 
the beginning of refolding of a protein under strongly native conditions [79, 80]. The 
available experimental data also suggest that the MG state is a productive on-pathway 
intermediate in the real folding reactions in many globular proteins [31], so that the specific 
folding pathways can well represent the real folding. 
1.4. Folding of IMultimeric Proteins 
Evolution allowed proteins to acquire the capacity (i) to create new fijnctions by the 
cooperation of two or more domains in the formation of one common active center, (ii) to 
become multifiinctional, this way allowing regulated networks of processes to develop, (iii) 
to enhance the rate of self organization by synchronous nucleation at multiple sites, and (iv) 
to improve the stability by protecting the folding polypeptide chain in its sub-structures fi-om 
cotranslational degradation. 
Regarding their folding and association mechanism, multi-domain and multimeric 
systems may be modeled as the sum of their constituent parts plus contributions attributable 
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to their mutual interactions [81]. The folding of multi-domain proteins may involve multiple 
intermediate species with different degrees of partial folding. They may look native by one 
physical parameter, partially folded by another, and unfolded by a third one, so that the 
underlying properties have only limited value as probes of unfolded or native-like structure. 
Under strongly native conditions, i.e., far away from the equilibrium denaturation transition, 
one may simplify the denaturation / renaturation process in terms of the two-state 
approximation so that only one rate-limiting first-order folding reaction remains [81]. For 
modular proteins this may be attributed to the last folding step connected with the docking of 
the domains; for multimeric proteins it represents the formation of 'structured monomers' 
with the correct complementary interfaces required for the specific recognition of subunits. 
In proceeding to quaternary structure formation, subunit association represents a bimolecular 
reaction, which adds concentration-dependent steps to the first-order folding processes. If 
biological fiinction (as Ae criterion of the native state) requires the cooperation of domains, 
e.g., two domains contributing amino-acid residues to a common substrate-binding site, 
domain pairing is expected to be essential in acquiring catalytic activity. In multimeric 
systems, the steps preceding subunit assembly are the same as in single domain proteins. The 
overall mechanism consists of three stages, (i) the formation of elements of secondary and 
super-secondary structure, (ii), their collapse to sub-domains and domains ending up with 
structured monomers and (iii) association to form the correct stoichiometry and geometry of 
the native quaternary structure [82]. Evidently, the collision-complex of the structured 
monomers may still undergo intramolecular rearrangements before reaching the state of 
maximum packing density and minimum hydrophobic surface area; on the other hand, it may 
be trapped in side reactions of misfolding and/or misassembly, ending up in aggregates or 
inclusion bodies [82]. Thus, the uni-bimolecular folding/association mechanism may involve 
fijrther rate limiting first-order steps belonging to slow shuffling processes at the level or the 
native-like assembly, or higher-order reactions attributable to the kinetic competition 
between correct reconstitution and misassembly. Focusing on the rate-determining steps, in 
the simplest case of a dimer, the overall reconstitution reaction would then obey either a uni-
bi-unimolecular reaction or a simple kinetic partitioning mechanism. The rate-limiting step in 
the folding kinetics of certain large multi-domain proteins has been found to be the pairing of 
the folded domains [83]. Hydrophobic collapse and the packing of sub domains and domains 
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may occur within fractions of a second, while docking of the domains to fonm the final 
tertiary structure sometimes takes exceedingly long time [84]. Regarding the sequence of 
events along the pathway of (re-) folding, this may have important implications: since active 
sites are often shared between domains, the slowest folding step is frequently characterized 
by the acquisition of enzymatic activity. Similarly, subunits in multimeric enzymes may 
share active sites, giving rise to late reactivation steps in the overall folding/association 
mechanism [84]. Evidence for the kinetic significance of the merging of domains has been 
mentioned in connection with the influence of viscosity on the folding rate of monomeric 
multidomain proteins. A quantitative hydrodynamic explanation cannot be given, because 
additives altering the solvent properties may also effect the intramolecular interactions, i.e., 
the stability and folding of solutes [85,86]. Site-directed mutagenesis was shown to allow the 
mutual stabilization of domains to be studied. What still remains to be discussed is the 
recognition and mutual stabilization of domains and subunits, and the gradual increase in 
protein stability, starting from fragments and subunits to the oligomeric state. Porcine lactate 
dehydrogenase may serve as an example. The enzyme is a tetramer with no detectable 
cooperativity of substrate or coenzyme binding. The dimer-of-dimers structure is stabilized 
by a decapeptide positioned at the N-terminal end of each the polypeptide chains. Cleaving 
off this arm, a metastable 'proteolytic dimer* is obtained, which shows anomalously high 
flexibility and gains enzymatic activity only in the presence of structure-making salts [87]. 
The monomer shows native-like structure, accessible exclusively as a short-lived, 
proteolytically sensitive kinetic intermediate on the pathway of reconstitution [88]. The 
separate NAD and substrate-binding domains are unstable, but still sufficiently structured to 
recognize one another and pair correctly. Upon joint reconstitution, they form active, nicked 
dimers; renaturation of the separate domains and subsequent mixing is unsuccessfiil, 
suggesting mutual stabilization of the firagments. Thus, domains not only serve to enhance 
the folding rate, but at the same time they may assist each other in advancing to their native 
structure by mutual stabilization through specific interactions. 
The stabilization of substructures on the folding pathway has also been observed at the 
subunit level, e.g., in the case of bacterial luciferase. -The enzyme from Vibrio harveyi is a 
heterodimer composed of homologous polypeptide chains. It contains a single active site on 
the a-subunit, whereas the P-subunit is responsible for the high quantum yield of 
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bioluminescence [89]. Urea denaturation and subsequent refolding upon dilution suggest 
multiple intermediates, leading to the native state via an inactive heterodimeric sjiecies [90, 
91]. Investigating the folding of the separate a- and p-chains showed that the lag in the 
formation of the active dimer is caused by slow folding steps of the individual subunit chains, 
which differ in their rates. Since separate folding of a and p leads to a decrease in 
reactivation, one may assume that the faster folding p-chain provides a 'matrix' for the slower 
folding a-chain, thus trapping a and shifting the equilibrium toward the native state. 
Obviously, kinetic competition of folding and association (corresponding to folding and 
docking in the previous example) constitutes a trap on the folding path, which guides the 
subunits to the energy minimum of the active heterodimer [92]. 
1.5. Why protein folding studies? 
Today, an intense search is being made for the principles that guide the folding process. 
The appreciation of protein folding can be seen in figure 1.3, which shows the number of 
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Fig. 1.3. Number of manuscripts published on protein folding over the last 15 years. 
manuscripts published on protein folding over the last 15 years. Although tfie detailed 
mechanism of folding are not completely known, significant advances have been made in the 
understanding of this complex process through both experimental and theoretical approaches. 
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Peoples might want to know what implications this has in the real world. A solution to the 
protein-folding problem is of enormous intellectual importance, in that it will provide the 
missing link in the flow of informations between a gene sequence and 3D native structure of 
a protein. Understanding protein-folding problem is not just a scientific curiosity, it has also 
application in various fields of science, technology and medicine (tablel .3). 
Table 13. Practical Application of Protein folding 
Field 
Biomedicine 
Biotechnology 
Nanotechnology 
Synthetic chemistry 
Applications 
(a) Drug design 
(b) Protein misfoiding/ aggregation 
(c) Protein toxic folding 
(a) Designing denaturant resistant protein 
(b) Designing protease resistant protein 
(c) Enzyme design for paper, pulp etc industry 
(d) Recovery of inclusion body 
Self assembly of nanomachine 
Polypeptide synthesis with desired function 
1.5.1 Function of unknown gene 
The potential of prediction of protein stmcture from DNA/amino acid sequence will rely 
on a detailed and complex understanding of how proteins fold. Prediction of protein fold and 
thus protein structure would mean that in conjunction with the Human Genome Project (or 
the sequence of any other organism's genome for that matter) the structure of proteins 
encoded for by genes of unknown function could have a structure determined without 
actually having to isolate the protein itself Such determined structures are likely to suggest 
the function (or at least a class of function) of the protein encoded and perhaps lead to the 
information. 
15 
1.2.5. Prevention of abnormal folding 
Proteins are known to fold in vivo to their final conformation either during or after their 
biosynthesis on ribosome. Very little is known directly about how and when this occurs in 
vivo. Protein folding in vivo is aided by molecular chaperones. These are proteins that bind 
to denatured states of proteins and prevent them misfolding and aggregating. The most 
interesting protein regarding folding is GroEL, which is a typical member of the Hsp60 or 
Cpn60 class of molecular chaperonins [93]. It consists of 14 x 58kDa subunits arranged in 
two-stacked seven-member rings, which have a large central cavity. In vivo a co-chaperonin 
GroES is also required as is the hydrolysis of ATP [93]. The mechanism of GroEL is 
controversial. One school proposes that the central cavity acts as a folding cage in which a 
single molecule of denatured protein can fold in isolation. The opposing school postulates 
that GroEL is an active unfoldase that catalyses the unfolding of misfolding and aggregated 
states. A series of experiments examining the folding of bamase and chymotrypsin inhibitor-
H in the presence of GroEL showed that both proteins can fold from their denatured states 
when bound to ch^erone. The chaperonin actually slows down folding by binding to the 
denatured state but it increases the yield of active protein. GroEL in vivo appeared to act as a 
folding and annealing cage. 
Protein folding in vivo differs from the situation in a test tube in that nascent 
polypeptides attempt to fold even before their entire length has been synthesized. Since the 
protein folding in cell is so complex, there is a significant likelihood of defects arising in the 
process. There are a number of causes that could lead to the loss of ftmction and thus a 
defective phenotype. These include thermodynamic destabilization of the native or 
intermediate state, alterations of the folding kinetics, prolonged or inappropriate association 
with molecular chaperones or folding enzyme preferential formation of off pathway or toxic 
conformations or folding in improper compartment. Therefore, inability of an essential 
protein to forms its native conformation under physiological conditions forms the basis of 
variety of human disease [94]. A list of some human diseases presented in table 1.4 has been 
found to be a ramification of altered protein conformations [95-103]. Possible treatment of 
these diseases could exploit detailed knowledge of protein folding and the prevention of 
abnormal folding. 
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Table 1.4. Some Protein Folding Diseases 
Diseases 
Crueltzfeldt-jacob 
Alzheimer's 
Cystic fibrosis 
Cancer 
protein involved 
Prion protein 
Beta-amyloid 
CFTR 
P53 
Familial amyloid polyneuropathy Apolipoprotein 
Parkinson 
Huntington's 
Familia visceral amyloidosis 
Cataract 
Mar&n syndrome 
Scurvy 
Osteigenesis imperfecta 
Amyotropic Lateral sclerosis 
Alpha-synuclein 
Huntington 
Lysozyme 
Ctystallins 
Fibrillin 
Collagen 
Type 1 procollagen pro 
SOD 
Finish type Familia amyloidosis Gesolin 
Kelanddic cerebral angiopathy 
Type 11 diabetes 
Cystatin C 
Islet anyloid polypeptide 
Cause 
Toxic ibid/aggregation 
Toxic folding/aggregation 
Misfolding 
Misfolding 
Aggr^ation 
Amyloid fibril formation 
Amyloid fibril formation 
Aggregation 
Aggregation 
Misfolding 
Misfolding 
alpha Misassambly 
Misfolding 
Amyloid fibril formation 
Amyloid fibril formation 
Amyloid fibril formation 
1.5.3. Protein folding and Biotechnology 
Two main applications concerning protein folding are involved in biotechnologies: 
protein engineering and the de novo design of proteins with novel functions. Recombinant 
proteins of pharmaceutical interest, such as growth hormone, insulin, and antihemophilic 
factor VIII, are commonly expressed and overproduced in E. coli or other cells. Since the 
over expression of genes in foreign hosts often results in the formation of inclusion bodies, 
further treatments in including unfolding and refolding are required. These proteins can also 
be modified by genetic engineering to increase their stability for storage, which is an 
important industrial application. 
De novo protein design has recently emerged with the hope of constructing proteins with 
functions unprecedented in nature. This research is based on our understanding of the 
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principles of protein folding. The conception of new proteins represents a burgeoning field of 
research. Genetic engineering provides a powerful methodology to redesign existing proteins. 
The aim of de novo protein design is to create completely new proteins with determined 
activities. The first step consists of choosing a function, and finding the amino acids with a 
favorable spatial arrangement capable of generating the desired function. Then it is necessary 
to find a polypeptide scaffold capable of supporting the reactive groups in the appropriate 
orientation. In the following step, it is necessary to determine an amino acid sequence able to 
fold into an adequate and stable three-dimensional structure, which presents the desired 
geometry of the binding site. Some folds such as triose phosphate isomerase barrel, three -
and four helix bundles, and immunoglobulin fold appear frequently in proteins with highly 
divergent sequences. They are highly designable and may be easily modified without 
perturbing their three-dimensional structure. 
At this stage, several different strategies may be used. One consists of using as a scaffold a 
protein of known structure with properties close to those desired. This is called the local 
conception. The other, the global conception, consists of design of a structure by analogy 
with one of the classical folds in the protein data bank. However, since in general a large 
number of sequences can fold into the same three-dimensional structure, it is only necessary 
to arrive at one of them. Genetic methods can be used to screen a great number of 
randomized sequences to find those that fold into the same three-dimensional structure. 
Combinatorial and computational algorithms provide a powerful complementary approach to 
genetic methods for exploring the sequence space. They consist of the exploration of a large 
number of side-chain combinations that can fit together to stabilize a given backbone fold 
and necessarily include a potential energy function. Automated design of functional proteins 
capable of generating a sequence compatible with the template fold and specific for some 
purpose is being developed. Once the sequence is conceived, tfie recombinant protein can be 
produced firom the corresponding gene. Another strategy uses peptide synthesis, for example 
in the design of monomeric P-sheets, or helical bundles. The different methods for de novo 
protein design have been reviewed by the De Grado et al [104]. 
Most accomplishments have concerned the synthetic design and structural 
characterization of secondary structures such as helices, helix bundles, P- hairpins, and P-
sheets. They have widely contributed to the understanding of secondary structures in 
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proteins. A large number of parallel or antiparallel helix bundles have been designed, 
resulting in the desired fold but showing a marginal stability, some of them displaying the 
characteristics of molten globules. Several designed helix-bundle peptides that adopt multiple 
conformations in solution have been crystallized in only one of these conformations. These 
motifs can serve as a starting point in protein design. 
Functionalization of designed polypeptide has been successfully obtained in the field of 
catalysis, metal ion and heme binding, and introduction of cofactors [105]. A 14-residue 
polypeptide that forms a bundle like structure catalyzes the decarboxylation of oxaloacetate 
with a low catalytic activity, a cystein residue acting as nucleophile. Designed four-helix 
bundles formed from 42-residue polypeptides in which histidine residues have been 
introduced have accomplished hydrolysis and transesterification reaction of paranitrophenyl 
esters. The successful design of a four-helix bundle protein that binds four heme groups with 
high affinity has been reported. The structure is well defined as shown by NMR 
spectroscopy. 
It is clear that de novo protein design represents a growing field of research that will be 
useful both in testing the principles of protein folding and in offering the perspectives to 
design new proteins with practical applications for pharmaceuticals and diagnostics. 
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Cfuipter 2. 
MATERIALS AND METHODS 
/ff 
2.1. Materials 
2.1.1. Proteins 
Stem bromelain (EC 3.4.22.32) from pineapple stem, essentially fatty acid free human 
serum albumin and glucose oxidase from Aspergillus niger (EC 1.1.3.4) were purchased 
from Sigma Chemical Co., St. Louis, USA. Commercial preparations of stem bromelain, 
human serum albumin and glucose oxidase were further purified to homogeneity by gel 
filtration chromatography. Stem bromelain (SB), human serum albumin (HSA) monomers 
and glucose oxidase (Gox), thus obtained, were found to be homogeneous with respect to 
size and charge as judged by gel filtration chromatography and polyacrylamide gel 
electrophoresis (PAGE). These preparations were used through out the study 
2.1.2. Reagents used in unfolding/refolding studies 
Urea (ultra pure), guanidine hydrochloride (ultra pure) and Trifluoroethnnol were 
obtained fix)m Sigma Chemical Co., St. Louis, USA. Poly (ethylene glycol) s of molecular 
weight 400, 6,000, and 20,000 were purchase from Sisco Research Laboratory, Mumbai, 
India. Sodium hydroxide (NaOH), hydrochloric acid (HCl) and acetic acid were obtained 
from Qualigens Fine Chemicals, Mumbai, India. 
2.1.3. Ligands used in binding studies 
Hemin and l-anilinonaphthalene-8-sulfonate (ANS) were obtained fi'om Sigma Chemical 
Co., St. Louis, USA. Bilirubin and chloroform were purchased fh)m Sisco Research 
Laboratories, India. Diazepam was a product of Ranbaxy Laboratories Ltd., India. 
2.1.4. Other reagents 
Blue dextran, coommassie brilliant blue R-250, N-acetyl-L-tryptophanamide (NATA), 2-
mercapoethanol, iodoacetamide, Sephacryl-SlOO (HR), and glycine were obtained from 
Sigma Chemical Co., St. Louis, USA. Acrylamide, N, N'-methylenebisacrylamide, 
ammonium persulphate (APS), sucrose, glycerol sodium dihydrogen phosphate, disodium 
hydrogen phosphate, sodium acetate, trichloroacetic acid (TCA), cycteine hydrochloride and 
acetic acid were obtained from Qualigens Fine Chemicals, Mumbai, India. N, N, N', 
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N'tetramethylethylenediamine (TEMED) was the product of Fluka AG Switzerland. All 
other chemicals used in this study were of analytical grade. 
2.1.5. Miscellaneous 
Dialysis tubings of 1-inch width were obtained from Sigma Chemical Co, MO, USA. 
Whatman filter papers (No. 1) were product of Whatman International Ltd, Maidstone, 
England. Parafilm 'M' was obtained from American Can Company, CT, USA. pH indicator 
papers were supplied by Qualigens Fine Chemicals, Mumbai, India. 
Double distilled water was used throughout these studies. All the experiments were 
performed at room temperature unless otherwise stated. 
2.2. Methods 
2.2.1. Concentration determination 
Proteins concentrations were determined from the value of specific extinction coefficients 
(E'°''''icm = 20.1, 5.3 and 13.8 for SB, HSA and Gox respectively) by measuring the 
absorbance of protein solutions at 280nm [106-108] on a Hitachi spectrophotometer, model 
U-1500 or alternately by method of Lowry et al [109]. 
ANS and Bilirubin concentration were also determined spectrophotometrically using a 
molar absorption coefficient of 5,000 M'^  cm^ and 47,500 M"' cm^ at 350 and 440 nm 
respectively [110, 111] 
2.2.2. pH measurements 
pH measurements were carried out on an Elico digital pH meter, model LI 610 using a 
PPC's combined electrode, type CL-51 consisting of glass and reference electrodes in a 
single entity. The least count of the pH meter was 0.01-pH unit. The pH meter was routinely 
calibrated at room temperature with 0.05 M potassium hydrogen phthalate buffer, pH 4.0 in 
the acidic range or 0.0 IM tetraborae buffer, pH 9.2 in the alkaline range 
2.2.3. Circular dichroism measurements 
Circular dichroism (CD) measurements were carried out with a Jasco spectropolarimeter, 
model J-720 equipped with a microcomputer. The instrument was calibrated with d-10-
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camphorsulphonic acid. All the CD measurements were made at 25°C with a thermostatically 
controlled cell holder attached to Neslab's RTE - 110 water bath with an accuracy of ± 0.1 
°C. Spectra were collected with scan speed of 20 nm/min and response time of I sec. Each 
spectrum was the average of 3-4 scans. Far and near UV CD spectra were obtained with I 
mm and 10 mm path length cells respectively. The results were expressed as MRE (Mean 
Residue EUipticity) in deg. cm .^ dmol' which is defined as MRE = Gobs/(10 x n x I x Cp) 
where Oobs is the CD in milli-dcgree, n is the number of amino acid residues, 1 is the path 
length of the cell and Cp is mole fi-action. Helical content was calculated from the MRE 
values at 222 nm using the following equation as described by Chen et al. [112]: 
% a-helix = [(MRE222nm- MRE^n) / MRE^aJx 100 (1) 
where MRE222nm is the molar ellipticity of the protein, MREmin (2340) is the minimum value 
of molar ellipticity at 222 nm calculated for the unordered fraction of five protein, and 
MREmax (30300) is the maximum value for the ellipticity at 222nm as measured for the 
helical fiiaction of the five proteins [112]. 
2.2.4. Fluorescence Measurements 
Fluorescence measurements were performed on Shimadzu spectrofluorimeter, model RF-
540 equipped with a data recorder DR-3. The fluorescence spectra were measured at 25 ± 
0.1° C with a 1 cm pathlength cell. The excitation and emission slits were set at 5 and 10 nm 
respectively. Intrinsic fluorescence was measured by exciting the protein solution at 280 or 
295 nm and emission spectra was recorded in the range of 300-400 nm. 
For ANS fluorescence, in the ANS binding experiments, the excitation wavelength was 
set at 380 nm and the emission spectra were taken in the range of 400-600 nm or at a fixed 
wavelength of 470nm or 480nm depending upon experimental requirements. And for FAD 
fluorescence, the excitation wavelength was set at 365nm and the emission spectra were 
taken in the range of 500-600 nm or at a fixed wavelength of 520nm 
2.2.5. Autolysis measurements of stem bromelain 
The extent of autolysis of stem bromelain was measured by trichloroacetic acid (TCA) 
precipitation method as described by Jiang et al [113]. 
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2.2.6. Preparation of catalytically inactive stem bromelain (mSB) 
Catalytically inactive stem bromelain was prepared by the procedure of Sharpira and 
Amon [114] with modification as reported earlier by our group [35]. Modification was 
carried out in 0.32 M 2-mercaptoethanol for Ihour at room temperature, followed by addition 
of solid iodoactamide to give a final concentration of 0.043 M. After stirring for 30min at 4 
deg. C, the solution was subjected to extensive dialysis in respective buffers. The inactive 
(modified) preparation of SB was fiirther purified by gel filtration chromatography and used 
in the study wherever it was needed. 
2.2.7. Acid induced unfolding and refolding of stem bromelain 
Unmodified stem bromelain solutions, of varying pH (pH 0.8-3.0) were prepared by 
adding 2970 jxl of glycine/HCl buffer (lOmM) of desired pH to a 30 ^1 of protein stock 
solution (300 nM). These tubes were incubated for 4 hours at 25 **€ before spectroscopic 
measurements. The pH of the sample was found to lie within ±0.1 -pH unit when taken before 
and after spectroscopic measurements. Solution for the renaturation experiments was 
prepared by dialyzing stem bromelain at pH 2.0 (acid unfolded state) against 10 mM sodium 
phosphate buffer, pH 7.0. 
2.2.8. Effect of Poly (ethylene glycol) s on acid unfolded state stem 
bromelain 
Acid denatured state of enzyme preparation was achieved by dialyzing against lOmM 
glycine-HCl buffer, pH 2.0. To a 100 p.1 stock protein solution, different volumes of the 
glycine-HCl buffer (pH 2; lOmM) was added first; followed by the addition of acidic stock 
polyethylene glycols solutions (100% w/v, PEG 400; 50% PEG 6000 and 45 % PEG 20,000) 
to get a desired concentration of PEGs. The final solution mixture (3.0ml) was incubated for 
6 hrs at room temperature before optical measurements. 
2.2.9. Preparation of different isomers of HSA 
The N (neutral), B (basic) and F (fast moving) isomers of human serum albumin were 
produced by mixing 20 nl of HSA monomer stock solution (250nM) with 980 l^l of pH 7.0 
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(60mM sodium phosphate), pH 9.0 (lOmM glycine.NaOH), pH 3.5 (lOmM. Acetic acid / 
sodium acetate) buffers at room temperature as described elsewhere (115). 
2.2.10. Urea and GnHCI induced unfolding and refolding of HSA 
Solutions for the denaturation experiments of N, B and F isomers of HSA were prepared 
in 60 mM sodium phosphate buffer of pH 7.0, 20mM acetate buffer of pH 3.5 and 20 mM 
glycine-NaOH (Gly-NaOH) buffer of pH 9.0 respectively. To a 0.5 ml stock protein 
solution, different volumes of the desired buffer was added first; followed by the addition of 
a stock denaturant solution (10 M urea or 8M GnHCI) or to get a desired concentration of 
denaturant. On the other hand, for renaturation experiments, to a stock protein solution, 
different volumes of concentrated denaturant solutions were added first and the mixture was 
incubated for 12 hours and finally buffer was added to get desired denaturant concentration. 
The final solution mixture for both the denaturation and renaturation experiments was 
incubated for 8 hours at 25 °C before optical measurements. 
2.2.11. Ligand binding studies 
2J.11.1. BiUrubin Binding 
Bilirubin solution was prepared by dissolving 5 mg of solid bilirubin in 0.5 N NaOH 
containing ImM EDTA and immediately diluting it with the desired volume of 50 mM 
sodium phosphate buffer, pH 7.0 and / or 10 mM Gly-NaOH buffer, pH 9.0. The binding of 
bilirubin to HSA (at pH 7.0 as well as pH 9.0) at different urea and GnHCI concentrations 
was studied using fluorescence enhancement technique [116, 117]. To a fixed volume of 
stock protein solution (3.5 jiM), previously incubated with different urea or GnHCI 
concentrations for 10 hrs at room temperature, increasing volumes of stock bilirubin solution 
was added to achieve different bilirubin/albumin molar ratios. The fluorescence was 
measured at 530 nm after exciting the bilirubin - albumin complex at 466 nm. The spectra 
were recorded in dark after 15-20 min of the addition of bilirubin to protein solution. The 
data were plotted as relative fluorescence against bilirubin/albumin molar ratio. 
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2.2.112.Chloroforni binding 
Binding of chloroform to various isomers of HSA at different urea and GnHCl 
concentrations were studied by fluorescence quenched titration method [118]. To a fixed 
volume (3.0 ml) of protein solution previously incubated with different urea and GnHCl 
concentrations for 10-12 hrs at room temperature, increasing volumes (1-15^1) of 
chloroform was added. Fluorescence was measured after 1 hr at 340 nm after exciting the 
protein samples at 295 nm. The data were plotted as relative fluorescence vs. chloroform 
concentration (mM), 
2.2.11 J . Diazepam binding 
To study the binding of diazepam (5mg/ml) to the HSA in the absence and presence of 
urea or GnHCl, stock protein solution (3.5 \xM), previously incubated with different urea or 
GnHCl concentrations for 10-12 hours at room temperature, were titrated with increasing 
diazepam concentrations to get different diazepam / protein molar ratios. The solution was 
excited at 280 nm after 30-40 minutes incubation at room temperature and the fluorescence 
emission was measured at 340 nm. The data were plotted as relative fluorescence vs. 
diazepam /protein molar ratio. 
2.2.11.4. Hemin binding 
Immediately prior to use, hemin was dissolved in 10 mM NaOH to obtain a stock 
concentration of 4.0 mM. To a fixed volume of stock protein solution (3.5 ^M), previously 
incubated with different urea or GnHCl concentrations for 10 hrs at room temperature, 
increasing volumes of stock hemin solution were added to achieve different hemin / albumin 
molar ratios and the fluorescence was measured at 340 nm after exciting the solution at 280 
nm. The spectra were recorded after 15-20 min of the addition of hemin to protein solution. 
The data were plotted as relative fluorescence against hemin / albumin ratio. 
2.2.12. Preparation of different states of glucose oxidase (Gox) 
The native, acid unfolded and molten globule states of Gox were produced by mixing 20 
^1 of Gox stock solution (250nM) with 980 ^l of pH 7.0 (60mM sodium phosphate), pH 2.6 
(lOmMglycine.HCl), pH 1.4(10mM. lOmM glycincHCl) buffers at room temperature as 
described earlier [50] 
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2.2.13. TFE induced conformational transition of Gox states 
Stock protein solutions of pH 7.0, 2.6 and 1.4 were prepared in the respective buffer 
solutions to be 10 times the requistize final protein concentration. Different volumes of 
buffers, TFE and 20 ]xL of protein stock solution were mixed to give a final volume of ImL. 
This yielded final TFE concentration fix)m 0% to 50% (v/v) and desired final protein 
concentration. Each sample was mixed by vortexing and was incubated overnight before 
spectroscopic measurements. 
2.2.14. Acryamide induced fluorescence quenching 
In the quenching experiments, aliquots of 5 M acrylamide stock solution were added 
to protein solutions (SjiM) to achieve the desired range of quencher concentration (0.1-
0.5M). Excitation was set at 296 nm in order to excite tryptophan residues only and the 
emission spectrum was recorded in the range 300-400 nm. The decrease in fluorescence 
intensity at Xmax was analyzed according to the Stem-Volmer and / or modified Stem-Volmer 
equation [119], 
Fo/F = Ksv[Q]+l (2) 
F o / ( F o - F ) = l / f a + l / ( f a . K c [ Q D (3) 
Where Fo and F are the fluorescence intensities at an appropriate wavelength in the 
absence and presence of quencher respectively, Kc is the effective collisional quenching 
constant, fa is the fraction of accessible fluorophore and [Q] is concentration of the quencher. 
A linear regression, Fo / Fo - F vs I / [Q] whose slope = 1 / (^ Kc) and intercept = 1/ ^ was 
used for data analysis. 
2.3. Data analysis 
2.3.1. Two states mechanism 
Unfolding transition for the N=^U process were normalized to the apparent fiaction of the 
unfolded form, Fu, using the following equation [120]: 
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FU = ( Y - Y N ) / ( Y U - Y N ) (4) 
Where Y is the observed variable parameter and YN and Yu are the values of the variable 
characteristics of the folded and unfolded conformations. The difference in free energy 
between the folded and unfolded states, AG was calculated by the following equation: 
AG = - RT In K = -RT In [Fu / (1 -Fu)] (5) 
where K is the equilibrium constant, R is the gas constant (1.987 cal K'mol"') and T is the 
absolute temperature. 
2.3.2. Three state mechanism 
For the unfolding process, N«* I =^  U where I is an intermediate state, each step may be 
assumed to follow a two state mechanism. The fraction of the intermediate state, Fi in the 
reaction N=^ I can be obtained from the following relations: 
F, = (Y-YN) / (Y , -YN) (6) 
Where F| + FN = 1 
The fraction of the unfolded state, Fu in the reaction 1 — U can be calculated from the 
relation: 
F U = ( Y - Y , ) / ( Y U - Y , ) (7) 
Where Fu + Fi = 1 
The free energy change for the above transitions can be calculated from the following 
equation: 
ForN^ I process 
AG = - RT In Ki = -RT In [Fi / (1 -F,)] (8) 
For I — U process 
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AG = - RT In Ku = -RT In [Fu / (1 -Fu)] (9) 
A least square analysis of the equations (5), (8) and (9) as a function of denaturant 
concentration, [D] was used to fit the data to the following equation for the determination of 
A G V , the free energy change in the absence of urea 
AG = AG "2° - m [D] (10) 
-1 x/r-l where m is the measure of dependence of AG on denaturant concentration in cal.mol" M 
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Cfuipter 3. 
IDENTIFICATION AND CHARACTERIZATION OF 
MOLTEN GLOBULE STATE OF STEM 
BROMELAIN 
3.1. Introduction 
Bromelain is the collective name for closely related proteolytic enzymes found in the 
tissues of the plant family bromeliaceae of which pineapple, Ananas comosus is the best 
known. Two distinct types of pineapple bromelain are recognized. Stem bromelain (EC 
3.4.22.32), the major proteolytic cysteinyl protease in pineapple stem, and fruit bromelain 
(EC 3.4.22.33), formally called as bromelin, which is the major proteolytic component in 
pineapple fruit. Bromelain preparations are widely used in medicine, as laboratory reagents 
and to a lesser extent in industry [121]. In medicine, it is frequently used to cure various 
disease conditions due to its following physiological actions: (i) antiedema action [122], (ii) 
anti-inflammatory action [123], (iii) tumor growth inhibition [124], (iv) platelet aggregation, 
fibrinolysis, cytokine induction and immunity [125], etc. 
Stem bromelain exists as a single polypeptide chain with 212 residues [126], having a 
molecular weight of 22, 828 daltons. The polypeptide chain can be divided into 3 regions - 2 
strongly homologous parts (N-terminal part 1-82 and C-terminal part 117-212) and middle 
part 83-116 with virtually no identity or homology. Stem bromelain is a glycoprotein with 
one oligosacharide moiety per molecule, which is covalently attached to the peptide chain 
[127, 128]. The sequence of stem bromelain contains one sulfydryl group and three disulfide 
bonds [126]. Stem bromelain belongs to the a+P protein class as other cysteine proteinases 
do and the highly identical amino acid sequences of the papain [129], actinidin [130], 
proteinase D [131], chymopapain [132, 133] and stem bromelain ( 126) indicate that the 
polypeptide chains of thses proteins share a common folding pattern. This has been 
confirmed for the first three proteinases by detailed X- Ray diffraction studies [134-136]. 
These proteins are rich in hydrophobic and uncharged amino acid residues and contained 
only ~14 % charged amino acid residues. Stem bromelain like other proteins of the family 
contains two domains an alpha-domain and a beta domain, which interact with each other by 
hydrogen bonds, hydrophobic interactions and salt bridges in which residues fi^om both the 
domains participate [126, 134-136]. 
Electrostatic interactions are important in determining the stability of a protein. pH is 
known to influence the stability of a protein by altering the net charge on the protein, and 
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many proteins denature at extremes of pH because of the presence of destabilizing repulsive 
interactions between like charges [137]. Several proteins are maximally unfolded around pH 
2. Further decrease in pH has no effect on the ionization state of the protein. On the other 
hand, increase in anion concentration leads to refolding to an A-state [137]. On the basis of 
conformational states of proteins under condition of acid induced denaturation. Fink etal has 
classified the proteins into three major types [53]. Type I proteins initially unfold in the 
vicinity of pH 3-4 and then refold to a molten globule like conformation on further lowering 
the pH. Type II proteins do not fully unfold but directly transform to the molten globule 
states. Type III proteins do not unfold even to pH as low as 1. 
Previous studies have showoi that poly (ethylene glycoI)s may have either stabilizing 
or destabilizing effect on proteins depending on chemical nature of the protein [138]. For 
PEG, two possible mechanisms for protein stabilization have been suggested, steric exclusion 
and exclusion due to protein charge [139]. Exclusion of PEG either by steric exclusion 
mechanism or / and unfavorable interaction with charges on protein lead to the protein 
preferential hydration which stabilize the structure of the protein. Arakawa and Timasheff 
have proposed that PEGs can bind to hydrophobic sites on protein based on the fact that PEG 
is essentially non polar [138]. 
Very little information about the folding aspects of cysteine proteases is available. Edwin 
and Jagannadham have reported the denaturation of papain over a pH range firom 0.5 to 9.0. 
The protein was found to loss most of its helices at pH 2.0. [140] The process of thermal 
denaturation of bromelain, as studied by circular dichroism (CD) and differential scanning 
calorimetry (DSC), is completely irreversible and apparently follows a simple two-state 
mechanism of the type N-»D [106]. Stem bromelain, when exposed to increasing alkalinity, 
exhibits conformational transition through at least three different stages due to the ionization 
of tyrosine hydroxyl groups [141]. 
From earlier studies of our laboratories on the folding of modified stem bromelain 
(catalytically inactive state), a partially folded intermediate (PFI) state was detected at pH 
2.0, which refolds to molten globule like state around pH 0.8 [35]. Further we have 
demonstrated that partially folded state of SB obtained at pH 2.0 acquires different 
conformational states in the presence of saU and alcohols [142,143]. In view of the fact that 
modified protein can not be native in the absence of activity even under physiological 
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condition, we report here a detailed investigation on acid induced unfolding of unmodified 
preparation of stem bromelain. An acid unfolded and a MG state was identified and 
characterized during acid induced unfolding study. Further, we demonstrated the formation 
of a molten globule state when the acid unfolded state of SB is subjected to high 
concentration of low molecular weight poly (ethylene glycol) (PEG-400). Interestingly, high 
molecular weight PEGs not only failed to induce MG state but unfold the acid unfolded state 
of SB. The information could be helpful in understanding the structural stability of stem 
bromelain in particular and cysteine proteases and other hydrophobic protein in general in the 
presence polyethylene glycols, which is a commonly used protein salting out and 
crystallization agents. 
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3.2. Results and Discussion 
3.2.1. Studies on the acid unfolded and molten globule states of cataly-
tically active stem bromelain: a comparison with catalytically in-
active form 
3.2.1.1. Autolysis measurements 
The time courses of the autolysis process of stem bromelain in the pH range 0.8-7 were 
monitored by TCA precipitation method [113]. Figure 3.1 shows the time dependent changes 
of absorbance at 275nm of supernatant of TCA precipitated SB at pH 7, 3, and 0.8. No 
autolysis was observed upto 4 hours in the pH region 0.8-3(all data not shown for clarity 
reason). Therefore, pH induced unfolding of unmodified SB can be determined in the pH 
region 0.8-3.0 without facing any complication of autocatalysis. 
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Figure 3 .1 . Extent of autolysis monitored by the time dependent changes of OD at 275nm of 
supernatant of trichloroacitic acid precipitated stem bromelain at pH 7.0,3.0, and 0.8. 
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3.2.1.2. Acidic pH induced unfolding of SB 
Figure 3.2A shows acidic pH induced unfolding profile of SB as monitored by ellipticity 
measurements at 208 and 222nm. The measurements of ellipticy at these wavelengths were 
used to monitor changes in the conformation of the polypeptide backbone. The ellipticities at 
222nm and 208 nm decreased markedly below pH 3 to a minimum value at around pH 2.0. A 
further decrease in the pH below 2.0 resulted in a second transition, corresponding to the 
formation of secondary structure, which became maximum at pH 0.8. Below pH 0.8, the 
protein was found to aggregate. In the first transition, 82.5% loss of secondary structure took 
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Figure 3.2. pH dependence of mean residue ellipticity (MRE) of unmodified stem bromelain at 222nm, 
208nm (A) and 285nm (B) 
place, calculated on the basis of the difference in the ellipticity at 222nm between the native 
and denatured state in 6.0 M GnHCl taken to be 100%. However in the second transition, 
81.8% secondary structure reformed. When the effect of pH was assessed by MRE 
measurements at 285nm, a probe for tertiary structure determination, a sharp decrease in the 
MRE values was observed on decreasing the pH below 3, reaching a minimum at pH 2.0 and 
remained almost unchanged down to pH 0.8 (figure 3.2 B). A comparison with 6M GnHCl 
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denatured state of SB, which is considered to exist in a random coil conformation [144], SB 
is appeared to devoid of specific tertiary contacts in the pH range 2.0-0.8. 
In order to study the exposure of hydrophobic clusters of the protein during acidic pH 
induced unfolding of SB, effect of pH was followed by ANS fluorescence at 480 nm after 
exciting the ANS-protein complex at 380nm (figure 3.3). The hydrophobic dye, ANS binds 
to hydrophobic patches in proteins and fluorescence emission is known to increase on 
binding [145]. As can be seen from the figure, a gradual increase in the fluorescence intensity 
was observed on decreasing the pH below 2.4, reaching a maximum at around pH 0.8, 
whereas no change in the ANS fluorescence was observed in the pH range 3-2.4. 
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Figure 3.3. Effect of pH on the ANS fluorescence intensity at 480nni of stem bromelain after exciting 
the ANS-protein complex at 380nm 
The transition obtained by ANS fluorescence measurements is not consistent with the 
transition followed by ellipticity measurements either in far-UV CD or near-UV CD regions 
(figures 3.2A and 3.2B). Acid unfolded state at pH2.0 retains small amount of secondary 
structure compared to completely unfolded protein in 6 M GnHCI but devoid of specific 
tertiary contacts. Thus small binding of ANS to the protein at pH 2.0 might be either due to 
small amount of hydrophobic clusters (present in residual secondary structure) or presence of 
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small population of MG state. These results suggest the presence of large number of solvent 
accessible non-polar clusters in the protein molecule at pH 0.8 and retention of small amount 
of non-polar clusters also at pH 2.0. 
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Figure 3.4. EfTect of pH on tryptophanyl fluorescence of stem bromelain. The protein was excited at 
296 nm (A) maximum wavelength of emission ()^ai) (B) and relative fluorescence intensity 
at 345 nm was measured. 
In order to study the acid induced unfolding transition of SB in great detail, acid induced 
unfolding is also followed by intrinsic fluorescence properties of the protein. Stem bromelain 
contains five tryptophanyl residues [126] and extensive sequence homology with papain 
indicates that three Trp-residuces are buried in the hydrophobic core whereas two of them are 
located near the surface of the molecule. As the fluorescence properties (fluorescence 
intensity and maximum wavelength of emission) are highly sensitive to the polarity of its 
microenvironments, the pH induced changes in the conformation of SB are followed by 
measurements of relative fluorescence intensity (RFl) at 345nm and X^ ax of emission after 
exciting the protein at 296 nm (figure 3.4A and 3.4B). Lowering the pH to 2.0 caused a red 
shift of 4nm and remained almost unchanged down to pH 1.4, but when the pH was 
decreased below 1.4 a second transition corresponding to blue shift of Inm occurred which in 
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turn tailed off at pH 1.0 (figure 3.4A). On the other hand, a gradual quenching of 
tryptophanyl fluorescence was observed in the pH region 3.0-0.8 (figure 3.4B). The observed 
red shift of >.maxand quenching of intensity in the pH region 3.0-2.0 could be ascribed to the 
exposure of tryphanyl residues to the polar environment due to unfolding of the protein. 
Whereas, slight blue shift (from 352 to 351) observed around pH 1.0-0.8 might be due to 
creation of slight hydrophobic environment around Trp residues may be due to reformation 
of secondary structure as discussed in the far UV-CD section. 
Taken together these results it may be concluded that stem bromelain at pH 2.0 exists as 
acid unfolded state which lost around 80 % of native secondary structure and almost 
complete loss of tertiary structure. However, SB at pH 0.8 exhibits characteristics of molten 
globule state [31] i.e. native like secondary structure contents, enhanced ability to bind 
hydrophobic dye ANS and absence of specific tertiary contacts. The acid induced unfolding 
of SB was found to be a irreversible process for all the transitions studied by different probes. 
Therefore, mechanism of acid induced unfolding of SB may be represented as 
N -^ UA-^ M G 
pH 2.0 pH 0.8 
where N, UA and MG are the native, acid unfolded and molten globule states respectively. To 
ascertain whether the protein state observed at pH 2.0 and 0.8 represented the UA and MG 
states, we compared the far UV CD spectra, near UV CD spectra, ANS and intrinsic 
fluorescence spectra of these states with those obtained at pH 7.0 (native state) and in the 6M 
GnHCl denatured states 
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3.2.1.3. Circular Dichroism 
Figure 3.5A shows the far UV CD of SB in the native, UA, MG states, and completely 
denatured state in presence of 6M GnHCl. Native SB revealed two negative peaks around 
222nm and at 208 nm with the signal pronounced in magnitude at the 208 nm, demonstrating 
typical of a+p proteins [146]. The spectra for UA acquired all the features of GnHCl 
denaturedstate, although it was slightly more structured compared to GnHCl unfolded state. 
The spectrum of molten globule like state was characterized by CD band at 222nm and 208 
nm indicating that it retained all the elements of secondary structure found in native protein. 
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although there was a decrease in the ellipticity values at 208 nm suggesting loss of secondary 
structure without affecting basic format. 
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Figure 3.5. Far-UV CD (A) and near UV CD(B) spectra of native state at pH 7.0 ( ) acid 
unfolded state at pH 2.0 (—), molten globule state at pH 0.8 ( ) and 6 M GnHCI 
denatured state ( ) of stem bromlain. Spectra were obtained at protein concentration 
of 0.31 mg/ml and 1.07 mg/ml in the far and near UV CD region respectively. 
Figure 3.5B shows CD spectra of different states of stem bromelain in the near UV 
region, which provide information about the tertiary structure of the protein. The spectrum of 
native SB exhibits a negative band maximum at 298 nm and a broad positive band at 280nm, 
which is in accordance with the previous findings [146]. At pH 2.0 the negative band at 
298nm converts into a broad positive band and positive band at 280nm into negative band. 
The spectrum at pH 2 of SB is essentially the same as that at pH 2 in the presence of 6 M 
GnHCI indicating that acid denatured stem bromelain has lost almost all its tertiary structural 
elements. As can be seen from the figure spectrum of MG state at pH 0.8 lacks all the 
features of native states and hence does not contains any specific tertiary contacts like MG 
states presents in many other monomeric proteins [25,31 ]. 
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3.2.1.4. ANS binding: 
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Figure 3.6. Fluorescence emission spectra of ANS bound to native, acid unfolded, molten globule and 
unfolded in 6 M GnHCI states of stem bromelain. 
ANS, a fluorescent hydrophobic dye is popularly used to monitor the exposure and / or 
disruption of hydrophobic patches of proteins during its unfolding /folding process [49, 
145,]. ANS has higher affinity for the intermediate state of protein than tfie protein in the 
native state or completely unfolded state. Because intermediate conformations of the protein 
has exposed hydrophobic patches for ANS binding, which is less accessible for ANS binding 
in the native protein and is disrupted in the completely unfolded state [147]. Figure 3.6 shows 
the fluorescence spectra of protein-ANS complex in the 400-550 nm range of native, acid 
unfolded, MG and unfolded (pH 2.0 + 6 M GnHCI) states of stem bromelain. As can be seen 
the binding of ANS to MG state produce a large increase in fluorescence intensity compared 
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to native and unfolded states indicating sizeable amount of exposed hydrophobic clusters of 
MG state of SB. 
3.2.1.5. Tryptophanyl fluorescence quenching studies 
Measurement of the extent of quenching of tryptophanyl fluorescence by an external 
quencher is a very sensitive probe in determining the exposure of the tryptophanyl residues to 
the solvent [119]. Uncharged molecules of acrylamide were used to quench the fluorescence 
of tryptophanyl residues. Analysis of quenching data by modified Stem-Volmer equation ( 
see materials and methods) enable us to determine effective quenching constant Kc, and 
number of accessible tryptophan residues 1^  
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Figure 3.7. Modified Stem-Volmer plots for acrylamide quenching of tryptophan fluorescence of native 
(#) , acid unfolded (o) and molten globule (A) states. For comparison, the acryl amide 
quenching of N-acetyle-L-tryptophanamide (NATA) is shown (dashed line). 
Stem bromelain contains five tryptophan residues at different locations throughout the 
polypeptide chain [126] Figure 3.7 shows the modified Stem-Volmer plots for acrylamide 
quenching studies for various states of stem bromelain. A comparison of parameters ( Kc and 
fa) provide information about the changes in the accessibility of tryptophanyl residues of SB 
during various treatments (table 3.1). Results for the quenching of tryptophan analogue N-
acetyltryptophanamide (NATA) are also included as a standard for complete accessibility to 
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quencher. Quenching of N- acetyltryptophanamide (NATA), as a model compound that is 
fijlly accessible to the solvent, is characterized by effective quenching constant Kc = 22.35 
Table 3.1. Acrylamide quenching of tryptophanyl fluorescence. 
Stem Bromelain 
States 
Native (pH 7.0) 
UA (pH 2.0) 
MG (pHO.8) 
NATA 
r . 2 ^ - - • - . : - _ , . « . _ • 
Kc (M') 
11.27 
3.89 
6.5 
22.35 
f. 
0.39 
0.89 
0.83 
1.05 
R^  Accessible fluorophore* 
0.994 1.95 
0.981 4.45 
0.997 4.15 
0.982 
^calculated on the basis that fa = 1.0 is indicating accessibility of all the 5 tryptophanyl 
and f a= 1-05. The effective quenching constant (Kc) for native SB (pH 7) was 11.2 M-' and 
the fraction of accessible fluorophore fa 0. 39 indicating that 2 tryptophan residues are 
accessible to solvent, which agrees with crystal structure of papain that showed extensive, 
sequence homology with SB [134]. Both papain and SB belong to cystein proteases family of 
the protein. The fraction of exposed tryptophan residues of SB increased in acid unfolded 
state to the value (fa = 0.89) corresponding to the exposure of 4 tryptophan residues to the 
solvent. As shown in table 3.1 small difference in the fri values between MG state and UA 
state indicate that they have almost similar tryptophanyl microenvironment. These results 
together with intrinsic fluorescence and aromatic CD results suggested that MG state of SB is 
very similar to UA state. The MG state is different from the UA state only in possessing 
pronounced amount of secondary structures. 
3.2.1.6. Effect of modification on the acid induced unfolding pathway of SB 
To avoid any complication due to autolysis, active amino acid side chain of proteolytic 
enzymes is generally modified before performing unfolding refolding studies. This inactive 
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enzyme cannot be in native state in the absence of activity even under the physiological 
condition. In view of this, here we are comparing the various spectroscopic properties of 
Table 32. Spectroscopic properties of difTerent states of SB and mSB 
Variables 
•MRE222mn 
''%a-helices 
"MREasonm 
ANS-protein complex 
Fluorescence 
^msK 
RFWnm 
XmQA) 
Unmodified SB 
pH7.0 pH2.0 
-8404 -3409 
20 3.5 
237 -20 
1 2.4 
348 352 
1 0.75 
-
pHO.8 
-8151 
19.3 
-6 
5.7 
351 
0.38 
2.3 
pH7.0 
-7984 
18.6 
198 
1 
347 
1 
3.5 
Modified SB 
pH2.0 
-4764 
8 
50 
5 
344 
0.41 
-
pHO.8 
-7156 
15.9 
51.2 
15 
346 
0.48 
2.3 
'MRE , deg-cm^dmol'' ; *" calculated by method of Chen et al; ^ obtained from GnHCl induced normalized 
transition curves shown in fig. 8. 
native (pH 7.0), acid unfolded (pH 2.0), and MG (pH 0.8) states of modified and unmodified 
stem bromelain (table 3.2) fi-om the results presented above and our previous reports on 
modified SB [35] 
The effect of modification on the secondary and tertiary structures of SB was monitored 
by far UV and near UV CD respectively. The far UV CD spectra were similar in both the 
cases as also reported elsev*diere [35, 146 ]. The near UV CD spectrum of unmodified SB 
showed a broad positive maximum around 280 ran and a negative minimum at 298nm. The 
absence of negative minimum at 298nm from the spectrum of modified SB together with 
small but significant changes in the fluorescence properties (table 3.2 ) may be due to change 
in the environment of Trp residues because of alkylation of active site Cys-26. These results 
suggest that modification of SB to inactivate also affect the native conformation of the 
protein. 
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As summarized in table 3.2, the effect of modification is more prominent at pH 2.0 where 
SB exists in acid unfolded state. At pH 2.0, the modified SB retains about 42% of the 
secondary structure while unmodified SB exhibits almost complete loss of secondary 
structure. Near UV CD, intrinsic fluorescence, ANS binding, and tryptophanyl fluorescence 
quenching studies indicated that mSB exsits as PFI and SB as unfolded states at pH 2.0. This 
indicated that alkylation impart stability to SB toward pH denaturation, although it does not 
affect the charge state of the protein. 
It is interesting to note that in spite of significant differences between the acid unfolded 
states of mSB and SB, molten globules states have almost same spectroscopic properties 
(table 32). The structural stability of the molten globule states of mSB and SB were 
determined by GnHCI induced unfolding followed by MRE measurements at 222nm. Figure 
3.8 showed the normalized transition curves for GnHCI induced unfolding of mSB at pH 7.0 
and molten MG states of mSB and SB at pH 0.8. GnHCI induced unfolding of both native 
and MG states were cooperative and the transitions curves were sigmoidal. The Cm values 
have been used as a measure of stability as delta Gu could not be determined because of the 
? 0.5 
[GnHCI], M 
Figure 3.8. Normalized transition curves for GnHCI induced unfolding of molten globule states of 
mSB, SB and mSB at pH 7.0 as followed by MRE measurements at 222nm. 
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irreversibility of the unfolding process. The Cm values of mSB at pH 7.0, MG states of mSB 
and SB are found to be 2.4, 2.3 and 3.5 M, respectively. The Cm values for MG states of 
both preparations are almost equal but lower than mSB at pH 7.0. Since both pseudo-native 
and MG states contains almost equal amount of secondeiry structure, lower stability of MG 
states compared to pseudo-native state might be due to loosely ordered secondary structure of 
MG states. Although, MG states generally unfold non-cooperatively [30,38,148], cooperative 
unfolding of MG states has also been reported in some proteins [30, 39, 149]. Usually, the 
chemical denaturation of MG state is cooperative, but thermal unfolding is either non-
cooperative or relatively cooperative. A possible explanation of this behavior as suggested by 
Aral and Kuwajima [31] is that the thermal unfolding more effectively disrupts the structures 
and interactions responsible for the origination of native state fcom molten globule state 
(stage II of hierarchical folding) while the denaturant induced unfolding disrupt all the 
structure and interactions organized at stage I (formation of MG from unfolded state) and 
stage II. 
In the study presented here, we have shown that stem bromelain acquired a MG state 
at pH 0.8 from native state through an acid unfolded state occurring at pH 2.0. The structure 
of acid unfolded states may be different depending on the states of modification, but no 
significant differences were noted either in structure or stability of the MG states. Thus, these 
observations lead us to believe that MG state is an essential intermediate in the unfolding 
pathway the stem bromelain. Our study on the acid induced unfolding of SB reveal that it 
exhibits unfolding behavior characteristic of type I proteins as classified by Fink et al [53] 
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3.2.2. Low versus high molecular weight poly (ethylene glycol)-induced 
states of stem bromelain at low pH: stabilization of molten globule 
and unfolded states 
32.2.1. Effect of PEGs on far-UV CD spectrum of UA state of stem bromelain 
As discussed above, SB existed in acid induced unfolded state at pH 2.0 (UA), which 
refold into MG state around pH 0.8. Here we have systematically investigated the effect of 
different molecular weight PEGs on the structure of acid induced unfolded state of 
unmodified preparation of stem bromelain at pH 2.0. As can be seen from figure 3.9A and 
3.9B unmodified stem bromelain at pH 2 exhibiting almost complete loss of helical contents 
(~ 78% table 3.3) compared to native state at pH7.0. The stem bromelain at pH 2.0 
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Figure 3.9. Far-UV CD spectra of native state at pH 7.0 ( ) acid unfolded state at pH lA ( ), 
reversibility point ( ) and 70% (w/v) PEG 400 induced state ( ) of stem bromelain 
(A). Figure B shows the Far-UV CD spectra of 6 M GnHCI denatured state ( ), 40% 
(w/v) PEG 6000 ( ) and PEG 20000 ( ) unfolded states of stem bromlain. Spectra 
were obtained at protein concentration of 0.23 mg/ml. 
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Table 3 3 Structural properties of different conformational states of stem bromelain as 
studied by far-UV CD at 222nm 
States Conditions MRE222niD Helix' Vo, 
Native pH 7.0,25 X -8437 20.1 
Acid unfolded (UA) pH2.0,25T -3409 3.8 
Irreversibility point dialyzingUA -3846 4.9 
against pH 7.0. 25 "C 
Unfolded (U) GnHCl,6.0M -642 
MG state UA+70%(W/W)PEG-400 2 5 ° C -7593 17.3 
PEG-6000 state UA + 40% (w/w) PEG-6000 25 X -2053 
PEG-20000 state UA + 40% (w/w) PEG-20000 25 X -830 
a calculated by the method of Chen et al [28], MRE, Mean retidue ellipticity (degree cm2dnioM) 
represents the acid unfolded state (UA) of the enzyme. The loss of helical contents have been 
calculated on the basis of difference in ellipticity at 222nm between the native and denatured 
state in 6.0 M gwanidine hydrochloride taken to be 100%. Results of the fer-UV CD studies 
on the reversibility of acid unfolded stem bromelain at pH 2.0 lead us to believe that UA state 
is irreversible retaining slightiy more secondary structure than the protein treated with 6.0 M 
GnHCl concentration, a concentration at which the protein is considered to exist in a random 
coil conformation [144] 
Figure 3.10 shows the effect of different molecular weight polyethylene glycols 
concentrations (PEG-400,6000 and 20,000) on acid unfolded state (UA) of stem bromelain at 
pH 2.0 as monitored by the measurements of mean residue ellipticity (MRE) at 222 nm. 
Alteration in the ellipticity at this wavelength is a useful probe for monitoring variations in 
secondary structure contents. As seen in figures 3.10, addition of PEG-400 leads to increase 
in MRE value at 222nm indicating formation of secondary structure. It is interesting to note 
that in the concentration range of 70-90 % (w/v) PEG-400 induced secondary structure 
approached almost to tiiat of the native state. On the other hand, PEG-6000 and 20,000 
45 
disrupt the secondary structure of acid induced state of SB cooperatively as manifested by 
sigmoidal transitions (fig 3.10). The transitions started at 15 % (w/v) PEG 6000 and 20,000 
and tailed off at 40 and 35 % (w/v) respectively. 
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Figure 3.10. Change in IMRE of acid unfolded stem bromelain at 222nm in the presence of 
increasing concentration of PEG-400 (•) , PEG-6000 (a) and PEG-20000 (A). 
To ascertain whether UA state in the presence of 70 % (w/v) PEG-400 and 40 % PEG 
6000 and 20, 000 represented the secondary structure features of native protein and unfolded 
protein respectively, we compared the far UV CD spectra of these states with those obtained 
at pH 7.0 and in the 6M GnHCl denatured state respectively (fig 3.9A and 35B). Native SB 
revealed two negative peaks around 220-222nm and at 208 nm with the signal pronounced in 
magnitude at the 208 nm, demonstrating characteristic typical of a + p proteins [146]. The 
spectra of UA state in the presence of 70 % (w/v) PEG-400 was characterized by the presence 
of a prominent negative minimum at 212 nm, suggesting that the state contains both the alpha 
helical and beta- sheet stmcture wiiich are also found in the native state. Figure 3.9B shows 
the spectra for UA state of SB in the presence of 40% (w/v) PEG-6000, PEG-20, 000 and 6.0 
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M GnHCI demonstrating extent of disruption of tiie secondary structure by these PEG's. The 
spectra for UA state of SB in the presence of 40% (w/v) PEG-6000 has feature of beta sheet 
protein (e.g. has negative minima -215 nm). The decrease in the ellipticity value at 222nm 
from the UA state as discussed in figure 3.9B may be due to loss of alpha helices and/ or 
retention of beta sheet structure, which constitute on of the domains of stem bromelain [146]. 
UA in the presence of 40% (w/v) PEG-20, 000 lost all the elements of secondary stucture and 
resemble the protein state in 6 M GnHCI concentration. 
Based on above results we may conclude that 70 % (w/v) PEG-400 led to the 
formation of native like secondary structure and 40 % (w/v) PEG-20, 000 unfold the UA 
state to random coil like state. On the other hand, in the presence of 40 % (w/v) PEG 6000, 
UA contained mainly beta-sheet conformation. 
32.22. Effect of PEGs on tryptophanyl fluorescence of UA state of stem bromelain 
The emission spectrum of tryptophanyl residues was measured after excitation at 
296 nm. This excitation wavelength was selected to minimize radiation less energy transfer 
from the tyrosine residues, which can contribute to tryptophan emission when an excitation 
wavelength of 280 nm is used. Figure 3.11 shows the tryptophanyl fluorescence spectra of 
native state, UA state, completely unfolded state (pH2 + 6M Gn.HCl) and in the presence of 
increasing concentration of PEG-400. The intensity of the fluorescence decreases by ~50% 
along with a red shift of 4nm in the emission maximum from 348 to 352 as the protein was 
transferred fi-om pH 7 to 2 indicating exposure of tryptophan residues to polar environment. 
The observed increase in X max and decrease in fluorescence intensity together with 
significant loss of secondary (fig 3.9A) structure are indicating that SB at pH 2, exist in a 
significantly unfolded state. Fluoresce spectra (figure 3.11 curve 3) again showed the almost 
irreversible nature of the UA state of stem bromelain. Whereas the florescence spectrum of 
completely unfolded SB (6M Gn. HCl) suffers a red shift from 348 to 356nm along with a 
decrease in fluorescence intensity of-50 %. As shown in figure 3.12A the wavelength of 
maximum of the tryptophanyl fluorescence of UA state of SB exhibited a one step decrease 
from 30% PEG-400 to 80% with a continuous increase in the fluorescence intensity (3.12B). 
A sigmoidal decrease in Xn^ x reaching a minimum equal to native SB but significantly higher 
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intensity (figure 3.11) compared to native protein indicated that 70%(w/v) PEG-400 induced 
state is different from the native one. As can be seen from figure 3.12A and 3.12B, addition 
too 
31O 41O 
W a v e l e n o t h ( n m ) 
Figure 3.11. Fluorescence spectra of native (curve 1), 6 M GnHCI denatured (curve 2), reversibility 
point (curve 3), acid denatured stem bromelain in tlie absence (curve 4) and presence of 
PEG400,40 (curve 5) 60 (curve 6), 70 (curve 7), 80 (curve) and 90 (curve 9) % WA'. 
of polyethylene glycols 6000 and 20000 results in an increase in tiyptophanyl fluorescence 
intensity and a concomitant red shift of the maximum wavelength of acid denatured stem 
bromelain at their higher concentration. The observed increase in maximum wavelength and 
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fluorescence intensity together with loss of secondary structure is indicating the unfolding of 
UA by these PEGs. 
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Figure 3.12. Effect of increasing concentration of PEG 400 (•), 6,000 (a) and 20,000 ( • ) on 
tryptophanyl fluorescence of acid unfolded stem bromelain. The protein was 
excited at 296 nm and tlie (A) maximum wavelength of emission (>.,„..) and (B) 
relative fluorescence intensity at 348 nm was measured. 
3.2.2 J. ANS binding studies 
ANS, a fluorescent hydrophobic dye is popularly used to monitor the exposure and / or 
disruption of hydrophobic patches of proteins during its unfolding /folding process [145]. 
ANS has higher affinity for the intermediate state of protein than the protein in the native 
state or completely unfolded state. Because intermediate conformations of the protein has 
exposed hydrophobic pockets for ANS binding, which is less accessible for ANS binding in 
the native protein and is disrupted in the completely unfolded state [147]. We therefore 
attempted to identify the induction of intermediate and denatured states of bromelain by 
following the ANS binding in the presence of PEGs of various molecular weights. Figure 
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3.13 A shows the fluorescence spectra of protein-ANS complex in the 400-550 nm range of 
native, acid unfolded and unfolded (pH 2.0 + 6 M GnHCl) states of stem bromelain. As can 
be seen the binding of ANS to UA state produce a large increase in fluorescence intensity 
400 Wavelength (nm) 550 Wavelengtti(mn) 400 550 
Figure 3.13. Fluorescence emission spectra of ANS bound to native (curve 1), acid unfolded (curve 2) 
and unfolded in 6 M GnHCI (curve 3) states of stem bromelain (A) and PEGs blank 70% 
(w/w) PEG-400 (curve 1), 40% (w/v) PEG-6000 (curve 2) and 40% (w/w) PEG-20,000 
(curve 3) (B). 
compared to native and unfolded states indicating sizeable amount of exposed hydrophobic 
clusters of UA state of SB. PEGs at pH 2.0 show marked increase in the ANS fluorescence 
intensity even in the absence of protein. As shown in figure 3.13 B, ANS fluorescence is 
maximum in the presence of 70% (w/w) PEG-400 followed by 40% (w/w) PEG-6000 while 
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40% (w/w) PEG-20000 show least ANS fluorescence. The observed ANS fluorescence with 
PEGs could be explaind on the basis that PEG is a nonpolar polymer can assume compact 
structure in aqueous solutions by intramolecular hydrophobic interactions [138]. These 
intramolecular hydrophobic interactions might be responsible for creating clustered 
hydrophobic pockets for the binding of hydrophobic dye, ANS. Due to greater non-ideality 
of high molecular weight PEGs (eg 6000, 20000), they acquire more compact structure 
compared to low molecular weight PEGs (e g PEG 400). The more compact structure of high 
molecular weight PEGs provide less hydrophobic surfaces for ANS binding than low 
molecular weight PEGs. These provide reason for higher ANS binding to PEG 400 than PEG 
6000 and PEG 20000. 
Figure 3.14 shows PEGs induced conformational changes as monitored by ANS-protein 
fluorescence at 480 nm by exciting the complex at 380 nm. As mentioned above 
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Figure 3.14 ANS fluorescence intensity at 480nni of acid unfolded SB in the presence of increasing 
concentration of PEG- 400 (•), PEG-6000 (a) and PEG-20,000 (A). 
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. PEG showed a significant amount of ANS binding. To rule out the contribution of PEGs, 
their respective blank were prepared and fluorescence emission corrections for possible 
contribution of PEGs were made. As can be seen from the figure 3.14 ANS binds maximally 
to UA state in the presence of 70% (w/v) PEG-400, while a decrease of ANS binding in the 
presence of increasing concentration of PEG-6000 and 20, 000 was observed. The decrease 
in ANS binding in the presence of 40% (w/v) PEG-6000 and 20, 000 were comparable to 
GnHCl unfolded state of stem bromelain. Since ANS binds to accessible hydrophobic 
patches on the protein with greater affinity, these observations suggest a remarkable increase 
in the number of solvent accessible non-polar clusters of the UA state at 70% PEG-400. 
Decrease in the ANS binding in the presence of PEG 6000 and 20, 000 might be due to the 
unfolding of UA as discusses in far-UV CD and intrinsic fluoresce section. It is 
understandable that ANS binding sites are absent in the completely unfolded proteins 
because of disruption of hydrophobic patches due to unfolding [150]. 
The changes in various structural properties like secondary structure, tryptophanyl 
fluorescence and ANS binding in the presence of various molecular weight PEGs indicate 
that low and high molecular weight PEGs have opposing effects on acid unfolded state of 
SB. The acid unfolded state at 70% (w/v) PEG-400 has characteristic features of 'molten 
globule' state i.e. native like secondary structure, altered tryptophanyl fluorescence, and 
exposed hydrophobic clusters [31-35]. On the other hand UA state in the presence of 40%' 
PEG 20, 000 resemble to completely unfolded state obtained by treating UA in 6 M GnHCl. 
Since molten globule has important implications in protein folding reaction, the MG state 
was further characterized by near UV CD and acrylamide induced tryptophanyl quenching. 
3.2.2.4. Near-UV CD 
Figure 3.15 shows CD spectra of different states of stem bromelain in the near UV region, 
which provide information about the tertiary structure of the protein. The spectrum of native 
SB exhibits a negative band maximum at 298 nm and a broad positive band at 280nm, which 
is in accordance with the previous findings [146]. At pH 2.0 the negative band at 298nm 
converts into a broad positive band and positive band at 280nm into negative band. The 
spectrum at pH 2 of SB is essentially the same as that at pH 2 in the presence of 6 M GnHCl 
indicating that acid denatured stem bromelain has lost almost all its tertiary structural 
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elements. As can be seen from the figure 3.15, additions of PEG-400 lead to the increase in 
positive ellipticity at 298 nm and small increase at 280 nm might indicate formation of 
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Figure 3.15 Near-UV CD spectra of native ( ), acid unfolded (•-) states, reversibility point ( ) 
and 70 % (W/V) PEG 400 induced state ( ), 6IV1 GnHCl unfolded state ( ),40 % 
(WAO PEG 6000 ( ) and PEG 20,000( ) unfolded states of stem bromlain. Spectra 
were obtained at protein concentration of 1.07 mg/ml. 
tertiary contacts. Comparing the near UV CD spectra of native, acid unfolded and GnHCl 
denatured SB with PEG-400 induced state, it may be concluded that PEG-400 induced state 
has a different conformation than either native or denatured state. 
The near UV CD studies of acid denatured SB in the presences of high molecular 
weight PEGs (6,000 and 20,000) show decrease in ellipticity in the region 320-250 nm but 
spectral features are essentially the same as that of denatured SB. This indicates that high 
molecular weight PEG stabilize the denatured state of stem bromlain. 
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3.2.2.5. Tryptophanyl fluorescence quenching 
Figure 3.16 shows the modified Stem-Volmer plots for acrylamide quenching studies for 
various states of stem bromelain. A comparison of parameters (KC and fa) provides 
information about the changes in the accessibility of tryptophanyl residues of SB during 
various treatments (table 3.4). Results for the quenching of tryptophan analogue N-
acetyltryptophanamide (NATA) are also included as a standard for complete accessibility 
o 
u. 
[1/Q] M-^  
Figure 3.16. Modified Stem-Volmer plots for acrylamide quenching of tryptophan fluorescence of 
native ( • ) , acid unfolded stem bromelain in the absence (o) and presence of 70% (W/V) 
PEG 400 ( • ) . For comparison, the acryl amide quenching of N-acetyie-L-
tryptophanamide (NATA) is shown (dashed Une). 
to quencher. Quenching of N-acetyltryptophanamide (NATA), as a model compound that is 
fully accessible to the solvent, is characterized by eflFective quenching constant Ko = 22.35 
and fa = 1.05. The effective quenching constant (JQ for native SB (pH 7) was 11.2 M"' and 
the fraction of accessible fluorophore fa 0. 39 indicating that 2 tryptophan residues are 
accessible to solvent, w^ich agrees with crystal structure of papain that showed extensive 
sequence homology with SB [134]. Both papain and SB belong to cystein proteases family of 
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the protein The fraction of exposed tryptophan residues of SB increased m acid unfolded 
state to the value (fa = 0 89) corresponding to the exposure of 4 tryptophan residues to the 
solvent The fa of NATA is significantly higher than those for UA and 6M GnHCl unfolded 
states, indicating that these denatured conformations are not fully unfolded As shown in 
table 3 4, fractions of tryptophanyl residues accessible to quencher decreases in 70 %(w/v) 
PEG 400 induced state of stem bromelain This suggests a possible compaction of acid 
unfolded state by PEG 400 As indicated by near UV CD (figure 3 15) compaction by PEG-
400 might be due to formation of non native contacts 
Table 3.4. Acrylamide quenching of tryptophanyl fluorescence. 
Stem Bromelain States Kc (M'') fa R^  Accessible fluorophore* 
Native (pH 7 0) 
UA {pH2 0) 
M G (pH 2 0 +70% WrV, PEG-400) 
11 27 
3 89 
6 50 
0 39 
0 89 
0 81 
0 994 
0 981 
0 996 
1 95 
4 45 
4-05, 
NATA 22 35 1 05 0 982 
R2 Correlation coefficient obtained by linear regression 
*calcul<ited on (he basis that fa - 1 0 is indicating accessibility of all the 3 tryptophanyl residues of stem Bromelain 
Previous studies have shovm that PEGs may have either stabilizing or destabilizing effect 
on proteins depending on chemical nature of the protein [138] For PEG, two possible 
mechanisms for protein stabilization have been suggested, stenc exclusion and exclusion due 
to protein charge [139] Exclusion of PEG either by stenc exclusion mechanism or / and 
unfavorable interaction with charges on protein lead to the protein preferential hydration 
which stabilize the stmcture of the protein Arakawa and Timasheff have proposed that PEG 
can bind to hydrophobic sites on protein based on the fact that PEG is essentially non polar 
[138] Thus the destabilizing effect of PEG on protein is due to binding through hydrophobic 
interactions Moreover, as discussed above (ANS bindmg section) high molecular weight 
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PEGs assumes more compact structure than smaller PEGs. According to this mechanism 
effective exclusion size of higher molecular weight PEGs should be less compared to low Mr 
PEGs. The decrease in preferential exclusion of high Mr PEGs should allow these molecules 
to penetrate the hydration layer of the protein and bind to the hydrophobic sites, which lead 
to the unfolding of the protein [138]. The results obtained on stem bromelain can be 
explained accordingly. Stem bromelain is a hydrophobic protein rich in uncharged amino 
acid residues ( ~82%). It contains only -18 % charged aminoacid residues [126]. Far-UV 
CD, near-UV CD, intrinsic fluorescence and ANS binding studies indicated unfolding of 
stem bromelain at pH 2.0 due to charge charge repulsion which led to the exposure of 
significant amount of buried hydrophobic residues. We propose that PEG-6000 and PEG-
20,000 bind to these hydrophobic sites based on the feet that they have smaller effective 
exclusion size which lead to the unfolding of stem bromelain at pH 2.0. This is in agreement 
with the finding of Pace and Marshal [151] that non polar compounds, in general, destabilize 
hydrophobic proteins more than less hydrophobic proteins. The observed stabilizing effects 
of PEG-400 can be explained in terms of fine balance between stabilizing effect due to PEG 
exclusion and destabilizing effects due to binding through hydrophobic interactions. Since 
alcohols are known to enhance local polar interactions (i.e. hydrogen bonds) of proteins [60, 
152, 153], formation of helical structure by high concentration of PEG-400 may be 
understand in terms of dominating effect of terminal hydroxyl group of polyethylene glycols. 
Due to low mass of PEG400, number of hydroxyl group in PEG-400 are much more than 
same concentration of PEG-6000 or 20,000. Similar helix inducing effect of low molecular 
weight PEG has also been reported earlier [154]. However, native tertiary contacts are not 
regenerated in 70% (w/w) PEG400 since near UV CD spectra and fluorescence properties do 
not exhibit native properties. This leads to the transformation of UA into a folded 
intermediate at 70% (w/w) PEG-400 with molten globule like properties. 70% (w/w) PEG-
400 induce stated of stem bromelain w^ich is characterized by native like secondary structure 
without any specific tertiary contacts appears to support fi:amework model of protein folding 
that proposed that local secondary structure elements could form independently of tertiary 
structure [7] 
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3.3. Conclusion and significance of the study 
On the basis of the results discussed above it is possible to conclude that (1) stem 
bromelain acquired a MG state at pH 0.8 from native state through an acid unfolded state 
occurring at pH 2.0. (2) PEG-400 is capable of inducing molten globule (MG) like state from 
acid denatured stem bromelain. (3) Formation of small amount of non-native tertiary contacts 
was also observed in the presence of 70% PEG-400. Interestingly, (4) high molecular weight 
PEG'S 6000 and 20000 which generally stabilize proteins by preferential hydration 
mechanism [138, 155], were found to play denaturing role on acid unfolded stem bromelain. 
In recent years great interest has been focused on detecting and charactering the 
intermediates that might be formed during the folding of proteins [156, 157]. The molten 
globule is one such intermediate of significance. Thus, our characterization of MG state of 
stem bromelain at low pH and in the presence of PEG expected to have a more relevance in 
understanding the folding mechanism of stem bromelain. Moreover, possible destabilizing 
effect of high molecular weight PEG 6000 and 20,000 suggest that care should be exercised 
when PEG is used for protein salting out or crystallization for proteins that are hydrophobic. 
57 
chapter 4. 
CHEMICALS INDUCED UNFOLDING OF HSA 
ISOMERS: IDENTIFICATION AND 
CHARACTERIZATION OF EQUILIBRIUM 
INTERMEDIATE STATES 
4.1. Introduction 
Human serum albumin (HSA), a monomelic protein of 585 residues and molecular mass 
of 66.5 kD is the major protein component of blood plasma [158]. According to X- ray 
crystallographic analyses of HSA and its recombinant version (rHSA), the polypeptide chain 
forms a heart shaped protein with approximate dimensions of 80 x 80 x 80 x 30 °A and about 
67 % a helix but no P sheet (figure 4.1)[158, 159]. It has three homologous domains, which 
are further divided, into sub domains A and B [159]. The A and B subdomins have six and 
four a helices, respectively, connected by flexible loops. HSA contains only one tryptophan 
residue at position 214 in domain II and one free cysteine residue at position 34 in domain I, 
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Figure 4.1. Stereo view of the heart shaped structure of human serum albumin with overall topology 
and secondary structure. Carter, D.C., Ho, J.X. (1994). 
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although it has 17 disulphide bonds [158]. Its overall native three dimensional conformation 
is stabilized by various intra and inter domain forces, such as salt bridges, hydrophobic 
interactions, and natural boundaries involving helical extensions h 10(domain I)-hl (domain 
2) and h 10(domain 2)- hl(domain 3) existing between three domains of albumin[l 15, 158-
J60]. 
HSA undergoes several transitions in dependence of pH, the N'^F transition between 
pH 5.0 and 3.5, the F-<-»^E transition (acid expansion) below pH 3.5, and the N-«-»B transition 
between pH 7.0 and 9.0 [115,158,161]. Geisow and Beaven [162] proposed that N*->F 
transition involved the unfolding of domain III from the rest of the molecule, which was later 
verified by Khan and Salahuddin.[163] using proteolytic fragment serum albumin containing 
residue 377-582. Dockal et al. [115] by using recombinant domains have provided evidence 
that the loosening of the HSA structure in the N-«-»F fransition takes place primarily in 
domain III. N+-+F transition involves major structural changes in domain III without effecting 
domain I and II [115]. Under slightly alkaline conditions, between pH 7.0 zmd 9.0, HSA as 
well as its bovine counterpart, BSA undergo a conformational change known as N •-* B 
transition. It is supposed to be a structural fluctuation, a loosening of the molecules with the 
loss of rigidity, particularly affecting the N-terminal region [164-168]. It has been suggested 
that N •<-» B transition involves breaking of salt bridges from domain I to domain III, causing 
increased flexibility of molecules [115,169,170]. Further in the alkaline pH range between 
pH 7.0 to pH 9.0, HSA showed a slight-reduction in helical content and a small increase in P-
sheet structure [115,170]. The recombinant domains of HSA did not show significant 
alteration in their secondary structure content in the alkaline pH region. It was therefore 
suggested that main losses in secondary structure were affecting the two inter-domain helices 
(hio domain I-hidomainii, hiodomainii" hidomainiii) of HSA and that the sccondary structural integrity 
of the domains is not impaired in the N<-»B transition [115]. In the F+-+E transition there is a 
loss of secondary structure of HSA- domain 111 [115] which may be ascribed to the 
disruptions of hydrogen bondings between the hydroxyl groups of tyrosyl residues in HSA 
domain III and carbonyl groups of the peptide backbone. 
Recent advances in physical techniques [171,172] have shown the presence of 
stable intermediate conformation in a number of proteins during chemical induced unfolding 
/refolding processes [173,174]. It has now become clear that folding of many proteins may 
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proceed through these intermediate states [31, 147]. The folding process is even more 
complex in multi-domains proteins [175-178] where each domain may be capable of 
unfolding / refolding independently and inter-domain interactions may affect the overall 
folding topology. 
Albumin denaturation by urea at neutral pH has been studied by a number of workers. 
These studies have established that a stable intermediate exists during urea denaturation of 
serum albumin [179-182]. Tayyab et al. [181], by using domain specific ligands to BSA, 
have suggested major conformational changes in domain III and partial but significant loss of 
native conformation in domain I prior to intermediate formation. 
In this study attempts have been made to characterize the urea induced structural 
transition in N and B isomers of human serum albumin using domain specific ligands 
namely, hemin which binds to domain IB [183, 184], chloroform which binds in the close 
vicinity of single Trp-214 [118], bilirubin which binds to domain II [183] and diazepam 
which binds to domain III [183]. Moreover, as discussed above F isomerisation of HSA 
displays specific structural characteristic. Unfolding studies of this protein (F isomer of 
HSA) will also provide powerful means for understanding important structural and fijnctionai 
characteristic of the native molecule. In view of this, conformational behavior of F isomer of 
HSA in acidic urea solution (pH 3.5) was monitored and the results were compared with 
behaviors of native HSA molecules in neutral urea solutions. Guanidine hydrochloride 
induced unfolding of different domains of N isomer of HSA was also monitored using 
domain specific ligands, which provided significant understanding of the stability of the each 
domain. 
The study will help in understanding the structural and functional stability of B 
isomer of HSA as compared to N isomer. That the N<->'B transition has physiological 
significance is suggested by the fact that under increased Ca^^concentration in blood plasma, 
the B isomer predominates [185]. Moreover, it will also help in understanding the role of 
inter-domain interactions such as salt bridges and natural boundaries between different 
domains as B isomer of HSA is lacking these interactions [115]. 
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4.2 Results And Discssion 
4.2.1 Intermediate formatioii at lower urea concentration in 'B' isomer of 
human serum albumin: a case study using domain speciflc ligands 
4.2.1.1 Urea induced denaturation of N isomer of HSA 
Figures 42A and B show ttie urea-induced denaturation of N isomer of HSA as 
monitored by the measurements of intrinsic fluorescence at 340 nm (after exciting the protein 
at 280 nm) and MRE at 222 nm, respectively. As can be seen from Figures 4.2A and B 
Figure 4.2. (A) Urea denaturatiun profile of'N* isomer of HSA as monitored by intrinsic fluorescence 
intensity measurement at 340 nm (B) by MRE measurement at 222 nm. 
urea-induced denaturation of N isomer of HSA, which started from 2.5 M urea and 
completed around 8.4 M urea, followed a two-step, three-state transition with accumulation 
of an intermediate (1) state around 4.8-5.2 M urea concentration. The T state was 
characterized by abundant secondary structure, i.e., -40% a-heiix as compared to -58% a-
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helix found in the native protein as calculated from MRE values at 222nm. These results are 
in agreement to the earlier observations made for a number of proteins including HSA and 
BSA [31-37, 179-182]. 
4.2.1^ Urea induced denaturation of B isomer of HSA 
Urea induced denaturation of basic (B) isomer of HSA (Figures 4.3A and B) was also 
found to be a two-step process with accumulation of an intermediate (1') state at lower urea 
concentration (-3.0-3.4M). The first transition which corresponded to transformation of B 
state to r state started at ~ 2.0 M urea and completed around 3.0 M urea concentration. 
21000 
Figure 43: (A) Urea denaturation profik of 'B' isomer of HSA as monitored by intrinsic fluorescence 
Intensity measurement at 340 nm (B) by MRE measurement at 222 nm. 
The second transition which corresponded to the unfolding of 1' state started at around 3.5 M 
urea and finally sloped off to the unfolded (U) state at 8.5 M urea concentration. The V state 
possesses -39% a helical stmcture as compared to 45% in basic form of HSA. Therefore, 
urea induced denaturation of both N and B isomers of HSA may be approximated to a two-
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step, three-state transition and mechanism for unfolding for the two forms may, respectively, 
be represented as: 
4 8-5 2 M urea 
N < • I < • U 
3 0-3 4 M urea 
BM • I'M • U 
in order to monitor the loss of native conformation in diflFerent domains of HSA (both N and 
B isomer) during intermediate formation, we studied the binding of different ligands hemin 
(for domain-I), chloroform and bilirubin (for domain-ll) and diazepam (for domain-ill) to 
native as well as urea denatured HSA. Further, conformational changes in domain II were 
also investigated by monitoring the fluorescence of single Trp-214, which resides in domain 
ii of the HSA. 
4.2.13 Conformational transition in domain-1 
Hemin binding 
X-ray crystal structure of HSA-hemin complex and binding studies indicated a single site 
for hemin in domain IB [183, 184]. To get insight into structural alterations in domain IB, the 
binding of hemin to HSA (both N and B isomers) was studied at different urea 
concentrations. The fluorescence quench titration data at increasing hemin / albumin molar 
ratio are shown in Figure 4.4A (data at 5.0 and 3.0 M urea for N and B isomers of HSA 
omitted for brevity). Absence of any significant decrease in hemin binding to N isomer of 
HSA denatured with urea up to 5.0 molar concentrations (Figure 4.4B) suggested that 
domain IB did not undergo any significant structural changes up to 5.0 M urea. Above 5.0 M 
urea concentration, binding of hemin decreased continuously up to 7.0 M urea concentration. 
Decrease in hemin binding to HSA denatured with urea at a concentration higher than 5.0 M 
urea indicated no structural perturbation in domain IB during intermediate formation. As can 
be seen from the Figure 4.4B, there was a significant decrease in the extent of hemin induced 
fluorescence quenching of B isomer of HSA as compared to N isomer indicating significant 
alteration of domain I during N+->B transition. Further, we observed no significant decrease 
in hemin binding to B isomer of HSA upto 3.0 M urea concentrations. Above 3.0 M urea 
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concentration, hemin binding decreased gradually up to 7 0 M urea These results showed 
non-involvement of domain IB during intermediate formation in either case 
01 02 03 04 05 
HemfatMlbumtn (Molar Ratio) 
Figure 4.4. (A) Fluorescence quench titration results of hemin binding to 'N' isomer of HSA ( • ) and 
'N' isomer denatured with 7.0 M ( • ) and 8.0 M (O) urea concentrations and 'B' isomer of 
HSA in the absence (D) and presence of 7.0 M (A) and 8.0 M (A) urea. Figure B shows 
the binding isotherm of hemin to 'N' ( • ) and 'B' (O) isomers of HSA as fuoctioo of urea 
concentration at a fixed hemin / albumin molar ratio of 0.5: lA 
4.2.1.4 Conformational transition in domain-II 
a. Tryptophanylfluorescence 
Figures 4 5A and B show the urea-mduced denaturation of N and B isomers of HSA, 
respectively, by measunng the tryptophan emission fluorescence at 344 nm As can be seen 
from the figure, transitions are single step with no apparent intermediate state The transitions 
started at around 5 2 M urea for N isomer and 3 3 M urea for B isomer of HSA and 
completed at 8 0 M and 6 0 M urea concentrations, respectively Smce HSA contains only 
one tryptophan residue (Trp-2]4), which resides m domam II, changes in fluorescence 
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intensity observed after exciting the protein at 296 nm may be ascribed to the conformational 
changes in domain II. Thus, it can be inferred that no stmctural change occurred in domain II 
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F i g u r e 4 . 5 : (A) Urea denaturation profile of 'N' bomer of HSA and (B) of 'B' isomer of HSA as 
monitored by Trp-214 fluorescence at 344 nm after exciting tlie protein at 296 nm. 
in the urea concentration range 0 -5.0 M and for N isomer 0 -3.2 M for B isomer of HSA. 
Further, the change in fluorescence intensit>' observed by exciting the protein at 280 nm as 
shown in Figures 4.2A and 4.3A, in the urea concentration range 2.5-6M for N form and 
2.0-3.25 M for B isomer may be attributed to conformational changes in domain HI and / or 
domain I. 
b. Chloroform binding 
Recent studies have demonstrated that chloroform binds to the albumin in the close 
vicinity of tryptophan residue (Trp 214) [118]. Since the lone Trp 214 resides in domain IIA, 
to get more insight into structural changes in sub domain IIA, binding of chloroform to N and 
B isomer of HSA was studied at different urea concentrations using tryptophan fluorescence 
(excitation wavelength, 296 nm). Figure 4.6A shows the chloroform-binding isotherm of 
HSA (both N and B isomers) in the absence and presence of different urea concentrations. 
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The equilibration of HSA with chloroform caused concentration dependent quenching of 
tryptophan fluorescence with no apparent shift in the emission maximum (344 nm), which is 
suggestive of the chloroform binding to HSA. 
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Figure 4.6 (A) Chloroform induced tryptophan fluorescence quenching of 'N' Lsomcr of HSA in the 
absence (A) and presence of 5.0 M ( • ) , 6.0 M (*) and 7.0 M (O) urea concentration and 'B' 
isomer of HSA in the absence ( • ) and presence of 3.0 M (O) and 6.0 M ( • ) urea concentration. 
(B) shows the effect of increasing urea concentrations on the chloroform induced tryptophan 
fluorescence quenching of 'N' (O) and 'B' ( • ) isomers of HSA at a fixed chlorofonn 
concentration (18 mM). 
Absence of any significant decrease in chloroform binding to HSA (N and B isomers) up 
to 5.0 and 3.0 M urea, respectively (Figure 4.6B) suggested that domain II did not undergo 
any significant structural change during intermediates formation. Binding of chloroform 
decreased above 5.0 M urea in case of N isomer and above 3.0 M urea in case of B isomer of 
HSA continuously up to 7.0 M urea concentration. These observations indicated the 
structural perturbations in domain n occurred only in second transition. These results were in 
agreement to earlier reports suggesting non-involvement of domain n in conformational 
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transition of HSA during intermediate formation [180, 186]. The above chloroform binding 
studies together with tryptophan fluorescence studies indicated that unfolding of domain II of 
B isomer started at a lower urea concentration (3.0 M) as compared to N isomer (5.0 M urea) 
of HSA. These studies confirmed the strong effect of N<->B transition in domain 11 and non-
involvement of the domain-ll in intermediate formation. 
4.2.1.5 Structural alteration between Domain-IB and Domain -IIA 
Bilirubin binding 
To study conformational changes in the bilirubin-binding cavity of N and B isomer of 
HSA, binding of bilirubin to the two isomer of HSA, was studied at different urea 
concentrations. Since the bilirubin binding cavity is formed by loop 4 of domain II A and 
loop 3 of domain I B, separation and unfolding of domain II from domain 1 can be selectively 
investigated by bilirubin binding studies. Figure 4.7A shows the binding of bilirubin to N and 
B form of HSA. As can be seen from Figure 4.7B, binding of bilirubin to B isomer of HSA 
increases significantly up to 3.0 M urea and then decreases thereafter. At 5.0 M urea, extent 
of bilimbin binding is similar to that of B isomer in the absence of urea, suggestive of 
retention of native like conformation of domain 11 at this urea concentration. Above 5.0 M 
urea, a marked decrease in bilirubin binding was observed which was abolished completely 
at 6.0 M urea. Similar effect was also observed with N isomer of HSA. Binding of bilirubin 
to N isomer of HSA increased significantly up to 5.0 M urea. At 6.0 M urea it became similar 
to N isomer in the absence of urea and binding abolished completely at 7.0 M urea again 
suggesting native like conformation of domain II; this is consistent to previous reports in case 
of BSA [181]. Increase in bilirubin binding to HSA at increasing urea concentration cannot 
be due to non-specific interaction of urea with bilirubin as no fluorescence was observed with 
free bilirubin at different urea concentrations. Since the occurrence of bilirubin fluorescence 
is due to acquisition of helicity in the pigment upon binding to albumin [116], a significant 
increase in bilirubin fluorescence upon binding to urea denatured HSA as compared to N and 
B isomers in the absence of urea suggests that in domain-II undergoes rearrangement as to 
allow the bound pigment to acquire a tight helical twisting. Marked decrease in bilirubin 
binding beyond 5.0 M urea and complete abolishment around 6.0 M urea in B isomer of HSA 
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are suggestive of disruption of bilirubin binding cavity, which is formed by loops 4 of 
domain U A and loop 3 of domain-IB. Thus, it can be concluded that around 6.0 M urea. 
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Figure 4.7 (A) Relative fluorescence of bilirubin bound to 'N' isomer of HSA in the presence of 0.0 M 
( • ) , 5-0 M (*), 6.0 M (O) and 7.0 M (+) urea and 'B' isomer of HSA in the presence of 0.0 M 
(D), 3.0 M (O), 5X) M ( • ) and 6.0 M (A) urea concentrations. The Huorescence was 
recorded at 530nm after exciting the biJurubin-albumin complex at 466 nm. (B) Effect of 
urea concentrations on the bindmg of bilirubin to 'N' ( • ) and *B' (O) isomers of albumin at 
a fixed bilirubin/ albumin molar ratio of 1.0:1.0. 
unfolding and complete separation of domain-II from domain-I occurred. Similarly a marked 
decrease in bilirubin binding to N isomer of HSA at 7.0 M urea are suggestive of unfolding / 
separation of domains 1 and II from each otiier at higher urea concentrations. Loss in 
bilirubin binding cavity at lower urea concentrations in case of B isomer of HSA as 
compared to N isomer of HSA was again suggestive of significant effect of N<->B transition 
on domain I and II. 
4.2.1.6. Structural transition in domain-lU 
Diazepam binding 
Earlier studies have shown that domain m is primarily responsible for intermediate 
formation in the urea-induced unfolding transition of HSA and BSA [180-182]. Dockal et.al. 
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[115], on the basis of their studies on confonnational transition of recombinant HSA domains 
and intact HSA, concluded that domain III of HSA is not involved in the N<->B transition of 
intact molecule. In view of the above information, we checked the urea induced structural 
alterations in both isomers of the HSA by measuring the binding affinity of diazepam at 
different urea concentrations. Figure 4.8A shows the binding isotherm of diazepam with N 
and B isomers of HSA, both in the absence and presence of increasing urea concentrations. A 
continuous decrease in diazepam binding to both 
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Figure 4.8 (A) Fluorescence quench titration results of diazepam binding to 'N' isomer of HSA ( • ) and 
'N' isomer denatured with 3.0 M (A) urea concentrations and 'B' uomer of HSA in the 
absence (^) and presence of 1.0 M (D) and 3.0 M (O) urea. (B) Shows the binding isotherm 
of diazepam to N (#) and B (O) isomers of HSA as function of urea concentration at a fixed 
diazepam/albumin molar ratio of 1.2:1.0. 
isomers of HSA was noticed at increasing urea concentrations (Figure 4.8B). A significant 
decrease in diazepam binding to both isomers of HSA denatured up to 3.0 molar urea (Figure 
4.8B) indicated gradual structural alterations in domain III against domain I which retained 
its conformation up to this urea concentration. Diazepam binding to N and B isomers in the 
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absence and presence of increasing concentrations followed an almost similar pattern (figure 
4.8B). Hence, these results were also indicative of no effect of N<->B transition on domain-
Ill. These results were in agreement to earlier reports suggesting that domain-lll is much 
more labile to urea denaturation [179, 181, 186], 
Taken together, these results, i.e., urea induced unfolding curves and binding of 
domain specific ligands to HSA indicate that domain III is much more labile to denaturation 
by urea and mainly involved in intermediate formation. Moreover, domain II does not unfold 
initially, instead it undergoes structural rearrangement that is favorable for binding of its 
specific ligand, bilirubin. Interestingly, above 5.0 M urea concentration for N isomer and 3.0 
M urea for B isomer, hemin and chloroform binding significantly decreased indicating loss of 
native conformation of domain IB and IIA only after intermediate formation. Non-
involvement of domain IB during intermediate formation was further confirmed by increased 
binding of bilirubin to HSA in this concentration range of urea. Since high affinity bilirubin 
binding site is located between loops 4 eind 3 of domains IIA and IB, respectively, therefore, 
it appears that the formation of intermediate in the unfolding transition of human serum 
albumin mainly involves unfolding of domain III. Since the 'B' isomerization particularly 
affects N-terminal region [166-170] and observed intermediate is at lower urea 
concentrations, therefore, it appears that formation of intermediates in the unfolding 
transition of human serum albumin also involves unfolding of domain lA. 
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4.2.2 Urea Induced Unfolding of F isomer of Human Serum Albumin: A 
Case Study Using Multiple Probes 
4.2.2.1. Far UV circular dichroism and intrinsic fluorescence 
Figures 4.9A and B show urea induced unfolding transition curves of N and F isomers of 
human serum albumin (HSA) as monitored by the measurements of MRE at 222 nm and 
intrinsic fluorescence intensity at 340 nm after exciting the protein at 280nm. Urea induced 
unfolding of N isomer (as discussed in section 4.2.1) of HSA, followed a two-step three state 
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Figure 4.9. Urea induced unfolding profile of N ( • ) and F (O) and isomers of HSA as monitored by 
MRE measurements at 222nm (A) and intrinsic fluorescence measurements at 340 nm by 
exciting the protein at 280nm(B). The shapes (D) and (^) represent the renaturation 
points of N and F isomers of HSA obtained by diluting the denatured proteins in 8.0 IM 
urea, respectively. 
transition with accumulation of an equilibrium intermediate state (1 state) around 4.8 to 5.2 M 
urea concentration.. At pH 3.5, where HSA exist as F isomer, urea induced unfolding 
transition curve of HSA was lacking intermediate state (open circle fig 4.9A and B) observed 
in its N isomeric form around 4.8-5.2 M urea. As shown in figure 4.9 (open circle) urea 
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induced unfolding transition of F isomer started at lower urea (1.6M) concentration and also 
completed at lower urea (6.4 and 4.4 M as monitored by the measurements of MRE at 222 
nm and intrinsic fluorescence intensity at 340 nm respectively) concentration compared to N 
isomer. 
Khan and Salahuddin [163] and Dockal et al[ll51, using serum albumin fragment 
(domain III) and recombinant domain III, respectively, have provided evidence that the N—F 
transition is accompanied by major conformational changes in domain HI without affecting 
domain I and 11. Moreover, F isomer and 'I' state in the unfolding pathway of N isomer of 
HSA are found to posses similar helical contents (-40%). Taken together, absence of T state 
in the unfolding transition of F isomer, equal loss of helical structure during N'^F transition 
and T state formation and unfolding of domain III during N==*^F isomerization provide direct 
evidence that unfolding of domain III is mainly responsible for T state accumulation. The 
unfolding of F isomer may be attributed to the unfolding of domain II and I. The beginning 
of unfolding transition of F isomer at lower urea concentration can be understand in view of 
unfolding of domain III, may destabilize rest of the molecule as domains are associated by 
various interdomain interactions. 
To see the unfolding process of rest of the HSA molecule (domain 1 and H), unfolding 
transition of F isomeric form of HSA has been studied in details by using multiple tertiary 
structure probes. 
4.2.2.2. Near-UV Circular Dichroism 
The CD spectra in the near UV region were used to probe the alterations of tertiary structure 
in more details. Figure 4.10A shows the near UV CD spectra of N isomer and F isomer in the 
absence and presence of 4.4 M and 8.0 M urea concentration. At pH 7.0 two prominent 
minima at 262 and 268 nm are observed. By reducing the pH to 3.5 (F isomerization) there 
was an increase in MRE at 262 and 268nm and a decrease between 290 and 300 nm. 
denoting loss of tertiary structure in the N—F transition. These observations agree well with 
results reported previously [115]. However, at pH 3.5 there are still significant amount of CD 
signal left corresponding with spectrum at 8 M urea showing tertiary structure content of F 
isomer. Figure 4.1 OB shows the urea-induced denaturation of F isomer of HSA as monitored 
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by the measurements of MRE at 268 nm. The unfolding transition from F to U state was 
found to be a reversible single step process. The unfolding transition which corresponds to 
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Figure 4.10. Near-UV CD spectra of N isomer (solid line) and F isomer in the absence (dashed line) and 
presence of 4.4 (dashed-dotted line) and 8.0 M (dotted line) urea (A). Urea denaturation 
profile of F isomer of HSA as monitored by MRE measurements at 268nm (B) The shape 
( • ) represent the renaturation points of F Isomer of HSA obtained by diluting the 
denatured proteins in 8.0 M urea, respectively. 
the transformation of F state to U state started at 1.6 M urea and completed around 4.4 M 
urea concentration. Since near-UV CD spectra of HSA and its three domains showed 
common minima at 262 and 268 nm [159], changes in MRE at 268 nm may be ascribed to 
the conformational alteration of whole HSA molecule. 
4.2.23. Tyrosyl fluorescence 
Since HSA harbors 18 tyrosyl residues distributed among all the domains of HSA, we 
investigated the tyrosyl fluorescence to get additional insight into the structural features of F 
isomer. Figures 4.11A and B show the fluorescence spectra of F isomer in the absence and 
presence of 8.0 M urea obtained after exciting the protein at 280nm and 295 nm. 
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respectively. The contribution of tyrosine emission in the denatured form is clear when 
spectra obtained with wavelength of excitation at 280 and 295 nm are compared. A 
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Figure 4.11. Fluorescence spectra of F-isomer of HSA in the absence (1) and presence (2) of 8 M 
urea (A) monitored by exciting the protein at 280nni (A) and 295 nm (B). Figure 3C 
shows the change in fluorescence intensity monitored by F 310 / 340 ratio. The protein 
(3.5 (iM) was excited at 280nm. (• ) Represent the renaturation points. 
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emission peat: in the tyrosine emission region (300-320nm) upon denaturation was observed 
when spectra was obtain with wavelength of excitation at 280 nm (fig 4.11 A),which is absent 
in the spectra obtain with wavelength of excitation at 295 nm. No change in the FI 310/350 
ratio was seen over the urea range of 0-1.6 M while an increase in the ratio from 2 to 4.4 M 
urea was noted. The increase in the tyrosine emission indicates that tyrosyl residues have 
moved away from the lone trp-214 and energy transfer from tyrosine to tryptophan has 
vanished. The results are suggestive of unfolding and separation of HSA domains. Similar 
observation was made in other proteins during urea denaturation studies [187]. 
4.2.2.4. ANS binding: 
The urea induced unfolding transition was also monitored by ANS-protein complex 
fluorescence at 470nm after exciting the protein at 380nm. Exposure of hydrophobic surface 
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Figure 4.12. Urea induced unfolding profile of F isomer of HSA monitored by ANS fluorescence at 470 
nm after exciting the protein at 380nm. 
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to the solvent could be detected by ANS binding studies. The urea induced unfolding 
transition of F isomer monitored by ANS fluorescence was also found to be a single step 
process (figure 4.12). ANS fluorescence data showed no apparent intermediate state in urea-
induced denaturation, reflecting the absence of accumulation of hydrophobic patches. This 
may be understood in view of even exposure of hydrophobic patches during N—F 
isomerization. 
4.2.2.5. Unfolding mechanism of F isomer 
Urea induced unfolding of F isomer of HSA as followed by far-UV CD (figure 4.9A, open 
circle), intrinsic fluorescence (figure 4.9B open circle), near-UV CD (figure 4.lOB),tyrosyl 
fluorescence(figure 4.1 IC) and ANS-protein complex fluorescence (figure 4.12) was seemed 
to be cooperative one step process. This is suggestive of structural integrity of F isomer. It is 
therefore possible that main losses in a-helical contents and tertiary structure contents during 
N==^ F transition is due to unfolding of domain HI and that tertiary and secondary structural 
integrity of domain I and II is not impaired significantly. The unfolding transition of F 
isomer of HSA monitored by measurements of MRE at 222nm, MRE at 268 nm, intrinsic 
florescence at 340 nm and FI 310/350 ratio were compared by converting the data to plots of 
fraction denatured as a function of urea concentration (figure 4.13). As shown in figure 4.13 
Fd analyzed by tertiary and secondary structure probes are not overlapping, providing 
evidence that urea induced unfolding is not a simple F=*^  U two state process. Such non-
coincidental transitions indicate the probable existence of an intermediate in unfolding [188]. 
It shows that large fraction of far-UV CD in the transition region (-4.0 M urea) does not 
originate from F isomer, but from a species that has lost its tertiary contacts completely. The 
denaturation was found to be completely reversible for all the transitions studied by different 
probes. Therefore, urea induced unfolding of F isomer of HSA may be approximated to a 
three state transition and the mechanism for unfolding may be represented as following: 
^ 4 M Urea 
F ^ MGLI ^ D 
No tertiary contacts 
~ 25% a-helices 
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Where F, MGLI and D are the fast moving, molten globule like intermediate and denatured 
states of F isomer of HSA. respectively. To verify the unfolding mechanism presented in 
Figure 4.13. Normalized transition curves for urea induced unfolding or F-isomer of HSA as followed 
by measurements of MRE at 222 nm ( • ) , MRE at 268 nm (A), Intrinsic fluorescence at 
340 nm (O) after exciting the protein at 280nm, Fl 310 / 350 ratio ( • ) and Trp-214 
fluorescence at 344 nm (A) after exciting the protein at 295 nm. 
above equation, thermodynamic parameters for F— MGLI and MGLI — D processes were 
calculated according to procedure described in data analysis section (material and methods). 
The value of AGF==MGLI , AGMGLI= D and AGD and there respective m values were shown 
in table 4.1. Since MGLI is characterized by significant amount of helical contents with no 
specific tertiary structure, the second transition was monitored by measurement of MRE at 
222nm and AGMGLI=D was found to bel.2Kcal/mol. Since AGD"^° being a thermodynamic 
property does not depend on path, the total fi-ee energy change of unfolding can be obtained 
by summation of free energy change of individual steps i.e. AGF=MGLI and AGMGLI-D-
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Tabic 4.1. Thermodynamic parameters for urea induced unfolding of F isomer of HSA 
m F«MGLi rn MGLI=D 
(Kcal mol') (cal mor'M-') (cal moP'M'') 
Probe 
MRE222nm 
Fl340nm 
FI310/340 
Ratio 
AO F=MGLI 
(Kcal mor') 
2.15 
2.74 
2.05 
AGMGLI=D 
(Kcal mor') 
1.2 
— 
— 
AG"^% 
ol 
3.35 
— 
— 
MRE '268nm 2.6 
903.7 
964 
805 
1002 
987 
MRE (deg cm^ dmol'); Fl (Fluorescence intensity monitored by exciting the protein at 280 nm 
The AGD'^^° associated with F to MGLl state and finally to D state was calculated to be 3.35 
kcal/mol. The values of AGF^MGLI and m (.-« MGLI are similar, if not identical for the first 
transition (F'^ *' MGLl) whether observed by different tertiary structure probes or helical 
structure probe. These further provide evidence that 'F' isomer coverts to an intermediate 
state (so called MGLI) having significant amount of helical structure without any specific 
tertiary contacts around ~4.4 M urea concentration. This state (MGLI) melt to D state above 
4.4 M urea concentration. Such intermediate possessing significant amount of secondary 
structure without tertiary structure has been defined as intermediate of "molten globule" type. 
But the absence of binding of hydrophobic dye (ANS) to this state might be due to presence 
of high concentration of urea, which competes directly with the interaction between ANS and 
protein [151] and/or disruption of exposed hydrophobic patches due to loss of significant 
amount of secondary structure. 
4.2.2.6. Tryptophanyl fluorescence 
HSA contains only one tryptophan residue (trp-214), which resides in domain II of HSA. 
To examine the conformational variations around this residue in HSA, protein was excited at 
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295 nm, which provides no excitation of tyrosine residues and therefore neither emission nor 
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Figure 4.14. Effect of urea concentrations on lone Trp-214 fluorescence of F-isomer of HSA. The 
protein (3.5 fiM) was excited at 295nm and the (A) fluorescence intensity at 344 nm (B) 
maximum wavelength of emission was measured. 
energy transfer to the lone indole side chain. The urea induced unfolding transitions 
monitored by measurements of fluorescence intensity at 344 nm after exciting the protein at 
295nm(figure 4.I4A) and Xmax of emission (figure 4.14B) started at 0.4 M urea and tailed 
off at 4.4 M urea. The observed decrease in fluorescence intensity with shift of energy 
maximum towards longer wavelength together with loss of helical structure from 0.4 molar 
urea are suggestive of unfolding of the domain II. 
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4.2.2.7. Chloroform binding 
Recent, studies have demonstrated that chloroform binds to the HSA in the close vicinity o 
tryptophan residue (Trp-214) [118]. Since, the Trp-214 resides in domain 11, to get more insight inU 
structural changes around environment of lone Trp, binding of chloroform to F isomer of HSA 
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Figure 4.15. Chlorororm induced tryptophanyl fluorescence quenching of F isomer of HSA in the 
absence ( • ) and presence of 0.4 M (D) 2.0 M (A), 4.4M(A) and 8.0 M (O) urea 
concentrations (A). Figure B shows the effect of increasing urea concentration on the 
binding of chloroform (18mM) to F isomer of HSA. The fluorescence was monitored at 
344nm after exciting the protein at 295nm. Each data point was the mean of 3-4 
independent observations 
was studied at diflFerent urea concentrations using tryptophan fluorescence (Xex =295 nm). 
Figure 4.15A shows the chloroform binding isotherm of F isomer of HSA in the absence and 
presence of different urea concentrations. The equilibration of the protein with chloroform 
caused concentration dependent quenching of tryptophan fluorescence with no apparent shift 
in the emission maximum (344 nm, data not shown), which is suggestive of chloroform 
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binding to HSA. As siiown in figure 4.I5B, a continuous decrease in chloroform induced 
quenching of Tryptophanyl fluorescence was observed in the urea concentration range 0.4 to 
4.4 M. The above chloroform binding studies together with tryptophan fluorescence studies 
and for UV-CD studies indicated that unfolding of domain H of F isomer of HSA started at 
0.4 M urea concentration. 
4.2.2.8. Acrylamide quenching: 
O 
u. 
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Figure 4.16. Stern-Volmer plots of acrylamide quenching for N-isomer (O) and F-isomer of HSA in 
the absence ( # ) and presence of4.4M (A) and 8.01V1 (A) urea. 
The lone tryptophanyl residue (trp-214) was also examined by fluorescence quenching using 
neutral quencher, acrylamide [119]. Figure 4.16 shows Stem-Volmer plots for fluorescence 
quenching of F isomer of HSA by acrylamide at different urea concentrations. N isomer of 
HSA was also included to compare the exposure of tryptophan in both isomers. Values of 
Stem-Volmer constant (Ksv) otained from the acrylamide quenching experiments are shown 
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in table 4.2. Ksv for N isomer (4.46) was found to be higher than that for the F isomer 
(2.478) and was accompanied by a blue shift in X max from 340nm to 334nm. These result 
indicate that tryptophanyi residue of F isomer is less accessible to quenching by acryl amide 
than the N isomer. As can be seen from table 4.2 Ksv value of F isomer stared increasing 
from 0.4M urea suggesting conformational changes in domain II in the range of 0-4.4 M 
urea. It must be noted that in 8.0 M urea concentration wherein protein was considered to 
exist in a random coil conformation contained some local region probably around trp-214 
retaining residual structure as evident from the much higher Ksv of NATA (17.2) than HSA 
in 8.0 M urea (5.449) (table4.2). This was further supported by Fd value (-0.85) of F isomer 
monitored by tryptophanyi fluorescence in 8.0 M urea is less than 1.0. This was in agreement 
with pervious reports suggesting retention of native like tertiary structure within local regions 
in random coil confirmation. 
Table 4.2. Acrylamide quenching parameter of HSA 
Subject Ksv 
HSA (N Isomer) 4.46 
HSA (F Isomer) 2.48 
F isomer in 0.4 M urea 2.78 
F isomer in 2.2 M urea 3.42 
F isomer in 4.4 M urea 4.99 
F isomer in 8.0 M urea 5.45 
NATA 17.2 
*Ksv values were calculated by linear least squares fitting 
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Since HSA contains only one tryptophan (Trp-214) residue which reside in domain 11, 
changes in fluorescence properties observed after exciting the protein at 295nm, decreased 
binding of chloroform and quenching by acrylamide may be ascribed to conformational 
changes in domain 11. Thus it can be inferred that changes in domain II of F isomer occurs in 
the urea concentration range 0.4 to 6 M. further changes in fluorescence intensity observed at 
340nmm after exciting the protein at 280nm, MRE at 268 nm and Fl 310/350 ratio, in the 
urea concentration range 1.6 to 6.0 may be attributed to conformational changes in domain I 
and 11. Therefore, it appears that domain II begin to unfold before domain I. Taken together 
earlier results (section 4.2.1) as well as present investigation, it can be concluded that urea 
induced unfolding of HSA occurs from C terminal to N terminal. As discussed previously 
(part I), more stability shown by domain II than domain I in N isomeric form HSA may be 
because of its sandwich position between domains III and I. 
4.2.3. Guanidine hydrochloride denaturation of human serum albumin 
originate by local unfolding of some stable loops in domain III 
4.2.3.1. Guanidine hydrochloride induced global unfolding of human serum albumin 
Figures. 4.17A, B, and C show the guanidine hydrochloride (GnHCl) induced 
unfolding of HSA as monitored by the measurements of MRE at 222nm, MRE at 268nm and 
intrinsic fluorescence intensity at 340 nm after exciting the protein at 280 nm. GnHCl 
induced unfolding of HSA was found to be a cooperative process without any detectable 
intermediate state. The data obtained by above different probes for secondary and tertiary 
structure were normalized and analyzed (as described in data analysis section) and are shown 
in figure 4.I7D. The normalized transition curves followed by changes in the secondary and 
tertiary structure contents were found to be non-coincidental (figure 4.17D) suggesting 
existence of intermediate states in the unfolding pathway of HSA [188]. The stability of HSA 
by tertiary structure probes was in the range of 4.8 to 5.0 Kcal mol". This data fit well with 
eariier reports on chemical denaturation of HSA [180, 189, 190]. The AGD was found to be 
much more higher (-13 Kcal/mol) when MRE at 222nm was used as probe. 
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Figure 4.17. Guanidine hydrochloride denaturation profile or HSA at pH 7.0 as monitored by 
measurements of MRE at 222nm (A), MRE at 268nm (B) fluorescence measurement at 
340 nra (C) and FigureD shows the normalized transition curves for GnHCI induced 
unfolding of HSA as followed by MRE at 222nm(0), MRE at 268nm(*) and relative 
fluorescence intensity at340nm(A). 
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4J13J2. ANS-protein complex fluorescence 
Figure 4 ISA shows the GnHCl denaturation of HSA as 
monitored by measurement of protein ANS complex 
fluorescence at 470nm by exciting the protein at 
380nm. As can be seen from the figure, a gradual 
increase in ANS-protein complex fluorescence was 
observed with increasing GnHCl concentrations, 
reaching a maximum at around 1.8M GnHCl. A further 
increase of GnHCl concentration above 1.8 M led to a 
gradual decrease in the ANS fluorescence, which tailed 
off at 5.5 M GmHCl concentration. In addition to this, 
emission maxin\a showed a blue shift from 480nm to 
470nm (figure 4.18B) on increasing the GnHCl 
concentration upto 1.8M. 
50 
i 
400 WL(nm) 550 
Figure 4.18. Guanidine hydrochloride induced unfolding of HSA at pH 7.0 as monitored by ANS 
Fluorescence at 470 nm after excitation at 380 nm (A). AIMS fluorescence spectra of HSA 
in the absence (curve 1) and presence of 1.8 M (curve 2), 33 M (curve 3) and 6.0 M 
GnHCl (curve 4) concentrations (B) 
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This enhanced binding of ANS to HSA is indicative of exposure of hydrophobic regions to 
the solvent [145]. Gradual decrease in ANS binding above 1.8M GnHCl together with 
decrease in helical content indicates the disruption of hydrophobic patches due to unfolding 
of HSA. Such, noncoincidental transitions (figure 4.17D), enhanced ANS binding and native 
like secondary structure ~ 1.8 M GnHCl indicate the existence of molten globule like 
intermediate state around 1.8 M GnHCl concentrations. 
Whether all the domains of HSA undergo unfolding simultaneously or unfold 
incrementally is an important issue conceming the unfolding of HSA by GnHCl. In order to 
monitor the extent of loss of native conformation/ stmcture in individual domains of HSA at 
a particular denaturant concentration, we studied the extent of binding of domain specific 
ligands, namely hemin (for domain I), bilirubin (between domain 1 and domain II), 
chloroform (for domain II) and diazepam (for domain III) at the mid-point of transition 
monitored by tertiary structure probe (Figure 4.19). 
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Figure 4.19. Binding of domain specific ligands to HSA at mid point of GnHCl denatuntioa transition 
(Cm = 2.2M) monitored by tertiary structure probes. 
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Binding of diazepam and bilirubin is lost completely indicating disruption of native 
conformation of domain HI and complete separation of domain 11 from domain 1. On the 
other hand binding of hemin and chloroform show only slight decrease at 2.2 M GnHCI 
suggesting retention of native-like conformation of domain II and I respectively. This 
observation clearly indicates that all the domains of HSA do not unfold simultaneously; 
hence we have been prompted to study in detail the binding of these ligands to HSA under 
denaturing conditions so as to monitor the sequence of loss of native conformation of the 
domains during GnHCI unfolding process. 
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Figure4.20. (A) Fluorescence quench titration results of hemin binding to native HSA ( • ) and HSA 
denatured with difTcrcnt GnHCI concentrations viz. 1.0 M (Q), 2.0 IV1 (A), 2.4 M (O) 3.1 M ( • ) and 6.0 
M (O) at pH 7.0. (B) shows the effect of increasing GnHCI concentration on the hemin-induced 
fluorescence quenching of HSA at a fixed hemin / albumin molar ratio of 03: 1. Each data point is the 
average of 3-4 independent observations. 
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Hemin was used as a structural probe to examine the guanidine hydrochloride induced 
unfolding of domain I of HSA as X-ray crystal structure of HSA-hemin complex and ligand 
binding studies have shown a single binding site for hemin on domain I [183, 184]. Figure 
4.20A shows the binding isotherm of hemin obtained with native HSA as well as HSA 
treated with different GnHCl concentration. It is apparent from the figure that equilibration of 
native HSA with hemin caused concentration dependent quenching in the intrinsic 
fluorescence intensity, which is suggestive of the hemin binding to HSA. Figure 4.20B 
shows the effect of increasing GnHCl concentration on the hemin induced fluorescence 
intensity quenching of HSA at a fixed hemin / albumin molar ratio (0.5:1.0). A ligand / 
protein molar ratio of 0.5 was selected to ensure that all the ligand is bound to the primary 
binding site, avoiding interactions with secondary, weaker binding sites. Absence of any 
decrease in hemin binding to HSA denatured with GnHCl up to 1.4 M suggested that domain 
I did not undergo any structural change upto 1.4 M GnHCl concentration. Above 1.4 M 
GnHCl concentration, binding of hemin decreased gradually up to 3.2 M GnHCl. Sigmoidal 
pattern of decrease of hemin binding to HSA denatured with GnHCl indicated that domain I 
underwent unfolding cooperatively by a one-step process. 
4.2.3.4. Conformational transition of domain II 
a. Chloroform binding 
Johansson has demonstrated that chloroform binds to albumin in the close vicinity of a 
tryptophan residue [118]. Since HSA contains only one tryptophan residue (Trp-214), which 
resides in domain IIA, chloroform was chosen in order to investigate structural perturbations 
in domain IIA. The binding of chloroform to HSA was studied at differentGnHCI 
concentrations and the results of titration of HSA in the absence and presence of GnHCl with 
chloroform are presented in figure 4.21 A. The equilibration of native HSA with chloroform 
caused concentration dependent quenching of tryptophan fluorescence with no apparent 
shifts in the emission maxima (344 nm data not shown), which is suggestive of chloroform 
binding to HSA. Figure 4.21 B shows the effect of increasing GnHCl concentration on the 
chloroform induced tryptophan fluorescence quenching of HSA at a fixed chloroform 
concentration (l8mM). Absence of any significant decrease in chlorofonn binding to HSA 
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denatured with GnHCl up to 1.8 M concentration (figure 4.2IB) suggested that domain II did 
not undergo any significant structural change up to 1.8 M GnHCl concentration. 
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Figure4.21 A Chloroform induced tryptophan fluorescence quenching of HSA in the absence (A) and 
presence of 1.8 M (A), 2.4 M ( • ) and 3.4 M (D) and 6.0 M ( • ) GnHCl concentration. 
Figure SB shows the effect of increasing GnHCl concentration on the chloroform 
induced tryptophan fluorescence quenching of HSA at a fixed chloroform concentration 
(18 mM). Each data point is the average of 3-4 independent observations 
Above 1.8M GnHCl, binding of chlorofonn decreased continuously up to 3.4 M GnHCl. 
b. Lone tryptophanylfluorescence 
Structural perturbations in domain II were further examined by tryptophanyl 
fluorescence, since the lone Trp-214 residue is located almost centrally in helix 2 of domain 
II. Figure 4.22 shows the GnHCl induced unfolding profile of domain II of HSA obtained by 
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Figure 4.22. GnHCI denaturation profile of HSA as monitored by Trp-214 fluorescence emission at 
344 nm after exciting the protein at 296 nm. 
measuring the tryptophanyl fluorescence emission at 344 nm after exciting the protein 
selectively at 296 nm. As seen in the figure, transition started at around 2.0 M GnHCI and 
completed at approximately 3.4 M GnHCI. There was a slight blue shift in the emission 
wavelength maximum of tryptophanyl residue (towards 338rmi) at low GnHCI (< 1.2 M) 
concentration with small increase in fluorescence intensity. The observed shift of the 
emission wavelength maximum to shorter wavelengths in low GnHCI concentration was 
attributed to movement of indole side chain towards a more hydrophobic environment [188]. 
Decrease of tryptophanyl fluorescence togather with chloroform binding only at a 
concentration higher than 1.8 M GnHCI provide evidence that structural perturbation in 
domain II started after unfolding of domain III. 
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4.2.3.5. Separation of domain I from domain II 
Bilirubin binding 
For studying the separation of domains (I and II) from each other, binding of bilirubin to 
HSA was studied at different GnHCl concentrations and results are shown in figure 4.23 A 
and B. Figure 4.23A shows the binding isotherm of bilirubin obtained with native HSA as 
well as HSA treated with different GnHCl concentration as monitored bv fluore.scence 
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Figure4.23. (A ) Relative fluorescence of bilirubin bound to HSA in the presence of 0.0 M ( • ) , 1.2 M 
( • ) , 2.2 M (A) and 2.4 M (O) and 6.0 M ( • ) GnHCL The fluorescence emission was 
recorded at 530 nm after exciting the bilurubin-albumin complex at 466 nm. (B) Effect 
of increasing GnHCl concentration on the binding of bilirubin to HSA at a flxed 
bilirubin/ albumin molar ratio of 1:1. Each data point is the average of 3-4 independent 
observations 
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enhancement technique [116,117]. An optimal bilirubin/albumin molar ratio of 1.0 was 
selected for studying the effect of GnHCl on bilirubin binding. Binding of bilirubin to HSA 
increased significantly on increasing GnHCl concentration reaching a maximum value at 
~1.2 M GnHCl (Figure 4.23B). Above 1.4 M GnHCl, a marked continuous decrease in 
bilirubin binding was observed that was subsequently lost at ~2.4 M GnHCl. Increase in 
bilirubin binding to HSA at increasing GnHCl concentration carmot be due to non-specific 
interaction of GnHCl with bilirubin as no fluorescence was observed with free bilirubin at 
different GnHCl concentrations. Since the occurrence of bilirubin fluorescence is due to 
acquisition of helicity in the pigment upon binding to albumin [117], a significant increase in 
bilirubin fluorescence upon binding to GnHCl-denatured HSA as compared to native 
albumin suggests that movement of domain I and II takes place in such a way as to allow the 
bound bilirubin pigment to acquire a tight helical twisting. Marked decrease in bilirubin 
binding beyond 1.4 M GnHCl and complete loss of binding around 2.4 M GnHCl is 
suggestive of separation of domain I from the domain II. We assign the decrease in bilirubin 
binding to the separation of domain I from domain II for two reasons: first, high-affinity 
bilirubin binding site is located between loops 4 and 3 of domain II and I respectively and 
second that domain I and II retained their structural integrity at this concentration of GnHCl 
as indicated from their ability to bind to specific ligands; hemin and chloroform. 
4.2.3.6. Conformational transition of domain III 
Diazepam binding 
Accumulating evidence suggests that the primary diazepam-binding site is located in HSA 
domain III [160,183]. We therefore examined the unfolding of domain III of HSA by 
measuring its binding to diazepam at different GnHCl concentration. Figure 4.24A shows the 
binding isotherms of diazepam with HSA both in the absence and presence GnHCl. The 
binding isotherms show that diazepam induced quenching of intrinsic fluorescence intensity 
becomes constant at a ligand / protein molar ratio of 2. Figure 4.24 B shows the effect of 
increasing GnHCl concentration on the binding of diazepam at a fixed diazepam / HSA 
molar ratio of 2:1. It is evident from the figure that around 1.4 M GnHCl, there was a 
complete loss in the binding of diazepam to HSA. A gradual decrease in the diazepam 
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Figure 4.24. (A) Fluorescence quench titration results of diazepam binding to native HSA (•) and 
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Shows the binding isotherm of diazepam to HSA as a function of GnHCl concentration 
at a fixed diazepam/albumin molar ratio of 2: 1. Each data point is the average of 3-4 
independent observations 
binding witli increasing GnHCl concentrations starting from 0.2 M GnHCl indicates that 
domain III is much more labile to GnHCl as compared to domain I and II, which retain their 
ligand binding abilities upto 1.4 and 2.0 M GnHCl concentrations respectively. These results 
were in agreement to earlier reports suggesting that domain III is the most labile domain 
towards chemical and acid denaturation [179-182,189,190]. 
4.2.3.7. Stability analysis of HSA and its domains 
Figure 4.25A shows the normalized transition curve of HSA and its three domains as a 
function of GnHCl concentration whereas dependence of free energy change on denaturant 
concentration is shown in figure 4.25B. As seen in figure 4.25A, all the three domains of 
HSA unfold almost independently whereby domain III receives the first shock of denaturant 
and unfolds between 0-1.8 M GnHCl. The unfolding process of domain II and I begin only 
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after domain III is completely unfolded. Both the domains (I and II) then unfold variably in 
which domain II is the last to unfold completely. The free energies of unfolding, AG. were 
calculated to be 1.4, 4.4 and 7.4 kcal / mol for domain III, II and I respectively. The free 
energy of global unfolding of HSA was found to be- 5 and 13.4 kcal/mol,when monitored by 
probes for tertiary and secondary structure respectively. The difference in the AG of 
unfolding of HSA associated with the transition curves monitored by different spectroscopy 
probes further provide evidence for the accumulation of intermediate in the unfolding 
pathway of HSA [30, 191, 192] 
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Figure 4.25. (A) Normalized transition curves for GnHCl induced denaturation of HSA (•) and its 
domains, Domain I (O), Domain II (A) and Domain III (•). (B) shows the dependence of 
free energy change of HSA and its domains as a function of GnHCl concentration for the 
transition shown in figure A. 
Numerous reports on the chemically and enzymatically isolated domains of serum 
albumin have been published in the literature, all of which were aimed at gaining insight imo 
the structure function relationships of the different domains of the albumin molecule [166, 
167,193, 194]. Recently individual domains (Mil) of HSA have been expressed and their 
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conformational behavior in acidic and alkaline pH has been characterized [115]. As can be 
deduced from the crystal structure of HSA [159], its domains are stabilized by various 
interdomain forces, including hydrophobic and salt bridge interactions and natural borders 
(helical extensions) existing between different domains. Therefore an isolated domain cannot 
be expected to fully reflect its behavior in context of the whole protein because of the 
absence of all inter- domain contacts. The present study is an attempt to elucidate the 
conformational behavior of all the domains of intact HSA under chemically denaturing 
conditions. 
GnHCl induced unfolding of HSA appears to follow a one-step transition, as monitored 
by measurements of MRE af 222nm,MRE at 268nm and fnfrinsic fluorescence emission 
measurements at 340 nm after exciting the protein at 280nm. The noncoincidence in figure 
ID between transitions monitored by probes for secondary and tertiary structure provide 
evidence that the unfolding of HSA is not a N'^U two state reaction [188]. The existence of 
a molten globule like intermediate in the unfolding pathway of HSA has been substantiated 
by strong ANS binding atl.8M GnHCl. The two-state assumption [180] that only native and 
unfolded states exist in equilibrium might appear aberrant when each domain of a 
multidomain protein is capable to unfold / refold independently [177,195]. Further, energy 
landscape existing between the native and unfolded forms of a multi-domain protein such as 
HSA is complex and folding intermediates might be expected to accumulate. The most likely 
explanation for the one-step transition profile observed during GnHCl induced denaturation 
is that a single probe is not often sufficient to characterize the changes in different domains 
of the protein. Thus it might be desirable to use multiple probes for characterization of a 
multi-domain protein as it could provide more insight into the unfolding process of HSA. In 
this study we have used multiple probes and domain specific ligand binding to follow the 
unfolding pathway of HSA and its domains. 
Loss of native conformation in different domains of HSA was investigated by domain 
specific ligand binding study (a qualitative study). This method was used regulariy in the past 
to follow unfolding pathway,[180-182]exploiied to generate transition curves for different 
domains of HSA. We have shown that at much lower GnHCl concentration, in the range of 
0.2-1.8M, only domain three looses its ligand (diazepam) binding activity (i.e. its native 
conformation) without affecting either helical content of HSA or the native conformation of 
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domain I or II. The stability of native conformation of domain III is found to be 1.4 
Kcal/mol. Above 1.8 M GnHCl binding of ligands for domain I and II together with 
secondary structure decrease gradually upto 3.4 and 5.5 M GnHCl for domain I and II and 
secondary structure respectively. The free energy of unfolding (AGu ) of domain I and II 
were calculated to be 7.4 and 4.4 kcal / mol. 
On the basis of above discussed results a pictorial model for unfolding of HSA has 
been formulated (figure 4.26) that conclude that GnHCl induced unfolding of HSA proceeds 
via local unfolding of some stable regions/ loops in domain III and at higher GnHCl 
concentrations, all the three domain start unfolding variably, the most labile is domain III 
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Figure 4.26. A pictorial model representing the mechanism of GnHCl induced unfolding of HSA. 
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followed by domain II and I is the most stable. Moreover, the changes in helical content of 
HSA occur at higher concentration of GnHCl than the changes in local native conformation 
of domain III. This suggests that folding intermediate of molten globule type may form 
around 1.8 M GnHCl. This model is consistent w^ ith previous reports that suggest a multi-
state unfolding / folding pathway for HSA [107, 189,190]. 
4.2.3.8. Conclusion and significances 
Finally, on the basis of the results obtained in this study it is possible to conclude that 
(1) GnHCl induced unfolding of HSA is reversible and proceed via local unfolding of some 
stable loops in domain III; (2) intermediate state observed arovmd 1.8 M GnHCl has all the 
common characteristics of molten globule; and (3) MG state retained entire native helical 
structure and native conformation of domain I and II, it is only domain III that has lost native 
conformation and exist as molten globule. 
All the three domains of HSA has been cloned and successfully expressed [115] in suitable 
vectors. Recent advances of gene cloning, together with complete understanding of albumin 
structure and function, should provide for a greater abundance of future applications. 
Accordingly, our information on the relative stability of HSA and its domains should provide 
a basis for drug design, as they possess binding site for a variety of exogenous and 
endogenous ligands. Further it may provide useful information for development of proteins 
with enhanced binding activity to carry therapeutic or diagnostic agents and /or to remove 
toxic metabolites and xenobiotics [196] 
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Cficipter 5. 
EFFECT OF TRIFLUOROETHANOL ON THE 
NATIVE AND ACID INDUCED STATES OF 
GLUCOSE OXIDASE FROM ASPERGILLUS NIGER 
5.1. Introduction 
Glucose oxidase (P-D-glucose:oxygen 1-oxidoreductase, EC 1.1.3.4) from Aspergillus niger 
is a dimeric enzyme of molecular mass 160 kDa [197]. The holoenzyme is made up of two 
identical subunits of MW 80,000 D (Figure 5.1 A).The monomers are connected non-
covalently via a long but narrow contact area. There are 120 contact points between the 
dimers centered on 11 residues, which form either salt linkages or hydrogen bonds. The 
monomeric molecule is a compact spheroid with approximate dimensions 60 A x 52 A x 37 
A. The monomer folds into two structural domains (Figure 5.2 B). One of the domains binds 
FAD and the other is involved with substrate binding. The subunit contains one disulphide 
bridge. The corresponding dimensions of the dimer are 70 A x 55 A x 80 A. The minimum 
distance between the flavin and the surface of the monomer is 13 A. The two isoalloxazine 
moieties are separated by a distance of about 40 A, a distance which excludes any electrical 
communication between them [198]. 
A B 
Figure 5.1. Overall topology of Gox holoenzyme (A) Subunit structure of Gox showing FAD (red 
spacefill) (B). 
It is an acidic protein having a net negative charge of-77 at neutral pH [199], which are 
mainly due to the presence of side chain carbohydrate groups present in the amino acids 
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[198]. Under denaturing conditions, the subunits of Gox dissociate accompanied by release 
of FAD molecules [200, 201]. 
Glucose oxidase catalyses the oxidation of p-D-glucose to D-glucono-1, 5-lactone and 
hydrogen peroxide, using molecular oxygen as the electron acceptor. The initial product of 
glucose oxidation is D-glucono-1,5-lactone (Eq. 1). This is a weak competitive inhibitor of 
Gox, which hydrolyses spontaneously to gluconic acid (Eq.2). This has made it an important 
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industrial enzyme. Industrially it has find applications in the removal of glucose or oxygen 
from the food products and in the production of gluconic acid. The most important 
application of Gox is as molecular diagnostic and analytical tool as the enzyme is used in 
biosensor for the quantitative determination of D-glucose in body fluids, foodstuffs, 
beverages and fermentation products. Discovery of antibiotic properties of Gox due to 
peroxide formation has increases the interest of biochemists in the enzyme [202-206]. 
Understanding structural and folding behavior the Gox in various solvent conditions may 
provide additional insight into the function of the protein. The effect of alcohols on protein 
and peptide are useful for considering how proteins specific structures are stabilized in 
aqueous environments. Alcohols are known to disrupt tertiary and quaternary contacts by 
weakening hydrophobic interactions and strengthening a-helical propensities by promoting 
local polar (hydrogen bonding) interactions [58, 60, 61, 207]. It is also found to disrupt 
coiled-coil interactions of helical proteins and thus stabilizes non-interacting a- helices 
99 
[208]. Thus, alcohols mainly fluorinated alcohols such as TFE has been used to transform 
native and denatured proteins into molten globule like intermediate [58, 209, 210] which is 
believed to be identical to the partially folded conformations transiently accumulated in the 
early stage of folding and in in vivo folding [31] 
Very little information about the folding / unfolding aspects of Gox is currently available. 
The process of thermal denaturation of Gox is irreversible and resulted in the loss secondary 
and tertiary structure, leading to the unfolding and non specific aggregation of the enzyme 
molecules because of hydrophobic interactions of side chains [211]. The urea-induced 
unfolding of Gox was a two-state process with dissociation and unfolding of the native 
dimeric enzyme molecule occurring in a single step. On the contrary, the GdmCI-induced 
unfolding of Gox was a multiphasic process with stabilization of a conformation more 
compact than the native enzyme at low GdmCI concentrations and dissociation along with 
unfolding of enzyme at higher concentration s of GdmCI [212,213] 
The present study describes the effect of increasing concentration of trifluoroethanol 
(TFE) on the structural parameters of Gox at pH 7.0, 2.6, and 1.4. These pHs were chosen for 
the study because Gox existed in native, acid unfolded and molten globule states at these pHs 
as reported from our laboratory earlier [50]. 
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5.2. Results 
5.2.1. Far-UV Circular dichroism (CD) studies: 
The Gox from Aspergillus niger is know to exist in native, acid unfolded and molten 
globule states at pHs 7.0, 2.6 and 1.4, respectively [50]. The effect of TFE on the far-UV CD 
spectra of native (pH 7.0), acid unfolded (pH 2.6) and molten globule states of Glucose 
oxidase (pH 1.4) are shown in figures 5.2A, 5.2B and 5.2C, demonstrating pattern of 
formation of secondary structures with increasing concentration (0-50%) of TFE (v/v). Far-
UV CD spectra of the each three states of Gox revealed trough at 222nm and 208 nm typical 
of a helical structure as reported earlier [50]. TFE is known to stabilize helical structure and 
disrupt tertiary and quatemary interactions that are stabilized by hydrophobic forces [58, 60, 
61, 207]. Alterations in the ellipticity at 222nm and ratio of the ellipticity at 222nm and 
208nm (MRE222nm / MRE208nm) are useful probes for visualizing varying helical content and 
presence of (non) interacting alpha helix respectively [208]. For a non-associating alpha helix 
the ratio MRE222nm / MRE20Knm has been found to be between 0.8 and 0.9, while for two 
stranded coiled-coils, the ratio was calculated to be 1± 0.03 [214-219]. In accordance, the 
effect of increasing concentrations of TFE on MRE at 222nm and the ratio MRE222nm / 
MRE208nm are presented in figures 5.3A and B. 
At pH 7.0, the MRE at 222nm and MRE222nm / MRE208nm ratio of Gox were -6717 deg 
cm^dmol' and 1.08 respectively indicating around 15% interacting alpha helices. An small 
decrease in the ellipticity at 222nm (11.1%) and ratio MRE222nm/ MRE208nm (from 1.08 to 
0.92) were noted upon titration of the native protein with TFE up to 15%(v/v) (fig 5.3A, B 
filled circles). However, above 20% (v/v) TFE an increase in the ellipticity (-41%) with 
decrease of ratio MRE222nm / MRE208ntti (to 0.82) were observed up to 50 % (v/v) TFE, 
indicating formation of non-interacting helices. As can be seen from the figure 5.JA (open 
square), an increase in the ellipticity of acid unfolded Gox by 119 % was observed upon 
addition of the TFE upto 50%. The increase in the MRE at 222nm of UA was noted only 
above 20 % (v/v) TFE concentation. The MRE values at 222nm remained essentially 
constant between 0-20% (v/v) TFE concentration. The ratio MRE222nm / MRE208nm in the 0% 
to 30% TFE concentration increased from 0.89 to 0.96 indicative of increase in helix 
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Figure 5.2. (A) Far-LV CD spectra of Gox at pH 7.0 in the presence of 0,20,30,40 and 50 % TFE (v/v) 
upto curve 5 respectively, (B) at pH 2.6 in the presence of 0, 25, 30 40 50 % TFE (v/v) upto 
curve 5 respectively and (C) at pH 1.4 in the presence of 0, 10, 15, 20, 25, 30, 40, 50 % TFE 
(v/v) upto curve 8 respectively. 
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Figure S3. Effect of increasing concentration of trifluoroethanol on native, acid unfolded and molten 
globule states of Gox as monitored by changes in mean residue ellipticities values at 222nm (A) 
and MRE 222nm/208nm ratio (B>. 
interaction. However, at 50% TFE, the ratio decreased to 0.88 indicating redissociation of the 
helices. 
Interestingly, addition of TFE upto I5%(v/v) appears to have opposite effect on the 
backbone conformation of molten globule state of Gox that existed at pHl.4. As can be seen 
from the figure 5.2C, far-UV CD spectrum of Gox at pH 1.4 in 15% TFE (v/v) shows a 
217nm CD band indicative of formation of B-sheet conformation. Abrupt increase of the 
ratio MRE222m„/ MRE208mn to 1.3 in 15% TFE (v/v) (figure 5.3B) further provided evidence 
of alpha helix-beta to sheet conformational transition of the MG state. The increase in the 
ratio MRE222nm / MRE2081U11 was due to appearance of more prominent minimum at 217 nm 
and loss of minimum at 208 nm. However, increase in TFE concentration above 15% TFE 
(v/v) reinduced the 208nm and 222nm bands, characteristic of alpha helical conformation. 
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The intensities of these bands was found to increase (fig 2C and 3A filled triangle) on further 
addition of TFE upto 30 % (v/v), above 30% TFE (v/v) no increase in ellipticity was 
observed suggesting a saturable build-up of helical conformation in the molten globule state 
of Gox. Based on these results, it appears that TFE induced backbone conformation transition 
of Gox is highly pH and /or structure dependent. 
5.2.2. Near-UV Circular Dichroism 
Near-UV CD spectra of native state showed a prominent positive CD band at 273 nm 
(figure 5.4A). In the acid unfolded state, there was a decrease of signals in the entire region 
from 320nm to 250nm nonetheless the protein retained all the features of native proteins. 
Interestingly, at pH 1.4, the near UV CD spectra approached to native state suggesting regain 
of tertiary contacts. Solid line of figures 5.4A-C represented near-UV CD spectra of native, 
acid unfolded and molten globule states of Gox. Since all the states retained the characteristic 
CD band at 273 nm, TFE induced changes in tertiary contacts were monitored by 
measurement of MRE at 273 nm (figure 5.5). No change in the MRE at 273 nm was 
observed with native state upto 40% TFE (v/v). At 50% TFE (v/v) only around 16 % 
decrease in the MRE value was observed without any loss of characteristic spectral features. 
Acid denatured Gox seems to regain ellipticity of native state at 5% TFE (v/v) and it 
remained constant upto 25% TFE (v/v). Appearance of tertiary interaction may be due to 
mimicking hydrophobic surfaces brought about by TFE, because TFE does not only disrupt 
tertiary structure, but the hydrophobic surface areas brought about by it may mimic non 
native or possibely even native like tertiary interactions as well [220]. Above 25% TFE (v/v), 
a gradual loss of MRE values at 273nm was noted suggesting loss of tertiary structure only 
above 25% TFE (v/v). On the other hand molten globule state at pH 1.4 showed a sigmoidal 
decrease in the MRE at 273nm with increasing concentration of TFE. The transition was 
found to be started at 10% TFE and completed around 25 % TFE (v/v). A comparison of near 
UV CD spectra of the protein at pH 1.4 in the presence of 50% TFE with guanidine 
hydrochloride denatured Gox showed that MG state had lost almost all its tertiary contacts. 
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Figure 5.5. Effect of increasing concentration of trifluoroetiianol on native, acid unfolded and molten 
globule states of Gox as monitored by changes in mean residue ellipticities values at273nro 
5.2.3. Intrinsic fluorescence 
Figure 5.6A and B show the dependence on TFE concentration of the fluorescence intensity 
at 340nm and wavelength of maximum emission (A^ a^x) respectively. With an increase in TFE 
concentration, small red shift in X^^ (2nm) with slight decrease of relative fluorescence 
intensity of native Gox was observed. These findings evidently agree with the TFE induced 
near UV CD results of the native protein, which showed only small alterations in the tertiary 
structure upto 50% TFE (v/v). Acid unfolded state of Gox showed essentially no change in 
m^ax of emission and relative fluorescence intensity at 340 nm in the range 0-20% TFE (v/v) 
concentrations. At TFE concentrations above 20% (v/v) relative fluorescence intensity at 
340nm increased by -43% with red shift of 5nm from 336nm to41nm (figure 5.6A and B 
open rectangle) upto 50% TFE (v/v). On the other hand, molten globule state at pHl.4 
showed a gradual red shift of 13nm of the maximal wavelength (figure 5.6B open triangle) in 
the TFE concentration range 0-30 %. No change in the K.^ of emission was observed above 
30% TFE (v/v) which was suggestive of maximal effect of TFE on the conformation of the 
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protein at pH 1.4. At pH 1.4, TFE induced transition as measured by relative fluorescence 
intensity at 340 nm (figure 5.6B open triangle) is clearly biphasic. 
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Figure 5.6. Effect of increasing concentration of trifluoroethanol on tryptophanyl fluorescence of Gox 
states. The protein was excited at 296 nm and the (A) relative fluorescence intensity at 340 nm 
and (B) maximum wavelength of emission (X,,,,) was measured. 
As TFE was added, there was an increase (-80%) in relative fluorescence intensity between 
0-15 percent TFE (v/v) and then there is decrease in intensity as the TFE concentration was 
further increased up to 50% (v/v). 
5.2.4. ANS Binding 
Changes in ANS fluorescence are frequently used to detect intermediate conformation of 
globular proteins [145]. ANS fluorescence intensity at 480nm increased markedly beyond 
25% TFE (v/v) and was maximum (-12 times compared to native protein) in the 40-50% 
TFE (v/v) concentration range (figure 5.7 filled circle). This result suggested the presence of 
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large number of solvent accessible non-polar cluster in the protein molecules in the 40-50% 
(v/v) range of TFE. On the other hand, a sigmoidal decrease of ANS fluorescence with the 
protein states at pH 2.6 and 1.4 were observed indicating cooperative loss of exposed 
hydrophobic clusters of these states in TFE. The decrease in ANS binding with 
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Figure 5.7. Effect of increasing concentration of trifluoroetlianol on tlie ANS fluorescence intensity at 
480nm of Gox states after exciting the ANS-protein complex at 380nm. 
the protein state at pH 1.4 in the presence of 40% (v/v) TFE were comparable to 6 M GnHCl 
unfolded state of Gox, while protein states at pH 2.6 retained significant amount of ANS 
binding ability in the said concentration range of TFE. 
5.2.5. FAD Fluorescence 
Glucose oxidase contains one tightly, non-covalently bound FAD cofactor per monomer 
[198]. The FAD group has been used as a natural marker to probe the dynamical 
microenvironment of the flavin fluorophore in flavanoproteins [221, 222]. Associations / 
dissociation of FAD molecules to/ from the protein can be used to probe the tertiary and /or 
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quaternary state of the protein as the FAD fluorescence is significantly quenched for native 
dimeric Gox and a large enliancement in FAD fluorescence is observed on denaturation of 
the enzyme [223, 224]. Figure 5.8 showed the changes in FAD 
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Figure 5.8. Effect of increasing concentration of trifluoroethanol on theFAD fluorescence intensity at 
SlOnm of Gox states after exciting the FAD at 36Snm. 
fluorescence intensity at 520nm of native, acid denatured and molten globule states of Gox 
on incubation with increasing concentrations of TFE. Incubation of native and acid 
denatured Gox upto 30% and 20 % TFE (v/v) respectively did not show significant change in 
the FAD fluorescence intensity. Above these concentrations of TFE fluorescence intensity of 
both the states increase gradually upto 50% TFE (v/v). However, a continuous increase of 
FAD fluorescence of molten globule state was noted in the TFE concentration range 0-30 % 
thereafter no significant enhancement was observed. At 50% TFE (v/v), the enhancements in 
the FAD fluorescence intensity of native, acid denatured and molten globule states were 
found to be 23,44 and 63 times respectively compared to native state. It is known that under 
conditions where FAD is dissociated fi-om the enzyme, the dissociation of dimmer into 
monomer also takes place [200, 223]. Therefore, from the above results it appears that 50% 
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TFE induced state of Gox at pH 1.4 may exits in monomeric state, because maximum 
dissociation of FAD has been observed in this case. 
5.3. Discussion 
5J.1. Effect of TFE on the native Gox at pH 7.0 
In the concentration region 0-30% (v/v), TFE was found to disrupt coiled - coil state 
of native dimeric Gox without any significant change in the far-UV CD spectra between 
250nm and 200nm. Tertiary structure of the enzyme as probed by near - UV CD and 
intrinsic fluorescence measurement, binding of hydrophobic dye ANS and bind status of 
cofactor FAD were also found to be unaffected in these TFE concentration region. Beyond 
30% TFE (v/v) formation of non-interacting alpha helix had been observed and the 
maximum percentage of helix induced was 41%. Slight red shift (2nm) with small decrease 
in intensity of tryptophanyl fluorescence, about 16 % decrease of MRE value at 273 nm and 
significant dissociation of FAD were observed at 50% TFE (v/v), suggesting small but 
obvious loss of tertiary contacts. ANS, a hydrophobic dye, which has greater affinity for the 
molten globule like state shows maximum binding at 50% TFE (v/v). Taken together, it 
appears that native Gox exists in an alpha helical intermediate around 50% TFE (v/v) that has 
significant amount of exposed hydrophobic clusters, a characteristic of molten globule state. 
ANS binding in saturable manner together with high propensity of the state to aggregation on 
addition of more TFE provide clear evidence of its intermediate conformation. 
53.2. Effect of TFE on the acid denatured Gox at pH 2.6: 
Like native state, induction of alpha helix in the acid denatured state is cooperative and 
unsaturable, but induction of helices is slightly more compared to native state. Probes for 
tertiary structure near UV CD, intrinsic fluorescence and FAD fluorescence indicated 
significant loss of tertiary contacts only at high concentration of TFE. Formation of non-
native tertiary contacts have also been observed at low concentration of TFE (5% v/v) which 
remained unaffected upto 20% TFE (v/v). Binding of ANS has been also found unchanged in 
the concentration range 0 to 20% (v/v). This suggested that formation of tertiary contacts as 
shown by near UV CD spectrum in the concentration range 0-20% may be due to local 
interactions of side chain. Because interaction of side chains in TFE, even if nonspecifically 
is only possible locally [224]. Decrease of ANS binding above 20 % TFE (v/v) may be due to 
disruption of hydrophobic clusters present in the acid unfolded state of Gox. Thus around 
50% TFE, acid unfolded state of Gox existed as an open helical coil. 
5.3.3. Effect of TFE on the MG state Gox obtained at pH 1,4: 
The far UV CD spectrum of MG state of Gox at pH 1.4 is representative of alpha-
helical conformation. The far UV CD spectrum of Gox at pH 1.4 in the presence of 15% TFE 
(v/v) shows a 215nm CD band-suggesting alpha to beta sheet transition in the TFE 
concentration range 5-15 %. Probes for tertiary structure, near UV CD, intrinsic fluorescence 
shows almost complete loss of tertiary contacts. Loss of ANS binding ability and dissociation 
of FAD molecules are also maximum at this concentration. Beyond 20% TFE (v/v) 
concentration, the 208rmi and 222nm CD bands, characteristics of helical conformations are 
reinduced with further loss of tertiary structure. At 40-50% TFE (v/v) concentration 
maximum helix was induced which was almost twice the value observed in either native state 
or acid unfolded state in the presence of same concentration of TFE. 
The effect of TFE on the different states of Gox can be summarized by the following 
mechanism: 
50% TFE (v/v) 
N • I(MGL)-
pH2.6 
Alpha helical, -80 % tertiary contacts, above 50% TFE (v/v) 
exposed hydrophobic clusters 
^ Aggregations 
50% TFE (v/v) 
helical state 
15% TFE (v/v) 50% TFE (v/v) 
MG >- MGL ^ Open helical state 
Beta structure dominated 
5.4. Conclusion and significance 
In order to understand the phenomena of protein folding, all conformational state should 
be described with respect to their structure, because such conformational state might 
resemble the intermediate state along the in vivo protein-folding pathway, and thus play an 
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important role in understanding tiie mechanism of protein folding [31]. Concerning the 
present case studies formation of different intermediate states (molten globule like state in 
the presence of 50% Tl'li (v/v) at pi I 7, beta structured intermediate in the presence of 15% 
TFE (v/v) at pH 1.4 and open helical intermediates in the presence of 50% TFE (v/v) at pH 
2.6 and 1.4 suggest that folding is not a unique process and may possibly involve more than 
on pathway, as postulated by new view of protein folding. Concerning the process of protein 
folding in cell, TFE denatured state may be just as important as guanidine hydrochloride or 
urea induced state, because a similar hydrophobic environment as in the presence of TFE 
does exist for a protein during translocation through membrane [225]. 
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We report the accumulation of an acid unfolded (UA) state and a molten globule (MG) 
state in the acid induced unfolding pathway of unmodified preparation of stem brome-
lain (SB) [EC 3.4.22.32], a cystein protease from Ananas cosmosuH. The conformation of SB 
was examined over the pH 0.8-3 regions by circular dichroism, tryptophanyl fluores-
cence, l-anilino-8-naphthalenesxilfonate (ANS) binding, and tryptophanyl fluorescence 
quenching study. The pH 0.8-3.0 regions were selected to study the acid induced unfold-
ing of SB because no autolysis of the enzyme was observed in these pH regions. The 
results show that SB at pH 2.0 is maximally unfolded and characterizes by significant 
loss of secondary structure (~80%) and almost complete loss of tertiary contacts. 
However, on further decreasing the pH to 0.8 a MG state was observed, with secondary 
structure content similar to that of native protein but no tertiary structure. We also made 
a comparative study of these acid induced states of SB with acid induced states of mod-
ified stem bromelain (mSB), reported by our group earlier [Eur. J. Biochem. (2002) 269, 
47-52]. We have shown that modification of SB for inactivation significantly affects the 
N-UA transition but neither affects the UA-MG transition nor the stability of the MG state. 
Key words: acid induced unfolding, circular dichroism, molten globule, fluorescence 
quenching, stem bromlain. 
Abbreviations: ANS, l-anilino-8-naphthalenesulfoiiate; UA, acid unfolded state; CD, circular dichroism; Cm, 
mid point of transition; K^, effective coUisional quenching constant; fa, fraction of accessible fluorophore; GnHCl, 
guanidine hydrochloride; MRE, mean residue ellipticity; MG, molten globule; mSB, modified stem bromlain 
(catalitically inactive form); NATA, JV-acetyltryptophanamide; TCA, trichloroacetic acid; SB, unmodified stem 
bromelain (catal}^ically active form). 
The function of a protein depends on its ability to acquire a the structure is more organized and native like with other 
unique three-dimensional structure. Understanding how portions of the structure being less organized and the 
this process occurs is one of the great challenges in protein detailed structural characteristics are remarkably depend 
science. Proteins are known to accumulate different con- on protein species (4). 
formational states during their unfolding by various dena- The stem bromelain, from Ananas cosmosus, like other 
turants (1-3). In order to understand the phenomenon cysteine proteinases, belongs to the a + p protein class and 
of protein folding, all conformational states should be the highly similar amino acid sequences of papain (9), acti-
described with respect to their structure and function. nidin UO), proteinase il ill), chymopapain (12), and stem 
Because such conformational states might resemble the bromelain (i3) indicate that the polypeptide chains of these 
intermediate state along the in vivo protein-folding path- proteins may share a common folding pattern. This has 
way, and thus play an important role in understanding the been substantiated for the former three proteinases by 
mechanismofproteinfolding(4,5). One such intermediate detailed X-ray diffraction studies (14-16). SB like other 
state know as "molten globule" (MG) has attracted much proteolytic enzyme, undergoes autocatalysis (17, 18). To 
attention in resent years. The molten globule is a state of avoid any complication due to autolysis, active amino 
the protein possessing native Hke "format" with no global acid side chain is modified during folding/unfolding studies 
tertiary structure. The common structural characteristics e.g. in case of cysteine proteases free sulphahydril group of 
of MG state are as follow: (i) the presence of pronounced active site cysteine is blocked by caboxymethylation (19). 
amount of secondary structure, (ii) the absence of most This inactive enzyme cannot be native even if observed 
of the specific tertiary structure produced by the tight physical parameters are very similar to the active enz3rme. 
packing of side chains, (iii) the presence of loosely packed While a detailed study on the folding aspects of modified 
hydrophobic core that increases the hydrophobic surface stem bromeledn (mSB, catal3rticaUy inactive state) has 
accessible to solvent (6-S). Resent studies have shown that been made by our group (20, 21), no information about 
structure of the MG state is heterogeneous. One portion of the general folding aspects of unmodified stem bromelain 
(catalytically active) is currently available. From our ear-
*To whom correspondence should be addressed. Tel: +91-571- lier studies on the folding ofmo«Med SB (mSB), a partially 
2720388. Fax: +91-571-2721776, E-mail: rizwanhkhan® ^^^^^'^ mtermediate state was detected at pH 2.0, which 
hotmail.com; rizwanhkhanl@yahoo.com refolds t« molten globule like state around pH 0.8 (20). 
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Low versus High Molecular 
Weight Poly(ethylene glycol)-
Induced States of Stem 
Bromelain at Low pH: 
Stabilization of Molten Globule 
and Unfolded States 
Published online 12 December 2005 in Wiley InierScience (wvi'w.imerscience.wiley.com). DOI10.1002/bip.20424 
Abstract: The effect of low, medium, and high molecular weight poly(ethylene glycol) (e.g., PEG-
400, -6000, and -20,000) on the structure of the acid unfolded state of unmodified stem bromelain 
(SB) obtained at pH 2.0 has been studied by various spectroscopic methods. The conformation of 
stem bromelain at pH 2.0 exhibits substantial loss of secondary structure and almost complete loss 
of native tertiary contacts and has been termed the acid unfolded state (A^). Addition of PEG-400 
to Au led to an increase in the mean residue ellipticity (MRE) value at 222 nm, indicating formation 
ofa-helical structure. On the other hand, PEG-6000 and 20,000 led to a decrease in the MRE value 
at 222 nm, indicating unfolding of the An state. Interestingly, at 70% (w/v) PEG-400 and 40% (w/v) 
PEG-20,000, MRE values at 222 nm almost approach the native state at pH 7.0 and the unfolded 
state (6 M GnHCl) of stem bromelain, respectively. The probes for tertiary structure showed forma-
tion of normative tertiary contacts in the presence of 70% (w/v) PEG-400, while 40% (w/v) PEG-
6000 and 20,000 were found to stabilize the unfolded state of SB. An increase in binding of 1-ani-
lino 8-naphthalene sulfonic acid and a decrease in fractional accessibility of tryptophan residues 
(ij compared to Au in the presence of 70% PEG-400 indicate that the PEG-400-induced state has 
a significant amount of exposed hydrophobic patches and is more compact than Au. The results 
imply that the PEG-400-induced state has characteristics of molten globule, and higher molecular 
weight PEGs led to the unfolding of the Ay state. ® 2005 Wiley Periodicals, Inc. Biopolymers 81: 
350-359, 2006 
This article was originally published online as an accepted preprint. The "Published Online" date 
corresponds to the preprint version. You can request a copy of the preprint by emailing the 
Biopolymers editorial office at biopolymers@wiley.com 
Keywords: stem bromelain; acid unfolded state; molten globule state; circidar dichroism; 
poly(ethylene glycol) 
INTRODUCTION 
Proteins are known to unfold/refold through different 
denatured states. It is crucial to know the differences 
in residual structure between different denatured 
states along the pathway of folding, as it is believed 
that such denatured states will provide useful infor-
Correspondence to: R. H. Khan; e-mail: rizwanhkhan@hotniail. 
com or rizwanhkhanl@yahoo.com 
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mation in understanding the mechanism of protein 
folding reaction. One such intermediate state, known 
as "molten globule" (MG), has attracted much atten-
tion in recent years because it is believed to be identi-
cal to the partially folded conformation transiently 
accumulated in the early stage of folding' and in 
in vivo folding.^'^ The MG is a state of the protein 
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Intermediate formation at lower urea concentration in 'B' isomer 
of human serum albumin: a case study using domain specific ligands 
Basir Ahmad, Mohd Khursheed Alam Khan, Soghra Khatun Haq, 
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Abstract 
The urea-induced unfolding of 'N' isomer (occurring at pH 7.0) and 'B' isomer (occurring at pH 9.0) of human serum albumin 
was studied by fluorescence and circular dichroism spectroscopic measurements. Urea-induced destabilization in different domains 
of both the isomers was monitored by using domain specific ligands, hemin (domain-I), chloroform, bilirubin (domain-II), and 
diazepam (domain-III). Urea-induced denaturation of N and B isomers of HSA showed a two-step, three-state transition with 
accumulation of intermediates around 4.8-5.2 M and 3.0-3.4 M urea concentrations, respectively. During first transition (0-4.8 M 
urea for N isomer and 0-3.0 M urea for B isomer) a continuous decrease in diazepam binding suggested major conformational 
changes in domain-III prior to intermediate formation. On the other hand, binding of hemin, a ligand for domain-IB and chlo-
roform, whose binding site is located in domain-IIA remains unchanged up to 5.0 M urea for N isomer and 3.0 M urea for B isomer. 
Similarly, fluorescence intensity of Trp-214 that resides in domain-IIA remained unchanged up to the above-said urea concentra-
tions and decreased thereafter. Absence of any decrease in hemin binding, chloroform binding, and Trp-214 fluorescence suggested 
the non-involvement of domain-IB and domain-IIA in intermediate formation. A significant increase in bilirubin binding prior to 
intermediate formation showed favorable conformational rearrangement in bilirubin binding cavity formed by loop 4 of domain-IB 
and loop 3 of domain-IIA. Further, a nearly complete abolishment of bilirubin binding to both isomers around 7.0 M and 6.0 M 
urea concentrations, respectively, indicated complete separation of domain-I from domain-II from each other. From these obser-
vations it can be concluded that N to B transition of human serum albumin shifted the intermediate formation towards lower urea 
concentration (3.0-3.4 M urea for B isomer as against 4.8-5.2 M urea for N isomer). Further both the intermediates were found to 
possess similar a-helical (~39%) content and ligand binding properties. 
© 2003 Elsevier Inc. All rights reserved. 
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Human serum albumin (HSA) is a single polypeptide 
chain, multi-domain protein that aids in the transport, 
metabolism, and distribution of exogenous and endog-
enous ligands [1]. HSA consists of three homologous 
domains encompassing the complete sequence. Its 
overall native three dimensional conformation is stabi-
lized by various intra- and inter-domain forces such as 
salt bridges, hydrophobic interactions, and natural 
boundaries involving heKcal extensions hio (domain-I)-
hi (domain-II) and hio (domain-II)-hi (domain-III) 
Corresponding author. Fax : +91-571-272-1776. 
E-mail addresses: rizwanhkhan@holmail.com, rizwanhkhanl@ya-
hoo.com (R.H. Khan). 
existing between three domains of albumin [2,3]. Under 
slightly alkaline conditions, between pH 7.0 and 9.0, 
HSA as well as its bovine counterpart, BSA undergo a 
conformational change known as N«-»B transition. It is 
supposed to be a structural fluctuation, a loosening of 
the molecules with the loss of rigidity, particularly af-
fecting the N-terminal region [4-8]. It has been sug-
gested that N •-• B transition involves breaking of salt 
bridges from domain-I to domain-III, causing increased 
flexibiUty of molecules [3,9,10]. Further in the alkaline 
pH range between pH 7.0 and 9.0, HSA showed a slight 
reduction in helical content and a small increase in 
P-sheet structure [3,10]. The recombinant domains 
of HSA did not show significant alteration in their 
0006-291X/$ - see front matter © 2003 Elsevier Inc. All rights reserved. 
doi:l0.1016/j.bbrc.2003.12.069 
Available online at www sciencedirect com 
S C I E N C E f/^) D I R E C T ® • N C E ^ I 
ELSEVIER Archives of Biochemistry and Biophysics 437 (2005) 159-167 
ABB 
www elsevier com/locate/vabbi 
Urea induced unfolding of F isomer of human serum albumin: 
A case study using multiple probes 
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Abstract 
The human serum albumin is known to undergo N ;= F (neutral to fast moving) i^-imeuzation between pH 7 and '^ 5 The 
N ^ F isomenzation in\ol\es unfolding and separation ot domain III from rest ot the molecule The uiea denatuiation of N isomer 
of HSA shows two step three state transition with accumulation of an inteimediate state aiound 4 8-5 2 M uiea concentiation 
While urea induced untolding transition of F isomer of HSA does not show the intermediate ^tate observed duiing unfolding of 
N isomei Therefore it provides direct evidence that the foimation of intermediate in the untolding transition ot HSA involves 
unfolding of domain III Although urea induced untolding of F isomer of HSA appears to be an one step piocess, but no coinci-
dence between the equilibrium transitions moniioied b\ tryptophanyl fluorescence tyrosyl fluorescence. fai-UV CD and near-UV 
CD spectroscopic techniques provides decisive evidence that unfolding of F isomer of HSA is not a two state piocess An interme-
diate state that retained significant amount of secondary structure but no tertiary structure has been identified (around 4 4 M urea) 
in the unfolding pathway of F isomer The emission of Trp-214 (located in domain II) and its mode of quenching by acrvlamide and 
binding of chloroform indicate that unfolding of F isomer stait from domain 11 (from 0 4 M uiea) But at higher uiea concentration 
(above 1 6 M) both the domain unfold simultaneously and the protein acquire random coil structure around 8 0 M urea Fuither 
much higher K^s of NATA (17 2) than completely denatuied F isomer (5 45) of HSA (8 0 M urea) suggests the existence of residual 
tertiary contacts within local regions m random coil confoimation (probably around lone Trp-214) 
© 2005 Elsevier Inc All rights reserved 
Ke\nord^ N == F isomenzation, Urea denaturation, Chloroform binding, Multidomain protein Human serum albumin 
Over the past four decades, much reseaich has been 
focused on two central questions what are the determi-
nants of the protein structures, and how does a polypep-
tide fold to its unique biologically active state'' Folding 
of a protein in in vitro is likely to differ in many details 
from that in the cell However, one feature, which is 
common in both in \ itro and in vivo folding, is the exis-
tence of the intermediate conformational state on the 
folding-unfoIding pathway [1,2] Recent advances in 
biophysical techniques [3,4] have shown the presence 
of stable intermediate conformational states in a number 
Corresponding author Fax -1-91 571 2721776 
E-mail addresses rizwanhkhan@hotmail com, 
yahoo com (R H Khan) 
rizwanhkhanl® 
of proteins [5-8] Theie has been considerable interest in 
characterizing these paitially folded states for gaining an 
insight into the possible determinants of the piotein 
folds and the mechanism of protein folding [9-14] The 
folding process is even more complex in multidomain 
proteins where each domain may be capable to un-
fold/refold independently and interdomain interactions 
may affect the overall folding topology of the proteins 
[15-17] 
Human serum albumin (HSA) is a monomeric. mul-
ti-domain protein of 66 5 kDa It consists of three 
' Abbreviations used HSA human serum albumin MRE mean 
residue elhpticity, I state intermediate state 
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Guanidine hydrochloride denaturation of human serum albumin originates 
by local unfolding of some stable loops in domain III 
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Abstract 
The effect of guanidine hydrochlonde (GnHCl) on the global stability of human serum albumin (HSA) has been studied by fluorescence 
and circular dichroism spectroscopic measurements The differential stability of native conformation of three HSA domains were explored by 
using domain-specific ligands, hemin (domain I), chloroform (domain II), bilirubin (at domain I/domain 11 interface) and diazepam (domain 
III) GnHCl induced unfolding transition curves as monitored by probes for secondary and tertiary structures were cooperative but 
noncoincidental A strong ANS binding to the protein was observed around 1 8 M GnHCl, suggesting existence of intermediate states in the 
unfolding pathway of HSA A gradual decrease (m the GnHCl concentration range 0 0-1 8 M) m the bmdmg of diazepam indicates that 
domain III is the most labile to GnHCl denaturation A significant increase in the binding of bilirubin up to 1 4 M GnHCl and decrease 
thereafter leadmg to complete abolishment of bihrubin binding at around 2 0 M GnHCl suggest favorable rearrangement and separation of 
domains I and II at 1 4 and 2 0 M GnHCl concentration, respectively Above 1 6 M GnHCl, decrease of the binding of hemin, a ligand for 
domain 1, chloroform, which binds in domain II and lone tryptophanyl fluorescence (Tip-214 located in domain II) indicate that at higher 
concentration of GnHCl domains I and II start unfolding simultaneously but the stability of domain I (7 4 Kcal/mol) is much more than 
domain II (4 3 Kcal/mol) A pictonal model for the unfolding of HSA domains, consistent with all these results, has been formulated, 
suggesting that domain III is the most labile followed by domain II while domain I is the most stable A molten globule like state of domain 
III around 1 8 M GnHCl has also been identified and charactenzed 
© 2005 Elsevier B V All rights reserved 
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1. Introduction 
Human serum albumm (HSA) is a monomenc, multi-
domain protem of 585 ammo acid residues It is composed 
of three homologous domains I-III, which are further 
divided into sub domains A and B [1,2] The most 
outstanding property of serum albumin is its ability to 
bind a variety of endogenous and exogenous hgands, and 
Abbreviations Dom, domain, FQ, fraction denatured, Fn, fraction 
native, GnHCl, Guanidine hydrochlonde, HSA, Human serum albumm, 1, 
intermediate state, N, native state, Trp, tryptophan, U, unfolded state 
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much of the interest m this protein denves from its effects 
on drug dehvery [3 6] The locations of vanous ligand-
binding sites have been assigned to some domain or sub 
domain in the past [1,6,7] In the light of such domain-
specific binding properties of vanous hgands to HSA, 
ligand-binding study becomes an interesting probe to 
monitor conformational alterations in the domains dunng 
unfolding of HSA [8-10] 
The unfolding of proteins by chemical denaturants under 
in vitro conditions has received greater attention as vanous 
partially folded intermediates have been found to accumu-
late dunng equilibnum unfolding of a number of proteins 
[11-13] There has been considerable interest in characte-
nzing these partially folded states for gaining insight into 
the possible mechanism of protein folding [14,15] How-
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Protein Folding: From Hypothesis Driven to Data Mining 
Basir Ahmad and Rizwan Hasan Khan 
Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh UP, India, 2002 
Abstract: There has been considerable progress made over the past year m both theoretical and experimental 
studies of protein folding In this review different aspects of protein folding phenomena is outlined and recent 
approaches which provide recent understanding of protein foldmg problem are described. The different types 
of protem substructures and intermediate states that have possible imphcation in protein folding have been 
discussed The vanous theoretical models and experimental developments that are being evolved to obtam a 
more detailed understanding of this complex process are tabulated and some are descnbed. In vivo protem 
folding and human diseases has been covered in a separate section to highhght the possible role of protem 
folding m vanous inhented and non-inhented diseases The m stltco approach of protein folding has been 
covered in great detail as because biomolecular simulation to protein folding is expected to shed significant 
light mto this process Blue gene is expected to enable a tremendous mcrease m the scale of simulation studies 
that can be earned out as compared with existing siperccmputers The data mining and analyzing from in vivo, 
m vitro and in silico approaches of folding may provide certam common trend that will lead to a unified 
mechanism of protem foldmg 
Key words: Protem flooding problem, autonomous folding units, energy landscape, molten globule. Blue gene 
INTRODUCTION 
The genehc infonnation encoded m DNA is 
expressed only after the unique three-dimensional 
structure is formed from newly synthesized polypeptide 
cham Thus the central dogma DNA-»-»-RNA-+protem is 
all about protem biogenesis The efforts to answer two 
central questions what are the determinants of protem 
structure and how does a linear polypeptide cham 
acquires its native structure has been addressed as 
protem folding problem From the classical experiment of 
Anfinsen''' to recent advancement of biophysical 
techniques'^' seem to have shifted protein-folding field 
from hypothesis dnven to data mining The emergence of 
computational biology has added another dimension to 
this field. The accumulation of larger data sets from all 
kind of proteins is needed for unraveling the second-
generation genetic code (folding code), which causes the 
linear sequence of ammo acid to acquire umque structure 
withm a reasonable time 
Understanding protein-foldmg problem is not just a 
scientific curiosity, it has also application m medicme, 
biotechnology and synthetic chemistry (Table 1) For 
example this information could be helpful in designmg the 
protem that are resistance to denaturation or to 
proteolysis, or m engmeerir^ proteins with new 
functions It may also provide important clues to the 
cause of certam disease that appears to involve 
misfoldmg or toxic folding of protein. This diverse 
apphcations m different field of biology necessitate an 
understanding of the folding process both m in vitro, 
in VIVO and also in silico Here we have tned to 
accumulate the major works, which has been earned to 
solve this problem 
Protein folding in vitro: Major advances m elucidatmg 
the foldmg mechamsm of proteins have been made m test 
tubes The unfolding/refoldmg of proteins occurs m 
submilhsecond''''', is reversible''' and vanous partially 
folded states accumulate dunr^ equilibnum unfolding of 
a number of proteins'''' These findings gave the concept 
of native intermediate and denatured states of the protem 
Native state: The three dimensional biologically active 
confoimation that a protem posses m its native 
environment It is the state where the mteratomic and 
intermolecular mteractions are maximum, the conformation 
IS quite ngid with a very low free energy*'"' 
Denatured state: The denatured state is an ensemble of 
energetically comparable conformational state possessing 
least possible mteractions with flexible structure more like 
a random coil'"' 
Intermediate states: A large number of proteins have 
been shown to accumulate mtermediate conformations 
Corresponding Author: Rizwan Hasan Khan, Interdisciplinary Biotechnology Unit, Ahgarh Muslim University, 
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